<!DOCTYPE html>
<html class="client-nojs vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled" lang="en" dir="ltr">
<head>
<meta charset="UTF-8">
<title>Non-alcoholic fatty liver disease - Wikipedia</title>
<script>document.documentElement.className="client-js vector-feature-language-in-header-enabled vector-feature-language-in-main-page-header-disabled vector-feature-sticky-header-disabled vector-feature-page-tools-pinned-disabled vector-feature-toc-pinned-enabled vector-feature-main-menu-pinned-disabled vector-feature-limited-width-enabled vector-feature-limited-width-content-enabled vector-feature-zebra-design-disabled";(function(){var cookie=document.cookie.match(/(?:^|; )enwikimwclientprefs=([^;]+)/);if(cookie){var featureName=cookie[1];document.documentElement.className=document.documentElement.className.replace(featureName+'-enabled',featureName+'-disabled');}}());RLCONF={"wgBreakFrames":false,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ff7ebd47-d4cd-4fd7-82d8-dd12a121ee36","wgCSPNonce":false,
"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Non-alcoholic_fatty_liver_disease","wgTitle":"Non-alcoholic fatty liver disease","wgCurRevisionId":1161272202,"wgRevisionId":1161272202,"wgArticleId":6319906,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 French-language sources (fr)","CS1: long volume value","Articles with short description","Short description is different from Wikidata","Good articles","Articles needing additional references from August 2022","All articles needing additional references","Articles to be expanded from January 2022","All articles to be expanded","Articles using small message boxes","Articles containing potentially dated statements from 2018","All articles containing potentially dated statements","Articles containing potentially dated statements from 2021","Diseases of liver","Hepatitis"],"wgPageViewLanguage":"en","wgPageContentLanguage":
"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Non-alcoholic_fatty_liver_disease","wgRelevantArticleId":6319906,"wgIsProbablyEditable":true,"wgRelevantPageIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgFlaggedRevsParams":{"tags":{"status":{"levels":1}}},"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"wgMFDisplayWikibaseDescriptions":{"search":true,"watchlist":true,"tagline":false,"nearby":true},"wgWMESchemaEditAttemptStepOversample":false,"wgWMEPageLength":100000,"wgNoticeProject":"wikipedia","wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wgPopupsFlags":10,"wgULSCurrentAutonym":"English","wgEditSubmitButtonLabelPublish":true,"wgCentralAuthMobileDomain":false,"wgULSPosition":"interlanguage","wgULSisCompactLinksEnabled":true,"wgULSisLanguageSelectorEmpty":false,"wgWikibaseItemId":"Q1546498","GEHomepageSuggestedEditsEnableTopics":true,"wgGETopicsMatchModeEnabled":false,
"wgGEStructuredTaskRejectionReasonTextInputEnabled":false,"wgGELevelingUpEnabledForUser":false};RLSTATE={"skins.vector.user.styles":"ready","ext.globalCssJs.user.styles":"ready","site.styles":"ready","user.styles":"ready","skins.vector.user":"ready","ext.globalCssJs.user":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.page.gallery.styles":"ready","ext.tmh.player.styles":"ready","codex-search-styles":"ready","skins.vector.styles":"ready","skins.vector.icons":"ready","jquery.makeCollapsible.styles":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.wikimediaBadges":"ready","ext.uls.interlanguage":"ready","wikibase.client.init":"ready"};RLPAGEMODULES=["ext.cite.ux-enhancements","ext.tmh.player","site","mediawiki.page.ready","jquery.makeCollapsible","mediawiki.toc","skins.vector.js","mmv.head","mmv.bootstrap.autostart","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eventLogging",
"ext.wikimediaEvents","ext.navigationTiming","ext.cx.eventlogging.campaigns","ext.quicksurveys.init","ext.centralNotice.geoIP","ext.centralNotice.startUp","ext.gadget.ReferenceTooltips","ext.gadget.charinsert","ext.gadget.extra-toolbar-buttons","ext.gadget.switcher","ext.centralauth.centralautologin","ext.popups","ext.echo.centralauth","ext.uls.compactlinks","ext.uls.interface","ext.cx.uls.quick.actions","wikibase.client.vector-2022","ext.growthExperiments.SuggestedEditSession"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@12s5i",function($,jQuery,require,module){mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=codex-search-styles%7Cext.cite.styles%7Cext.tmh.player.styles%7Cext.uls.interlanguage%7Cext.visualEditor.desktopArticleTarget.noscript%7Cext.wikimediaBadges%7Cjquery.makeCollapsible.styles%7Cmediawiki.page.gallery.styles%7Cskins.vector.icons%2Cstyles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector-2022">
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=vector-2022"></script>
<meta name="ResourceLoaderDynamicStyles" content="">
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=vector-2022">
<meta name="generator" content="MediaWiki 1.41.0-wmf.13">
<meta name="referrer" content="origin">
<meta name="referrer" content="origin-when-crossorigin">
<meta name="referrer" content="origin-when-cross-origin">
<meta name="robots" content="max-image-preview:standard">
<meta name="format-detection" content="telephone=no">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/1200px-Stage_of_liver_damage_high.jpg">
<meta property="og:image:width" content="1200">
<meta property="og:image:height" content="630">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/800px-Stage_of_liver_damage_high.jpg">
<meta property="og:image:width" content="800">
<meta property="og:image:height" content="420">
<meta property="og:image" content="https://upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/640px-Stage_of_liver_damage_high.jpg">
<meta property="og:image:width" content="640">
<meta property="og:image:height" content="336">
<meta name="viewport" content="width=1000">
<meta property="og:title" content="Non-alcoholic fatty liver disease - Wikipedia">
<meta property="og:type" content="website">
<link rel="preconnect" href="//upload.wikimedia.org">
<link rel="alternate" media="only screen and (max-width: 720px)" href="//en.m.wikipedia.org/wiki/Non-alcoholic_fatty_liver_disease">
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit">
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png">
<link rel="icon" href="/static/favicon/wikipedia.ico">
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)">
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd">
<link rel="canonical" href="https://en.wikipedia.org/wiki/Non-alcoholic_fatty_liver_disease">
<link rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/deed.en">
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom">
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<link rel="dns-prefetch" href="//login.wikimedia.org">
</head>
<body class="skin-vector skin-vector-search-vue mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject mw-editable page-Non-alcoholic_fatty_liver_disease rootpage-Non-alcoholic_fatty_liver_disease skin-vector-2022 action-view"><a class="mw-jump-link" href="#bodyContent">Jump to content</a>
<div class="vector-header-container">
	<header class="vector-header mw-header">
		<div class="vector-header-start">
			<nav class="vector-main-menu-landmark" aria-label="Site" role="navigation">
				
<div id="vector-main-menu-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-main-menu-dropdown vector-button-flush-left vector-button-flush-right"  >
	<input type="checkbox"
		id="vector-main-menu-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-main-menu-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Main menu"
		
	/>
	<label
		id="vector-main-menu-dropdown-label"
		for="vector-main-menu-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-menu mw-ui-icon-wikimedia-menu"></span>


		<span class="vector-menu-heading-label">Main menu</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


				<div id="vector-main-menu-unpinned-container" class="vector-unpinned-container">
		
<div id="vector-main-menu" class="vector-main-menu vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-main-menu-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="main-menu-pinned"
	data-pinnable-element-id="vector-main-menu"
	data-pinned-container-id="vector-main-menu-pinned-container"
	data-unpinned-container-id="vector-main-menu-unpinned-container"
>
	<div class="vector-pinnable-header-label">Main menu</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-main-menu.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-main-menu.unpin">hide</button>
</div>

	
<div id="p-navigation" class="vector-menu mw-portlet mw-portlet-navigation"  >
	<div class="vector-menu-heading">
		Navigation
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-mainpage-description" class="mw-list-item"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z"><span>Main page</span></a></li><li id="n-contents" class="mw-list-item"><a href="/wiki/Wikipedia:Contents" title="Guides to browsing Wikipedia"><span>Contents</span></a></li><li id="n-currentevents" class="mw-list-item"><a href="/wiki/Portal:Current_events" title="Articles related to current events"><span>Current events</span></a></li><li id="n-randompage" class="mw-list-item"><a href="/wiki/Special:Random" title="Visit a randomly selected article [x]" accesskey="x"><span>Random article</span></a></li><li id="n-aboutsite" class="mw-list-item"><a href="/wiki/Wikipedia:About" title="Learn about Wikipedia and how it works"><span>About Wikipedia</span></a></li><li id="n-contactpage" class="mw-list-item"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us" title="How to contact Wikipedia"><span>Contact us</span></a></li><li id="n-sitesupport" class="mw-list-item"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us by donating to the Wikimedia Foundation"><span>Donate</span></a></li></ul>
		
	</div>
</div>

	
	
<div id="p-interaction" class="vector-menu mw-portlet mw-portlet-interaction"  >
	<div class="vector-menu-heading">
		Contribute
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="n-help" class="mw-list-item"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia"><span>Help</span></a></li><li id="n-introduction" class="mw-list-item"><a href="/wiki/Help:Introduction" title="Learn how to edit Wikipedia"><span>Learn to edit</span></a></li><li id="n-portal" class="mw-list-item"><a href="/wiki/Wikipedia:Community_portal" title="The hub for editors"><span>Community portal</span></a></li><li id="n-recentchanges" class="mw-list-item"><a href="/wiki/Special:RecentChanges" title="A list of recent changes to Wikipedia [r]" accesskey="r"><span>Recent changes</span></a></li><li id="n-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_upload_wizard" title="Add images or other media for use on Wikipedia"><span>Upload file</span></a></li></ul>
		
	</div>
</div>

	
<div class="vector-main-menu-action vector-main-menu-action-lang-alert">
	<div class="vector-main-menu-action-item">
		<div class="vector-main-menu-action-heading vector-menu-heading">Languages</div>
		<div class="vector-main-menu-action-content vector-menu-content">
			<div class="mw-message-box-notice vector-language-sidebar-alert mw-message-box">Language links are at the top of the page across from the title.</div>
		</div>
	</div>
</div>

</div>

				</div>

	</div>
</div>
		</nav>
			
<a href="/wiki/Main_Page" class="mw-logo">
	<img class="mw-logo-icon" src="/static/images/icons/wikipedia.png" alt=""
		aria-hidden="true" height="50" width="50">
	<span class="mw-logo-container">
		<img class="mw-logo-wordmark" alt="Wikipedia"
			src="/static/images/mobile/copyright/wikipedia-wordmark-en.svg" style="width: 7.5em; height: 1.125em;">
		<img class="mw-logo-tagline"
			alt="The Free Encyclopedia"
			src="/static/images/mobile/copyright/wikipedia-tagline-en.svg" width="117" height="13" style="width: 7.3125em; height: 0.8125em;">
	</span>
</a>

		</div>
		<div class="vector-header-end">
			
<div id="p-search" role="search" class="vector-search-box-vue  vector-search-box-collapses vector-search-box-show-thumbnail vector-search-box-auto-expand-width vector-search-box">
	<a href="/wiki/Special:Search"
	
		id=""
		class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only search-toggle"
		title="Search Wikipedia [f]"accesskey="f"><span class="vector-icon mw-ui-icon-search mw-ui-icon-wikimedia-search"></span>

<span>Search</span>
	</a>
	
	<div class="vector-typeahead-search-container">
		<div class="cdx-typeahead-search cdx-typeahead-search--show-thumbnail cdx-typeahead-search--auto-expand-width">
			<form action="/w/index.php" id="searchform" class="cdx-search-input cdx-search-input--has-end-button">
				<div id="simpleSearch" class="cdx-search-input__input-wrapper"  data-search-loc="header-moved">
					<div class="cdx-text-input cdx-text-input--has-start-icon">
						<input
							class="cdx-text-input__input"
							 type="search" name="search" placeholder="Search Wikipedia" aria-label="Search Wikipedia" autocapitalize="sentences" title="Search Wikipedia [f]" accesskey="f" id="searchInput"
							
						>
						<span class="cdx-text-input__icon cdx-text-input__start-icon"></span>
					</div>
					<input type="hidden" name="title" value="Special:Search">
				</div>
				<button class="cdx-button cdx-search-input__end-button">Search</button>
			</form>
		</div>
	</div>
</div>

			<nav class="vector-user-links" aria-label="Personal tools" role="navigation" >
	
<div id="p-vector-user-menu-overflow" class="vector-menu mw-portlet mw-portlet-vector-user-menu-overflow"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Non-alcoholic+fatty+liver+disease" title="You are encouraged to create an account and log in; however, it is not mandatory"><span>Create account</span></a></li><li id="pt-login-2" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Non-alcoholic+fatty+liver+disease" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span>Log in</span></a></li></ul>
		
	</div>
</div>

	
<div id="vector-user-links-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-user-menu vector-button-flush-right vector-user-menu-logged-out"  title="Log in and more options" >
	<input type="checkbox"
		id="vector-user-links-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-user-links-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Personal tools"
		
	/>
	<label
		id="vector-user-links-dropdown-label"
		for="vector-user-links-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-ellipsis mw-ui-icon-wikimedia-ellipsis"></span>


		<span class="vector-menu-heading-label">Personal tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


		
<div id="p-personal" class="vector-menu mw-portlet mw-portlet-personal user-links-collapsible-item"  title="User menu" >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-createaccount" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Non-alcoholic+fatty+liver+disease" title="You are encouraged to create an account and log in; however, it is not mandatory"><span class="vector-icon mw-ui-icon-userAdd mw-ui-icon-wikimedia-userAdd"></span> <span>Create account</span></a></li><li id="pt-login" class="user-links-collapsible-item mw-list-item"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Non-alcoholic+fatty+liver+disease" title="You&#039;re encouraged to log in; however, it&#039;s not mandatory. [o]" accesskey="o"><span class="vector-icon mw-ui-icon-logIn mw-ui-icon-wikimedia-logIn"></span> <span>Log in</span></a></li></ul>
		
	</div>
</div>

<div id="p-user-menu-anon-editor" class="vector-menu mw-portlet mw-portlet-user-menu-anon-editor"  >
	<div class="vector-menu-heading">
		Pages for logged out editors <a href="/wiki/Help:Introduction" aria-label="Learn more about editing"><span>learn more</span></a>
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="pt-anoncontribs" class="mw-list-item"><a href="/wiki/Special:MyContributions" title="A list of edits made from this IP address [y]" accesskey="y"><span>Contributions</span></a></li><li id="pt-anontalk" class="mw-list-item"><a href="/wiki/Special:MyTalk" title="Discussion about edits from this IP address [n]" accesskey="n"><span>Talk</span></a></li></ul>
		
	</div>
</div>

	
	</div>
</div>
</nav>

		</div>
	</header>
</div>
<div class="mw-page-container">
	<div class="mw-page-container-inner">
		<div class="vector-main-menu-container ">
			<div id="mw-navigation">
				<nav id="mw-panel" class="vector-main-menu-landmark" aria-label="Site" role="navigation">
					<div id="vector-main-menu-pinned-container" class="vector-pinned-container">
				
					</div>
		</nav>
			</div>
		</div>
		<div class="vector-sitenotice-container">
			<div id="siteNotice"><!-- CentralNotice --></div>
		</div>
		<input type="checkbox" id="vector-toc-collapsed-checkbox" class="vector-menu-checkbox">
		<nav id="mw-panel-toc" role="navigation" aria-label="Contents" data-event-name="ui.sidebar-toc" class="mw-table-of-contents-container vector-toc-landmark vector-sticky-pinned-container">
			<div id="vector-toc-pinned-container" class="vector-pinned-container">
					<div id="vector-toc" class="vector-toc vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-toc-pinnable-header vector-pinnable-header-pinned"
	data-feature-name="toc-pinned"
	data-pinnable-element-id="vector-toc"
	
	
>
	<h2 class="vector-pinnable-header-label">Contents</h2>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-toc.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-toc.unpin">hide</button>
</div>


	<ul class="vector-toc-contents" id="mw-panel-toc-list">
		<li id="toc-mw-content-text"
			class="vector-toc-list-item vector-toc-level-1">
			<a href="#" class="vector-toc-link">
				<div class="vector-toc-text">(Top)</div>
			</a>
		</li>
		<li id="toc-Definition"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Definition">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">1</span>Definition</div>
		</a>
		
		<ul id="toc-Definition-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Signs_and_symptoms"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Signs_and_symptoms">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">2</span>Signs and symptoms</div>
		</a>
		
			<button aria-controls="toc-Signs_and_symptoms-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Signs and symptoms subsection</span>
			</button>
		
		<ul id="toc-Signs_and_symptoms-sublist" class="vector-toc-list">
			<li id="toc-Comorbidities"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Comorbidities">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">2.1</span>Comorbidities</div>
			</a>
			
			<ul id="toc-Comorbidities-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Risk_factors"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Risk_factors">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">3</span>Risk factors</div>
		</a>
		
			<button aria-controls="toc-Risk_factors-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Risk factors subsection</span>
			</button>
		
		<ul id="toc-Risk_factors-sublist" class="vector-toc-list">
			<li id="toc-Genetics"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Genetics">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.1</span>Genetics</div>
			</a>
			
			<ul id="toc-Genetics-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-From_diet"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#From_diet">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.2</span>From diet</div>
			</a>
			
			<ul id="toc-From_diet-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-From_lifestyle"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#From_lifestyle">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">3.3</span>From lifestyle</div>
			</a>
			
			<ul id="toc-From_lifestyle-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Pathophysiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Pathophysiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">4</span>Pathophysiology</div>
		</a>
		
			<button aria-controls="toc-Pathophysiology-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Pathophysiology subsection</span>
			</button>
		
		<ul id="toc-Pathophysiology-sublist" class="vector-toc-list">
			<li id="toc-Fructose_consumption"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Fructose_consumption">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.1</span>Fructose consumption</div>
			</a>
			
			<ul id="toc-Fructose_consumption-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Insulin_resistance"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Insulin_resistance">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.2</span>Insulin resistance</div>
			</a>
			
			<ul id="toc-Insulin_resistance-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Dysbiosis"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Dysbiosis">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">4.3</span>Dysbiosis</div>
			</a>
			
			<ul id="toc-Dysbiosis-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Diagnosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Diagnosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">5</span>Diagnosis</div>
		</a>
		
			<button aria-controls="toc-Diagnosis-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Diagnosis subsection</span>
			</button>
		
		<ul id="toc-Diagnosis-sublist" class="vector-toc-list">
			<li id="toc-Blood_tests"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Blood_tests">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.1</span>Blood tests</div>
			</a>
			
			<ul id="toc-Blood_tests-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Imaging"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Imaging">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.2</span>Imaging</div>
			</a>
			
			<ul id="toc-Imaging-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Liver_biopsy"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Liver_biopsy">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">5.3</span>Liver biopsy</div>
			</a>
			
			<ul id="toc-Liver_biopsy-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Management"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Management">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">6</span>Management</div>
		</a>
		
			<button aria-controls="toc-Management-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Management subsection</span>
			</button>
		
		<ul id="toc-Management-sublist" class="vector-toc-list">
			<li id="toc-Lifestyle"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Lifestyle">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.1</span>Lifestyle</div>
			</a>
			
			<ul id="toc-Lifestyle-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Diet"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Diet">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2</span>Diet</div>
			</a>
			
			<ul id="toc-Diet-sublist" class="vector-toc-list">
				<li id="toc-Vitamin_E"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Vitamin_E">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.1</span>Vitamin E</div>
			</a>
			
			<ul id="toc-Vitamin_E-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Red_yeast_rice"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Red_yeast_rice">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.2</span>Red yeast rice</div>
			</a>
			
			<ul id="toc-Red_yeast_rice-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Essential_phospholipids"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Essential_phospholipids">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.3</span>Essential phospholipids</div>
			</a>
			
			<ul id="toc-Essential_phospholipids-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Choline"
			class="vector-toc-list-item vector-toc-level-3">
			<a class="vector-toc-link" href="#Choline">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.2.4</span>Choline</div>
			</a>
			
			<ul id="toc-Choline-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
		</li>
		<li id="toc-Physical_activity"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Physical_activity">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.3</span>Physical activity</div>
			</a>
			
			<ul id="toc-Physical_activity-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Medication"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medication">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.4</span>Medication</div>
			</a>
			
			<ul id="toc-Medication-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Surgery"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Surgery">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.5</span>Surgery</div>
			</a>
			
			<ul id="toc-Surgery-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Screening"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Screening">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.6</span>Screening</div>
			</a>
			
			<ul id="toc-Screening-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Transplantation"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Transplantation">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.7</span>Transplantation</div>
			</a>
			
			<ul id="toc-Transplantation-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Related_complications"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Related_complications">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">6.8</span>Related complications</div>
			</a>
			
			<ul id="toc-Related_complications-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Prognosis"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Prognosis">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">7</span>Prognosis</div>
		</a>
		
		<ul id="toc-Prognosis-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Epidemiology"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Epidemiology">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">8</span>Epidemiology</div>
		</a>
		
		<ul id="toc-Epidemiology-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-History"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#History">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">9</span>History</div>
		</a>
		
		<ul id="toc-History-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Society_and_culture"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Society_and_culture">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">10</span>Society and culture</div>
		</a>
		
			<button aria-controls="toc-Society_and_culture-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Society and culture subsection</span>
			</button>
		
		<ul id="toc-Society_and_culture-sublist" class="vector-toc-list">
			<li id="toc-Political_recommendations"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Political_recommendations">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.1</span>Political recommendations</div>
			</a>
			
			<ul id="toc-Political_recommendations-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Lobbying"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Lobbying">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">10.2</span>Lobbying</div>
			</a>
			
			<ul id="toc-Lobbying-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-Children"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Children">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">11</span>Children</div>
		</a>
		
		<ul id="toc-Children-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-Research"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#Research">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">12</span>Research</div>
		</a>
		
			<button aria-controls="toc-Research-sublist" class="cdx-button cdx-button--weight-quiet cdx-button--icon-only vector-toc-toggle">
				<span class="vector-icon vector-icon--x-small mw-ui-icon-wikimedia-expand"></span>
				<span>Toggle Research subsection</span>
			</button>
		
		<ul id="toc-Research-sublist" class="vector-toc-list">
			<li id="toc-Diagnosis_and_biomarkers"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Diagnosis_and_biomarkers">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">12.1</span>Diagnosis and biomarkers</div>
			</a>
			
			<ul id="toc-Diagnosis_and_biomarkers-sublist" class="vector-toc-list">
			</ul>
		</li>
		<li id="toc-Medication_development"
			class="vector-toc-list-item vector-toc-level-2">
			<a class="vector-toc-link" href="#Medication_development">
				<div class="vector-toc-text">
				<span class="vector-toc-numb">12.2</span>Medication development</div>
			</a>
			
			<ul id="toc-Medication_development-sublist" class="vector-toc-list">
			</ul>
		</li>
	</ul>
	</li>
	<li id="toc-See_also"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#See_also">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">13</span>See also</div>
		</a>
		
		<ul id="toc-See_also-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-References"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#References">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">14</span>References</div>
		</a>
		
		<ul id="toc-References-sublist" class="vector-toc-list">
		</ul>
	</li>
	<li id="toc-External_links"
		class="vector-toc-list-item vector-toc-level-1">
		<a class="vector-toc-link" href="#External_links">
			<div class="vector-toc-text">
			<span class="vector-toc-numb">15</span>External links</div>
		</a>
		
		<ul id="toc-External_links-sublist" class="vector-toc-list">
		</ul>
	</li>
</ul>
</div>

			</div>
		</nav>
		<div class="mw-content-container">
			<main id="content" class="mw-body" role="main">
				<header class="mw-body-header vector-page-titlebar">
					<label
						id="vector-toc-collapsed-button"
						class="cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet vector-button-flush-left cdx-button--icon-only"
						for="vector-toc-collapsed-checkbox"
						role="button"
						aria-controls="vector-toc"
						tabindex="0"
						title="Table of Contents">
						<span class="vector-icon mw-ui-icon-wikimedia-listBullet"></span>
						<span>Toggle the table of contents</span>
					</label>
				
					<nav role="navigation" aria-label="Contents" class="vector-toc-landmark">
						
<div id="vector-page-titlebar-toc" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-titlebar-toc vector-button-flush-left"  >
	<input type="checkbox"
		id="vector-page-titlebar-toc-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-titlebar-toc"
		class="vector-menu-checkbox "
		
		aria-label="Toggle the table of contents"
		
	/>
	<label
		id="vector-page-titlebar-toc-label"
		for="vector-page-titlebar-toc-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--icon-only "
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-listBullet mw-ui-icon-wikimedia-listBullet"></span>


		<span class="vector-menu-heading-label">Toggle the table of contents</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


							<div id="vector-page-titlebar-toc-unpinned-container" class="vector-unpinned-container">
			</div>
		
	</div>
</div>
					</nav>
					<h1 id="firstHeading" class="firstHeading mw-first-heading"><span class="mw-page-title-main">Non-alcoholic fatty liver disease</span></h1>
				
							
<div id="p-lang-btn" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-lang"  >
	<input type="checkbox"
		id="p-lang-btn-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-lang-btn"
		class="vector-menu-checkbox mw-interlanguage-selector"
		aria-label="Go to an article in another language. Available in 24 languages"
		
		
	/>
	<label
		id="p-lang-btn-label"
		for="p-lang-btn-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet cdx-button--action-progressive mw-portlet-lang-heading-24"
		aria-hidden="true"
		
	>
		<span class="vector-icon mw-ui-icon-language-progressive mw-ui-icon-wikimedia-language-progressive"></span>


		<span class="vector-menu-heading-label">24 languages</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

		<div class="vector-menu-content">
			
			<ul class="vector-menu-content-list"><li class="interlanguage-link interwiki-ar mw-list-item"><a href="https://ar.wikipedia.org/wiki/%D9%85%D8%B1%D8%B6_%D8%A7%D9%84%D9%83%D8%A8%D8%AF_%D8%A7%D9%84%D8%AF%D9%87%D9%86%D9%8A_%D8%A7%D9%84%D9%84%D8%A7%D9%83%D8%AD%D9%88%D9%84%D9%8A" title="مرض الكبد الدهني اللاكحولي – Arabic" lang="ar" hreflang="ar" class="interlanguage-link-target"><span>العربية</span></a></li><li class="interlanguage-link interwiki-az mw-list-item"><a href="https://az.wikipedia.org/wiki/Yu-%C3%A7enq_x%C9%99st%C9%99liyi" title="Yu-çenq xəstəliyi – Azerbaijani" lang="az" hreflang="az" class="interlanguage-link-target"><span>Azərbaycanca</span></a></li><li class="interlanguage-link interwiki-ca mw-list-item"><a href="https://ca.wikipedia.org/wiki/Malaltia_per_fetge_gras_no_alcoh%C3%B2lic" title="Malaltia per fetge gras no alcohòlic – Catalan" lang="ca" hreflang="ca" class="interlanguage-link-target"><span>Català</span></a></li><li class="interlanguage-link interwiki-es mw-list-item"><a href="https://es.wikipedia.org/wiki/Esteatohepatitis_no_alcoh%C3%B3lica" title="Esteatohepatitis no alcohólica – Spanish" lang="es" hreflang="es" class="interlanguage-link-target"><span>Español</span></a></li><li class="interlanguage-link interwiki-eo mw-list-item"><a href="https://eo.wikipedia.org/wiki/Ne-alkohola_grasa_hepata_malsano" title="Ne-alkohola grasa hepata malsano – Esperanto" lang="eo" hreflang="eo" class="interlanguage-link-target"><span>Esperanto</span></a></li><li class="interlanguage-link interwiki-fa mw-list-item"><a href="https://fa.wikipedia.org/wiki/%D8%A8%DB%8C%D9%85%D8%A7%D8%B1%DB%8C_%DA%A9%D8%A8%D8%AF_%DA%86%D8%B1%D8%A8_%D8%BA%DB%8C%D8%B1_%D8%A7%D9%84%DA%A9%D9%84%DB%8C" title="بیماری کبد چرب غیر الکلی – Persian" lang="fa" hreflang="fa" class="interlanguage-link-target"><span>فارسی</span></a></li><li class="interlanguage-link interwiki-fr mw-list-item"><a href="https://fr.wikipedia.org/wiki/St%C3%A9atoh%C3%A9patite_non_alcoolique" title="Stéatohépatite non alcoolique – French" lang="fr" hreflang="fr" class="interlanguage-link-target"><span>Français</span></a></li><li class="interlanguage-link interwiki-id mw-list-item"><a href="https://id.wikipedia.org/wiki/Penyakit_perlemakan_hati_non-alkoholik" title="Penyakit perlemakan hati non-alkoholik – Indonesian" lang="id" hreflang="id" class="interlanguage-link-target"><span>Bahasa Indonesia</span></a></li><li class="interlanguage-link interwiki-it mw-list-item"><a href="https://it.wikipedia.org/wiki/Steatosi_epatica_non_alcolica" title="Steatosi epatica non alcolica – Italian" lang="it" hreflang="it" class="interlanguage-link-target"><span>Italiano</span></a></li><li class="interlanguage-link interwiki-he mw-list-item"><a href="https://he.wikipedia.org/wiki/%D7%9E%D7%97%D7%9C%D7%AA_%D7%94%D7%9B%D7%91%D7%93_%D7%94%D7%A9%D7%95%D7%9E%D7%A0%D7%99_%D7%A9%D7%90%D7%99%D7%A0%D7%94_%D7%A0%D7%95%D7%91%D7%A2%D7%AA_%D7%9E%D7%A6%D7%A8%D7%99%D7%9B%D7%AA_%D7%90%D7%9C%D7%9B%D7%95%D7%94%D7%95%D7%9C" title="מחלת הכבד השומני שאינה נובעת מצריכת אלכוהול – Hebrew" lang="he" hreflang="he" class="interlanguage-link-target"><span>עברית</span></a></li><li class="interlanguage-link interwiki-lv mw-list-item"><a href="https://lv.wikipedia.org/wiki/Bezalkoholisk%C4%81_taukaino_aknu_slim%C4%ABba" title="Bezalkoholiskā taukaino aknu slimība – Latvian" lang="lv" hreflang="lv" class="interlanguage-link-target"><span>Latviešu</span></a></li><li class="interlanguage-link interwiki-ms mw-list-item"><a href="https://ms.wikipedia.org/wiki/Penyakit_hati_berlemak_bukan_alkohol" title="Penyakit hati berlemak bukan alkohol – Malay" lang="ms" hreflang="ms" class="interlanguage-link-target"><span>Bahasa Melayu</span></a></li><li class="interlanguage-link interwiki-mn mw-list-item"><a href="https://mn.wikipedia.org/wiki/%D0%90%D1%80%D1%85%D0%B8%D0%BD%D1%8B_%D0%B1%D1%83%D1%81_%D0%B3%D0%B0%D1%80%D0%B0%D0%BB%D1%82%D0%B0%D0%B9_%D1%8D%D0%BB%D1%8D%D0%B3_%D3%A9%D3%A9%D1%85%D0%BB%D3%A9%D1%85_%D3%A9%D0%B2%D1%87%D0%B8%D0%BD" title="Архины бус гаралтай элэг өөхлөх өвчин – Mongolian" lang="mn" hreflang="mn" class="interlanguage-link-target"><span>Монгол</span></a></li><li class="interlanguage-link interwiki-nl mw-list-item"><a href="https://nl.wikipedia.org/wiki/Niet-alcoholische_steatohepatitis" title="Niet-alcoholische steatohepatitis – Dutch" lang="nl" hreflang="nl" class="interlanguage-link-target"><span>Nederlands</span></a></li><li class="interlanguage-link interwiki-ja mw-list-item"><a href="https://ja.wikipedia.org/wiki/%E9%9D%9E%E3%82%A2%E3%83%AB%E3%82%B3%E3%83%BC%E3%83%AB%E6%80%A7%E8%84%82%E8%82%AA%E6%80%A7%E8%82%9D%E7%96%BE%E6%82%A3" title="非アルコール性脂肪性肝疾患 – Japanese" lang="ja" hreflang="ja" class="interlanguage-link-target"><span>日本語</span></a></li><li class="interlanguage-link interwiki-or mw-list-item"><a href="https://or.wikipedia.org/wiki/%E0%AC%85%E0%AC%A3-%E0%AC%AE%E0%AC%A6%E0%AD%8D%E0%AD%9F%E0%AC%AA%E0%AC%BE%E0%AD%9F%E0%AD%80_%E0%AC%9A%E0%AC%B0%E0%AD%8D%E0%AC%AC%E0%AC%BF%E0%AC%B3_%E0%AC%AF%E0%AC%95%E0%AD%83%E0%AC%A4_%E0%AC%B0%E0%AD%8B%E0%AC%97" title="ଅଣ-ମଦ୍ୟପାୟୀ ଚର୍ବିଳ ଯକୃତ ରୋଗ – Odia" lang="or" hreflang="or" class="interlanguage-link-target"><span>ଓଡ଼ିଆ</span></a></li><li class="interlanguage-link interwiki-pl mw-list-item"><a href="https://pl.wikipedia.org/wiki/Niealkoholowa_st%C5%82uszczeniowa_choroba_w%C4%85troby" title="Niealkoholowa stłuszczeniowa choroba wątroby – Polish" lang="pl" hreflang="pl" class="interlanguage-link-target"><span>Polski</span></a></li><li class="interlanguage-link interwiki-pt mw-list-item"><a href="https://pt.wikipedia.org/wiki/Doen%C3%A7a_hep%C3%A1tica_gordurosa_n%C3%A3o_alco%C3%B3lica" title="Doença hepática gordurosa não alcoólica – Portuguese" lang="pt" hreflang="pt" class="interlanguage-link-target"><span>Português</span></a></li><li class="interlanguage-link interwiki-ru mw-list-item"><a href="https://ru.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B0%D0%BB%D0%BA%D0%BE%D0%B3%D0%BE%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F_%D0%B6%D0%B8%D1%80%D0%BE%D0%B2%D0%B0%D1%8F_%D0%B1%D0%BE%D0%BB%D0%B5%D0%B7%D0%BD%D1%8C_%D0%BF%D0%B5%D1%87%D0%B5%D0%BD%D0%B8" title="Неалкогольная жировая болезнь печени – Russian" lang="ru" hreflang="ru" class="interlanguage-link-target"><span>Русский</span></a></li><li class="interlanguage-link interwiki-sl mw-list-item"><a href="https://sl.wikipedia.org/wiki/Nealkoholna_ma%C5%A1%C4%8Dobna_jetrna_bolezen" title="Nealkoholna maščobna jetrna bolezen – Slovenian" lang="sl" hreflang="sl" class="interlanguage-link-target"><span>Slovenščina</span></a></li><li class="interlanguage-link interwiki-sr mw-list-item"><a href="https://sr.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B0%D0%BB%D0%BA%D0%BE%D1%85%D0%BE%D0%BB%D0%BD%D0%B0_%D0%BC%D0%B0%D1%81%D0%BD%D0%B0_%D0%B1%D0%BE%D0%BB%D0%B5%D1%81%D1%82_%D1%98%D0%B5%D1%82%D1%80%D0%B5" title="Неалкохолна масна болест јетре – Serbian" lang="sr" hreflang="sr" class="interlanguage-link-target"><span>Српски / srpski</span></a></li><li class="interlanguage-link interwiki-fi mw-list-item"><a href="https://fi.wikipedia.org/wiki/Ei-alkoholiper%C3%A4inen_rasvamaksa" title="Ei-alkoholiperäinen rasvamaksa – Finnish" lang="fi" hreflang="fi" class="interlanguage-link-target"><span>Suomi</span></a></li><li class="interlanguage-link interwiki-ta mw-list-item"><a href="https://ta.wikipedia.org/wiki/%E0%AE%AE%E0%AE%A4%E0%AF%81%E0%AE%9A%E0%AE%BE%E0%AE%B0%E0%AE%BE_%E0%AE%95%E0%AF%8A%E0%AE%B4%E0%AF%81%E0%AE%AA%E0%AF%8D%E0%AE%AA%E0%AF%81%E0%AE%A8%E0%AE%BF%E0%AE%B1%E0%AF%88_%E0%AE%95%E0%AE%B2%E0%AF%8D%E0%AE%B2%E0%AF%80%E0%AE%B0%E0%AE%B2%E0%AF%8D_%E0%AE%A8%E0%AF%8B%E0%AE%AF%E0%AF%8D" title="மதுசாரா கொழுப்புநிறை கல்லீரல் நோய் – Tamil" lang="ta" hreflang="ta" class="interlanguage-link-target"><span>தமிழ்</span></a></li><li class="interlanguage-link interwiki-uk mw-list-item"><a href="https://uk.wikipedia.org/wiki/%D0%9D%D0%B5%D0%B0%D0%BB%D0%BA%D0%BE%D0%B3%D0%BE%D0%BB%D1%8C%D0%BD%D0%B0_%D0%B6%D0%B8%D1%80%D0%BE%D0%B2%D0%B0_%D1%85%D0%B2%D0%BE%D1%80%D0%BE%D0%B1%D0%B0_%D0%BF%D0%B5%D1%87%D1%96%D0%BD%D0%BA%D0%B8" title="Неалкогольна жирова хвороба печінки – Ukrainian" lang="uk" hreflang="uk" class="interlanguage-link-target"><span>Українська</span></a></li></ul>
			<div class="after-portlet after-portlet-lang"><span class="wb-langlinks-edit wb-langlinks-link"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1546498#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>
		</div>

	</div>
</div>
				</header>
				<div class="vector-page-toolbar">
					<div class="vector-page-toolbar-container">
						<div id="left-navigation">
							<nav aria-label="Namespaces">
								
<div id="p-associated-pages" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-associated-pages"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-nstab-main" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Non-alcoholic_fatty_liver_disease" title="View the content page [c]" accesskey="c" class=""><span>Article</span></a>
</li>
<li id="ca-talk" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Talk:Non-alcoholic_fatty_liver_disease" rel="discussion" title="Discuss improvements to the content page [t]" accesskey="t" class=""><span>Talk</span></a>
</li>

		</ul>
		
	</div>
</div>

								

<div id="p-variants" class="vector-menu vector-dropdown vector-menu-dropdown mw-portlet mw-portlet-variants emptyPortlet"  >
	<input type="checkbox"
		id="p-variants-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-p-variants"
		class="vector-menu-checkbox"
		aria-label="Change language variant"
		
		
	/>
	<label
		id="p-variants-label"
		for="p-variants-checkbox"
		class="vector-menu-heading "
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">English</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">

	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"></ul>
		
	</div>

	</div>
</div>
							</nav>
						</div>
						<div id="right-navigation" class="vector-collapsible">
							<nav aria-label="Views">
								
<div id="p-views" class="vector-menu vector-menu-tabs mw-portlet mw-portlet-views"  >
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list">
			<li id="ca-view" class="selected vector-tab-noicon mw-list-item"><a data-mw="interface" href="/wiki/Non-alcoholic_fatty_liver_disease" class=""><span>Read</span></a>
</li>
<li id="ca-edit" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit" title="Edit this page [e]" accesskey="e" class=""><span>Edit</span></a>
</li>
<li id="ca-history" class="vector-tab-noicon mw-list-item"><a data-mw="interface" href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class=""><span>View history</span></a>
</li>

		</ul>
		
	</div>
</div>

							</nav>
				
							<nav class="vector-page-tools-landmark" aria-label="More options">
								
<div id="vector-page-tools-dropdown" class="vector-menu vector-dropdown vector-menu-dropdown vector-page-tools-dropdown"  >
	<input type="checkbox"
		id="vector-page-tools-dropdown-checkbox"
		role="button"
		aria-haspopup="true"
		data-event-name="ui.dropdown-vector-page-tools-dropdown"
		class="vector-menu-checkbox "
		
		aria-label="Tools"
		
	/>
	<label
		id="vector-page-tools-dropdown-label"
		for="vector-page-tools-dropdown-checkbox"
		class="vector-menu-heading cdx-button cdx-button--fake-button cdx-button--fake-button--enabled cdx-button--weight-quiet"
		aria-hidden="true"
		
	>
		
		<span class="vector-menu-heading-label">Tools</span>
	</label>
	<div class="vector-menu-content vector-dropdown-content">


									<div id="vector-page-tools-unpinned-container" class="vector-unpinned-container">
						
<div id="vector-page-tools" class="vector-page-tools vector-pinnable-element">
	<div
	class="vector-pinnable-header vector-page-tools-pinnable-header vector-pinnable-header-unpinned"
	data-feature-name="page-tools-pinned"
	data-pinnable-element-id="vector-page-tools"
	data-pinned-container-id="vector-page-tools-pinned-container"
	data-unpinned-container-id="vector-page-tools-unpinned-container"
>
	<div class="vector-pinnable-header-label">Tools</div>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-pin-button" data-event-name="pinnable-header.vector-page-tools.pin">move to sidebar</button>
	<button class="vector-pinnable-header-toggle-button vector-pinnable-header-unpin-button" data-event-name="pinnable-header.vector-page-tools.unpin">hide</button>
</div>

	
<div id="p-cactions" class="vector-menu mw-portlet mw-portlet-cactions emptyPortlet vector-has-collapsible-items"  title="More options" >
	<div class="vector-menu-heading">
		Actions
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="ca-more-view" class="selected vector-more-collapsible-item mw-list-item"><a href="/wiki/Non-alcoholic_fatty_liver_disease"><span>Read</span></a></li><li id="ca-more-edit" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit"><span>Edit</span></a></li><li id="ca-more-history" class="vector-more-collapsible-item mw-list-item"><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=history"><span>View history</span></a></li></ul>
		
	</div>
</div>

<div id="p-tb" class="vector-menu mw-portlet mw-portlet-tb"  >
	<div class="vector-menu-heading">
		General
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="t-whatlinkshere" class="mw-list-item"><a href="/wiki/Special:WhatLinksHere/Non-alcoholic_fatty_liver_disease" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j"><span>What links here</span></a></li><li id="t-recentchangeslinked" class="mw-list-item"><a href="/wiki/Special:RecentChangesLinked/Non-alcoholic_fatty_liver_disease" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k"><span>Related changes</span></a></li><li id="t-upload" class="mw-list-item"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u"><span>Upload file</span></a></li><li id="t-specialpages" class="mw-list-item"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q"><span>Special pages</span></a></li><li id="t-permalink" class="mw-list-item"><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;oldid=1161272202" title="Permanent link to this revision of this page"><span>Permanent link</span></a></li><li id="t-info" class="mw-list-item"><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=info" title="More information about this page"><span>Page information</span></a></li><li id="t-cite" class="mw-list-item"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Non-alcoholic_fatty_liver_disease&amp;id=1161272202&amp;wpFormIdentifier=titleform" title="Information on how to cite this page"><span>Cite this page</span></a></li><li id="t-wikibase" class="mw-list-item"><a href="https://www.wikidata.org/wiki/Special:EntityPage/Q1546498" title="Structured data on this page hosted by Wikidata [g]" accesskey="g"><span>Wikidata item</span></a></li></ul>
		
	</div>
</div>

<div id="p-coll-print_export" class="vector-menu mw-portlet mw-portlet-coll-print_export"  >
	<div class="vector-menu-heading">
		Print/export
	</div>
	<div class="vector-menu-content">
		
		<ul class="vector-menu-content-list"><li id="coll-download-as-rl" class="mw-list-item"><a href="/w/index.php?title=Special:DownloadAsPdf&amp;page=Non-alcoholic_fatty_liver_disease&amp;action=show-download-screen" title="Download this page as a PDF file"><span>Download as PDF</span></a></li><li id="t-print" class="mw-list-item"><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;printable=yes" title="Printable version of this page [p]" accesskey="p"><span>Printable version</span></a></li></ul>
		
	</div>
</div>

</div>

									</div>
				
	</div>
</div>
							</nav>
						</div>
					</div>
				</div>
				<div class="vector-column-end">
					<nav class="vector-page-tools-landmark vector-sticky-pinned-container" aria-label="More options">
						<div id="vector-page-tools-pinned-container" class="vector-pinned-container">
			
						</div>
	</nav>
				</div>
				<div id="bodyContent" class="vector-body" aria-labelledby="firstHeading" data-mw-ve-target-container>
					<div class="vector-body-before-content">
							<div class="mw-indicators">
		<div id="mw-indicator-good-star" class="mw-indicator"><div class="mw-parser-output"><a href="/wiki/Wikipedia:Good_articles" title="This is a good article. Click here for more information."><img alt="This is a good article. Click here for more information." src="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/19px-Symbol_support_vote.svg.png" decoding="async" width="19" height="20" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/29px-Symbol_support_vote.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/94/Symbol_support_vote.svg/39px-Symbol_support_vote.svg.png 2x" data-file-width="180" data-file-height="185" /></a></div></div>
		</div>

						<div id="siteSub" class="noprint">From Wikipedia, the free encyclopedia</div>
					</div>
					<div id="contentSub"><div id="mw-content-subtitle"></div></div>
					
					
					<div id="mw-content-text" class="mw-body-content mw-content-ltr" lang="en" dir="ltr"><div class="mw-parser-output"><div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Excessive fat buildup in the liver not caused by alcohol use</div>
<p class="mw-empty-elt">
</p>
<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">Medical condition</div><style data-mw-deduplicate="TemplateStyles:r1066479718">.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}</style><table class="infobox"><tbody><tr><th colspan="2" class="infobox-above" style="background:#ccc">Non-alcoholic fatty liver disease</th></tr><tr><th scope="row" class="infobox-label">Other names</th><td class="infobox-data">NAFLD, metabolic (dysfunction) associated fatty liver disease, MAFLD<sup id="cite_ref-MAFLD_1-0" class="reference"><a href="#cite_note-MAFLD-1">&#91;1&#93;</a></sup></td></tr><tr><td colspan="2" class="infobox-full-data"><a href="/wiki/File:Stage_of_liver_damage_high.jpg" class="image"><img alt="Stage of liver damage high.jpg" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/300px-Stage_of_liver_damage_high.jpg" decoding="async" width="300" height="158" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/450px-Stage_of_liver_damage_high.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7b/Stage_of_liver_damage_high.jpg/600px-Stage_of_liver_damage_high.jpg 2x" data-file-width="3000" data-file-height="1576" /></a></td></tr><tr><td colspan="2" class="infobox-full-data">Stages of non-alcoholic fatty liver disease, progressing from healthy, to steatosis (fat accumulation), inflammation, fibrosis and cirrhosis.</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_specialty" title="Medical specialty">Specialty</a></th><td class="infobox-data"><a href="/wiki/Hepatology" title="Hepatology">Hepatology</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Signs_and_symptoms" title="Signs and symptoms">Symptoms</a></th><td class="infobox-data"><a href="/wiki/Asymptomatic" title="Asymptomatic">Asymptomatic</a> in the early stages<br />In later stages:<br />* <a href="/wiki/Xanthomas" class="mw-redirect" title="Xanthomas">Deposits of cholesterol on the eye lids</a><br />* <a href="/wiki/Fatigue" title="Fatigue">Fatigue</a><br />* <a href="/wiki/Prurigo_nodularis" title="Prurigo nodularis">Crusty red nodules</a><br />* Digestive issues<br />Lastly causes <a href="/wiki/Liver_dysfunction" class="mw-redirect" title="Liver dysfunction">liver dysfunction</a> and eventually <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Complication_(medicine)" title="Complication (medicine)">Complications</a></th><td class="infobox-data"><a href="/wiki/Cirrhosis" title="Cirrhosis">Cirrhosis</a>, <a href="/wiki/Liver_cancer" title="Liver cancer">liver cancer</a>, <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a>, <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a><sup id="cite_ref-ICD11_2-0" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-NIH2016_3-0" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Duration</th><td class="infobox-data">Long term</td></tr><tr><th scope="row" class="infobox-label">Types</th><td class="infobox-data">Non-alcoholic fatty liver (NAFL),<br />non-alcoholic steatohepatitis (NASH)<sup id="cite_ref-NIH2016_3-1" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-AASLD2018_4-0" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Causes</th><td class="infobox-data">Genetic, environmental</td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Risk_factor" title="Risk factor">Risk factors</a></th><td class="infobox-data"><a href="/wiki/Obesity" title="Obesity">Obesity</a>, <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>, <a href="/wiki/Type_2_Diabetes" class="mw-redirect" title="Type 2 Diabetes">type 2 diabetes mellitus</a>, <a href="/wiki/Liver_disease" title="Liver disease">liver disease</a></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Medical_diagnosis" title="Medical diagnosis">Diagnostic method</a></th><td class="infobox-data">Lipid spectrum blood tests<br />* <a href="/wiki/Cholesterol" title="Cholesterol">Cholesterol</a> (+5,00 mmol/L)<br />* <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL cholesterol</a> (1,00 – 2,10 mmol/L)<br />* <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL cholesterol</a> (+3,00 mmol/L)<br />* <a href="/wiki/Triacylglycerol" class="mw-redirect" title="Triacylglycerol">Triacylglycerol</a> (+1,70 mmol/L)<br />* non HDL (+3,80 mmol/L)<br /><a href="/wiki/Liver_biopsy" title="Liver biopsy">Liver biopsy</a></td></tr><tr><th scope="row" class="infobox-label">Treatment</th><td class="infobox-data"><a href="/wiki/Weight_loss" title="Weight loss">Weight loss</a> (in case of <a href="/wiki/Obesity" title="Obesity">obesity</a>)<br />Dietary reduction of <a href="/wiki/Fructose" title="Fructose">fructose</a> and <a href="/wiki/Glucose" title="Glucose">glucose</a><sup id="cite_ref-5" class="reference"><a href="#cite_note-5">&#91;5&#93;</a></sup> (diet and exercise)<sup id="cite_ref-NIH2016_3-2" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-0" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label"><a href="/wiki/Prognosis" title="Prognosis">Prognosis</a></th><td class="infobox-data">Depends on type<sup id="cite_ref-AFP2013_7-0" class="reference"><a href="#cite_note-AFP2013-7">&#91;7&#93;</a></sup></td></tr><tr><th scope="row" class="infobox-label">Frequency</th><td class="infobox-data">24% in worldwide population, 80% in obese, 20% in normal-weight</td></tr><tr><th scope="row" class="infobox-label">Deaths</th><td class="infobox-data">NASH: 2.6% risk of death per year<sup id="cite_ref-AASLD2018_4-1" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><br />NAFL: Unknown<sup id="cite_ref-8" class="reference"><a href="#cite_note-8">&#91;8&#93;</a></sup></td></tr></tbody></table>
<p><b>Non-alcoholic fatty liver disease</b> (<b>NAFLD</b>), also known as <b>metabolic (dysfunction) associated fatty liver disease</b> (<b>MAFLD</b>), is excessive <a href="/wiki/Fat" title="Fat">fat</a> build-up in the <a href="/wiki/Liver" title="Liver">liver</a> without another clear cause such as <a href="/wiki/Alcoholism" title="Alcoholism">alcohol use</a>.<sup id="cite_ref-ICD11_2-1" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-NIH2016_3-3" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> There are two types; <b>non-alcoholic fatty liver</b> (<b>NAFL</b>) and <b>non-alcoholic steatohepatitis</b> (<b>NASH</b>), with the latter also including <a href="/wiki/Hepatitis" title="Hepatitis">liver inflammation</a>.<sup id="cite_ref-NIH2016_3-4" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-AASLD2018_4-2" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AFP2013_7-1" class="reference"><a href="#cite_note-AFP2013-7">&#91;7&#93;</a></sup> Non-alcoholic fatty liver is less dangerous than NASH and usually does not progress to NASH.<sup id="cite_ref-NIH2016_3-5" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> When NAFL does progress to NASH, it may eventually lead to complications such as <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, <a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">liver cancer</a>, <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a>, or <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>.<sup id="cite_ref-NIH2016_3-6" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-Nature2016_9-0" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup>
</p><p><a href="/wiki/Obesity" title="Obesity">Obesity</a> and <a href="/wiki/Type_2_diabetes" title="Type 2 diabetes">type 2 diabetes</a> are strong risk factors for NAFLD.<sup id="cite_ref-AsiaPacific2017-1_6-1" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> Other risks include being <a href="/wiki/Overweight" title="Overweight">overweight</a>, <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a> (defined as at least three of the five following medical conditions: abdominal obesity, <a href="/wiki/Hypertension" title="Hypertension">high blood pressure</a>, <a href="/wiki/Hyperglycemia" title="Hyperglycemia">high blood sugar</a>, <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">high serum triglycerides</a>, and low serum <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL cholesterol</a>), a diet high in <a href="/wiki/Fructose" title="Fructose">fructose</a>, and older age.<sup id="cite_ref-NIH2016_3-7" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-AFP2013_7-2" class="reference"><a href="#cite_note-AFP2013-7">&#91;7&#93;</a></sup> NAFLD and <a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">alcoholic liver disease</a> are types of <a href="/wiki/Fatty_liver_disease" title="Fatty liver disease">fatty liver disease</a>.<sup id="cite_ref-AFP2013_7-3" class="reference"><a href="#cite_note-AFP2013-7">&#91;7&#93;</a></sup> <a href="/wiki/Liver_biopsy" title="Liver biopsy">Obtaining a sample of the liver</a> after excluding other potential causes of fatty liver can confirm the diagnosis.<sup id="cite_ref-ICD11_2-2" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-2" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-AFP2013_7-4" class="reference"><a href="#cite_note-AFP2013-7">&#91;7&#93;</a></sup>
</p><p>Treatment for NAFLD is <a href="/wiki/Weight_loss" title="Weight loss">weight loss</a> by dietary changes and exercise.<sup id="cite_ref-AASLD2018_4-3" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-0" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-BMJKENNEALLY2017_11-0" class="reference"><a href="#cite_note-BMJKENNEALLY2017-11">&#91;11&#93;</a></sup> There is tentative evidence for <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a> and <a href="/wiki/Vitamin_E" title="Vitamin E">vitamin E</a>;<sup id="cite_ref-NIH2016_3-8" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup><sup id="cite_ref-NICE2016_12-0" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-Tilg2016_13-0" class="reference"><a href="#cite_note-Tilg2016-13">&#91;13&#93;</a></sup> and <a href="/wiki/Bariatric_surgery" title="Bariatric surgery">bariatric surgery</a> can improve or resolve severe cases.<sup id="cite_ref-AsiaPacific2017-2_10-1" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-EASL2016_14-0" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> Those with NASH have a 2.6% increased risk of dying per year.<sup id="cite_ref-AASLD2018_4-4" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>NAFLD is the most common liver disorder worldwide and is present in approximately 25% of the world's population.<sup id="cite_ref-Marjot2020_15-0" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> It is very common in developed nations, such as the United States, and affected about 75 to 100&#160;million Americans in 2017.<sup id="cite_ref-Younossi2016_16-0" class="reference"><a href="#cite_note-Younossi2016-16">&#91;16&#93;</a></sup><sup id="cite_ref-Rinella2015_17-0" class="reference"><a href="#cite_note-Rinella2015-17">&#91;17&#93;</a></sup><sup id="cite_ref-Rich2018_18-0" class="reference"><a href="#cite_note-Rich2018-18">&#91;18&#93;</a></sup><sup id="cite_ref-EASL2019_19-0" class="reference"><a href="#cite_note-EASL2019-19">&#91;19&#93;</a></sup> Over 90% of obese, 60% of <a href="/wiki/Diabetes" title="Diabetes">diabetic</a>, and up to 20% of normal-weight people develop NAFLD.<sup id="cite_ref-Younossi2017_20-0" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Younossi2019_21-0" class="reference"><a href="#cite_note-Younossi2019-21">&#91;21&#93;</a></sup> NAFLD is the leading cause of <a href="/wiki/Chronic_liver_disease" title="Chronic liver disease">chronic liver disease</a><sup id="cite_ref-EASL2019_19-1" class="reference"><a href="#cite_note-EASL2019-19">&#91;19&#93;</a></sup><sup id="cite_ref-Younossi2017_20-1" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> and the second most common reason for <a href="/wiki/Liver_transplantation" title="Liver transplantation">liver transplantation</a> in the US and Europe as of 2017.<sup id="cite_ref-AsiaPacific2017-2_10-2" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> NAFLD affects about 20 to 25% of people in Europe.<sup id="cite_ref-EASL2016_14-1" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> In the United States, estimates suggest between 30 and 40% of adults have NAFLD, and about 3 to 12% of adults have NASH.<sup id="cite_ref-NIH2016_3-9" class="reference"><a href="#cite_note-NIH2016-3">&#91;3&#93;</a></sup> The annual economic burden was approximately US$103&#160;billion in the US in 2016.<sup id="cite_ref-Younossi2017_20-2" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup>
</p>
<style data-mw-deduplicate="TemplateStyles:r886046785">.mw-parser-output .toclimit-2 .toclevel-1 ul,.mw-parser-output .toclimit-3 .toclevel-2 ul,.mw-parser-output .toclimit-4 .toclevel-3 ul,.mw-parser-output .toclimit-5 .toclevel-4 ul,.mw-parser-output .toclimit-6 .toclevel-5 ul,.mw-parser-output .toclimit-7 .toclevel-6 ul{display:none}</style><div class="toclimit-3"><meta property="mw:PageProp/toc" /></div>
<h2><span class="mw-headline" id="Definition">Definition</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=1" title="Edit section: Definition">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>An abnormal accumulation of fat in the liver in the absence of secondary causes of fatty liver, such as significant alcohol use, <a href="/wiki/Viral_hepatitis" title="Viral hepatitis">viral hepatitis</a>, or medications that can induce fatty liver, characterizes non-alcoholic fatty liver disease (NAFLD).<sup id="cite_ref-Marjot2020_15-1" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> The term NAFLD encompasses a continuum of liver abnormalities, from non-alcoholic fatty liver (NAFL, simple steatosis) to non-alcoholic <a href="/wiki/Steatohepatitis" title="Steatohepatitis">steatohepatitis</a> (NASH). These diseases begin with fatty accumulation in the liver (hepatic <a href="/wiki/Steatosis" title="Steatosis">steatosis</a>). A liver can remain fatty without disturbing liver function (NAFL), but by various mechanisms and possible <a href="/wiki/Insult_(medical)" title="Insult (medical)">insults</a> to the liver, it may also progress into non-alcoholic steatohepatitis (NASH), a state in which steatosis is combined with <a href="/wiki/Inflammation" title="Inflammation">inflammation</a> and sometimes <a href="/wiki/Fibrosis" title="Fibrosis">fibrosis</a> (steatohepatitis). NASH can then lead to complications such as <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> and <a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">hepatocellular carcinoma</a>.<sup id="cite_ref-ICD11_2-3" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AASLD2018_4-5" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Friedman2018_22-0" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup>
</p><p>A new name, metabolic dysfunction associated fatty liver disease, was proposed after 70% of a panel of experts expressed support for this name.<sup id="cite_ref-MAFLD_1-1" class="reference"><a href="#cite_note-MAFLD-1">&#91;1&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=2" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:312px;"><video id="mwe_player_0" poster="//upload.wikimedia.org/wikipedia/commons/thumb/0/05/Non-alcoholic_fatty_liver_disease.webm/310px-seek%3D14-Non-alcoholic_fatty_liver_disease.webm.jpg" controls="" preload="none" class="thumbimage" width="310" height="174" data-durationhint="397" data-mwtitle="Non-alcoholic_fatty_liver_disease.webm" data-mwprovider="wikimediacommons"><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.480p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="SD VP9 (480P)" data-shorttitle="VP9 480P" data-transcodekey="480p.vp9.webm" data-width="854" data-height="480" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.720p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="HD VP9 (720P)" data-shorttitle="VP9 720P" data-transcodekey="720p.vp9.webm" data-width="1280" data-height="720" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.1080p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Full HD VP9 (1080P)" data-shorttitle="VP9 1080P" data-transcodekey="1080p.vp9.webm" data-width="1920" data-height="1080" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.480p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="SD WebM (480P)" data-shorttitle="WebM 480P" data-transcodekey="480p.webm" data-width="854" data-height="480" /><source src="//upload.wikimedia.org/wikipedia/commons/0/05/Non-alcoholic_fatty_liver_disease.webm" type="video/webm; codecs=&quot;vp9, vorbis&quot;" data-title="Original WebM file, 1,920 × 1,080 (1.28 Mbps)" data-shorttitle="WebM source" data-width="1920" data-height="1080" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.720p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="HD WebM (720P)" data-shorttitle="WebM 720P" data-transcodekey="720p.webm" data-width="1280" data-height="720" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.1080p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="Full HD WebM (1080P)" data-shorttitle="WebM 1080P" data-transcodekey="1080p.webm" data-width="1920" data-height="1080" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.120p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Lowest bandwidth VP9 (120P)" data-shorttitle="VP9 120P" data-transcodekey="120p.vp9.webm" data-width="214" data-height="120" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.160p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="Low bandwidth WebM (160P)" data-shorttitle="WebM 160P" data-transcodekey="160p.webm" data-width="284" data-height="160" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.180p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Low bandwidth VP9 (180P)" data-shorttitle="VP9 180P" data-transcodekey="180p.vp9.webm" data-width="320" data-height="180" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.240p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="Small VP9 (240P)" data-shorttitle="VP9 240P" data-transcodekey="240p.vp9.webm" data-width="426" data-height="240" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.240p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="Small WebM (240P)" data-shorttitle="WebM 240P" data-transcodekey="240p.webm" data-width="426" data-height="240" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.360p.vp9.webm" type="video/webm; codecs=&quot;vp9, opus&quot;" data-title="VP9 (360P)" data-shorttitle="VP9 360P" data-transcodekey="360p.vp9.webm" data-width="640" data-height="360" /><source src="//upload.wikimedia.org/wikipedia/commons/transcoded/0/05/Non-alcoholic_fatty_liver_disease.webm/Non-alcoholic_fatty_liver_disease.webm.360p.webm" type="video/webm; codecs=&quot;vp8, vorbis&quot;" data-title="WebM (360P)" data-shorttitle="WebM 360P" data-transcodekey="360p.webm" data-width="640" data-height="360" /><track src="https://commons.wikimedia.org/w/api.php?action=timedtext&amp;title=File%3ANon-alcoholic_fatty_liver_disease.webm&amp;lang=ar&amp;trackformat=vtt&amp;origin=%2A" kind="subtitles" type="text/vtt" srclang="ar" label="العربية ‪(ar)‬" data-dir="rtl" /></video>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Non-alcoholic_fatty_liver_disease.webm" class="internal" title="Enlarge"></a></div>Overview of non-alcoholic fatty liver disease</div></div></div>
<p>People with NAFLD often have no noticeable symptoms, and NAFLD is often only detected during routine blood tests or unrelated abdominal imaging or <a href="/wiki/Liver_biopsy" title="Liver biopsy">liver biopsy</a>.<sup id="cite_ref-AASLD2018_4-6" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Friedman2018_22-1" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup> In some cases, NAFLD can cause symptoms related to liver dysfunction such as fatigue, <a href="/wiki/Malaise" title="Malaise">malaise</a>, and dull right-upper-quadrant <a href="/wiki/Abdominal_pain" title="Abdominal pain">abdominal discomfort</a>. Mild <a href="/wiki/Jaundice" title="Jaundice">yellow discoloration of the skin</a> may occur, although this is rare.<sup id="cite_ref-AlKhater2015_23-0" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup> NASH can severely impair liver function, leading to <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a>, <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a>, and <a href="/wiki/Liver_cancer" title="Liver cancer">liver cancer</a>.<sup id="cite_ref-AASLD2018_4-7" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Comorbidities">Comorbidities</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=3" title="Edit section: Comorbidities">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>NAFLD is strongly associated with or caused by type 2 diabetes, insulin resistance, and metabolic syndrome (defined as at least three of the five following medical conditions: abdominal obesity, high blood pressure, high blood sugar, high serum triglycerides, and low serum high-density lipoprotein). It is also associated with <a href="/wiki/Hormonal_disorder" class="mw-redirect" title="Hormonal disorder">hormonal disorders</a> (<a href="/wiki/Panhypopituitarism" class="mw-redirect" title="Panhypopituitarism">panhypopituitarism</a>, <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a>, <a href="/wiki/Hypogonadism" title="Hypogonadism">hypogonadism</a>, <a href="/wiki/Polycystic_ovary_syndrome" title="Polycystic ovary syndrome">polycystic ovary syndrome</a>), persistently <a href="/wiki/Elevated_transaminases" title="Elevated transaminases">elevated transaminases</a>, increasing age and <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">hypoxia</a> caused by <a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">obstructive sleep apnea</a>, with some of these conditions predicting disease progression.<sup id="cite_ref-ICD11_2-4" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-3" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-Nature2016_9-1" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-Tilg2016_13-1" class="reference"><a href="#cite_note-Tilg2016-13">&#91;13&#93;</a></sup><sup id="cite_ref-Younossi2016_16-1" class="reference"><a href="#cite_note-Younossi2016-16">&#91;16&#93;</a></sup><sup id="cite_ref-Younossi2017_20-3" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Musso2013_24-0" class="reference"><a href="#cite_note-Musso2013-24">&#91;24&#93;</a></sup>
</p><p>The majority of normal-weight people affected by NAFLD ("lean NAFLD") have impaired insulin sensitivity, are sedentary, and have increased cardiovascular disease risk and increased liver lipid levels. These are the consequences of a decreased capacity for storing fat and reduced mitochondrial function in adipose tissue and increased hepatic de novo <a href="/wiki/Lipogenesis" title="Lipogenesis">lipogenesis</a>.<sup id="cite_ref-AsiaPacific2017-1_6-4" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-Younossi2017_20-4" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> A recent systematic review has reported an increased risk of severe COVID-19 infection in NAFLD patients; however, no difference in mortality was observed between NAFLD and non-NAFLD patients.<sup id="cite_ref-25" class="reference"><a href="#cite_note-25">&#91;25&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Risk_factors">Risk factors</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=4" title="Edit section: Risk factors">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=5" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Two-thirds of families with a history of diabetes type 2 report more than one family member having NAFLD. There is a higher risk of fibrosis for family members where someone was diagnosed with NASH.<sup id="cite_ref-Friedman2018_22-2" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup> Asian populations are more susceptible to metabolic syndrome and NAFLD than their western counterparts.<sup id="cite_ref-AsiaPacific2017-1_6-5" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> Hispanic persons have a higher prevalence of NAFLD than white individuals, whereas the lowest prevalence is observed in black individuals.<sup id="cite_ref-Younossi2017_20-5" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> NAFLD is twice as prevalent in men as in women,<sup id="cite_ref-AASLD2018_4-8" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> which might be explained by lower levels of estrogen in men.<sup id="cite_ref-26" class="reference"><a href="#cite_note-26">&#91;26&#93;</a></sup>
</p><p><a href="/wiki/Gene_polymorphism" title="Gene polymorphism">Genetic variations</a> in two genes are associated with NAFLD: non-synonymous <a href="/wiki/Single-nucleotide_polymorphisms" class="mw-redirect" title="Single-nucleotide polymorphisms">single-nucleotide polymorphisms</a> (SNPs) in <a href="/wiki/PNPLA3" title="PNPLA3">PNPLA3</a> and <a href="/wiki/TM6SF2" title="TM6SF2">TM6SF2</a>. Both correlate with NAFLD presence and severity, but their roles for diagnosis remain unclear.<sup id="cite_ref-Younossi2017_20-6" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Wong2018_27-0" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup> Although NAFLD has a genetic component, the <a href="/wiki/American_Association_for_the_Study_of_Liver_Diseases" title="American Association for the Study of Liver Diseases">American Association for the Study of Liver Diseases</a> (AASLD) does not recommend screening family members as there is not enough confirmation of heritability,<sup id="cite_ref-AASLD2018_4-9" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> although there is some evidence from <a href="/wiki/Familial_aggregation" class="mw-redirect" title="Familial aggregation">familial aggregation</a> and <a href="/wiki/Twin_studies" class="mw-redirect" title="Twin studies">twin studies</a>.<sup id="cite_ref-Younossi2017_20-7" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="From_diet">From diet</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=6" title="Edit section: From diet">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>According to the Asia-Pacific Working Group (APWG) on NAFLD, overnutrition is a major factor of NAFLD and NASH, particularly for lean NAFLD.<sup id="cite_ref-AsiaPacific2017-1_6-6" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> Diet composition and quantity, in particular <a href="/wiki/Omega-6_fatty_acid" title="Omega-6 fatty acid">omega-6 fatty acid</a> and <a href="/wiki/Fructose" title="Fructose">fructose</a>, have important roles in disease progression from NAFL to NASH and fibrosis.<sup id="cite_ref-Lim2010_28-0" class="reference"><a href="#cite_note-Lim2010-28">&#91;28&#93;</a></sup><sup id="cite_ref-Wree2013_29-0" class="reference"><a href="#cite_note-Wree2013-29">&#91;29&#93;</a></sup> Choline deficiency can lead to the development of NAFLD.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30">&#91;30&#93;</a></sup>
</p><p>There may be a link between some kinds of meat and NAFLD; a study published in 2022 found a link between processed and red meat consumption and NAFLD,<sup id="cite_ref-31" class="reference"><a href="#cite_note-31">&#91;31&#93;</a></sup> while another study on Chinese adults concluded that "organ meat consumption was related to a modestly higher risk of NAFLD among Chinese adults."<sup id="cite_ref-32" class="reference"><a href="#cite_note-32">&#91;32&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="From_lifestyle">From lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=7" title="Edit section: From lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Habitual <a href="/wiki/Snoring" title="Snoring">snoring</a> may be a risk factor for NAFLD, even after accounting for established risk factors in individuals. Severe cases of snoring lead to airway blockage or difficulty breathing when sleeping, and usually signals the presence of obstructive sleep apnea (OSAS), a much more serious breathing condition. Blockage or narrowing of the airways, even temporarily, can cause the body to experience lowered oxygen levels in the blood, and these conditions of <a href="/wiki/Hypoxia_(medical)" title="Hypoxia (medical)">hypoxia</a> are recurring in those with <a href="/wiki/Obstructive_sleep_apnea" title="Obstructive sleep apnea">obstructive sleep apnea</a> (OSAS). Constant hypoxia may cause a variety of changes within the body, such as tissue inflammation, increased insulin resistance, and liver injury.<sup id="cite_ref-33" class="reference"><a href="#cite_note-33">&#91;33&#93;</a></sup> A prospective cohort study found the association between habitual snoring and NAFLD development to be significant, and the trend was noted to be most prominent in lean individuals.<sup id="cite_ref-34" class="reference"><a href="#cite_note-34">&#91;34&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Pathophysiology">Pathophysiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=8" title="Edit section: Pathophysiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The primary characteristic of NAFLD is the accumulation of lipids in the liver, largely in the form of <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>.<sup id="cite_ref-Marjot2020_15-2" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> However, the mechanisms by which triglycerides accumulate and the reasons that accumulation can lead to liver dysfunction are complex and incompletely understood.<sup id="cite_ref-Marjot2020_15-3" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup><sup id="cite_ref-HEPAMARCHESINI2016_35-0" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup><sup id="cite_ref-36" class="reference"><a href="#cite_note-36">&#91;36&#93;</a></sup><sup id="cite_ref-37" class="reference"><a href="#cite_note-37">&#91;37&#93;</a></sup> NAFLD can include steatosis along with varied signs of liver injury: either lobular or portal inflammation (a form of liver injury) or <a href="/wiki/Ballooning_degeneration" title="Ballooning degeneration">ballooning degeneration</a>. Similarly, NASH can include histological features such as portal inflammation, <a href="/wiki/Granulocyte" title="Granulocyte">polymorphonuclear cell</a> infiltrates, <a href="/wiki/Mallory_body" title="Mallory body">Mallory bodies</a>, <a href="/wiki/Apoptosis" title="Apoptosis">apoptotic</a> bodies, clear vacuolated nuclei, <a href="/wiki/Microvesicular_steatosis" class="mw-redirect" title="Microvesicular steatosis">microvesicular steatosis</a>, <a href="/wiki/Megamitochondria" title="Megamitochondria">megamitochondria</a>, and <a href="/wiki/Perisinusoidal_space" title="Perisinusoidal space">perisinusoidal fibrosis</a>.<sup id="cite_ref-EASL2016_14-2" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> Hepatocyte death via apoptosis or <a href="/wiki/Necroptosis" title="Necroptosis">necroptosis</a> is increased in NASH compared with simple steatosis, and inflammation is a hallmark of NASH.<sup id="cite_ref-Wong2018_27-1" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup>
</p><p>One debated mechanism proposes that hepatic steatosis progresses to steatosis with inflammation following some further injury, or <i>second hit</i>. <a href="/wiki/Oxidative_stress" title="Oxidative stress">Oxidative stress</a>, hormonal imbalances, and <a href="/wiki/Mitochondrion" title="Mitochondrion">mitochondrial</a> abnormalities are potential causes of this "second hit" phenomenon.<sup id="cite_ref-Friedman2018_22-3" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup> A further <a href="/wiki/Nutritional_genomics" title="Nutritional genomics">nutrigenomics</a> model named <i>multiple hit</i> extends the <i>second hit</i> model, suggesting that multiple disease biomarkers and factors such as genes and nutrition influence NAFLD and NASH progression. This model attempts to use these factors to predict the impact of lifestyle changes and genetics for the evolution of the NAFLD pathology.<sup id="cite_ref-38" class="reference"><a href="#cite_note-38">&#91;38&#93;</a></sup> Many researchers describe NAFLD as a <i>multisystem</i> disease, as it impacts and is influenced by organs and regulatory pathways other than the liver.<sup id="cite_ref-Byrne2015_39-0" class="reference"><a href="#cite_note-Byrne2015-39">&#91;39&#93;</a></sup><sup id="cite_ref-40" class="reference"><a href="#cite_note-40">&#91;40&#93;</a></sup><sup id="cite_ref-Bagherniya2018_41-0" class="reference"><a href="#cite_note-Bagherniya2018-41">&#91;41&#93;</a></sup>
</p><p>The accumulation of <a href="/wiki/Cellular_senescence" title="Cellular senescence">senescent cells</a> in the liver is seen in persons with NAFLD.<sup id="cite_ref-pmid31451866_42-0" class="reference"><a href="#cite_note-pmid31451866-42">&#91;42&#93;</a></sup> In mice, liver senescent <a href="/wiki/Hepatocyte" title="Hepatocyte">hepatocytes</a> result in increased liver fat deposition.<sup id="cite_ref-pmid31451866_42-1" class="reference"><a href="#cite_note-pmid31451866-42">&#91;42&#93;</a></sup> Treatment of NAFLD mice with <a href="/wiki/Senolytic" title="Senolytic">senolytic</a> agents has been shown to reduce hepatic steatosis.<sup id="cite_ref-pmid31451866_42-2" class="reference"><a href="#cite_note-pmid31451866-42">&#91;42&#93;</a></sup>
</p><p>Based on <a href="/wiki/Gene_knockout" title="Gene knockout">gene knockout</a> studies in murine models, it has been suggested that, among many other pathogenic factors, <a href="/wiki/TGF_beta_signaling_pathway" title="TGF beta signaling pathway">TGF beta signals</a> may be crucially involved in promoting the progression of NASH.<sup id="cite_ref-43" class="reference"><a href="#cite_note-43">&#91;43&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Fructose_consumption">Fructose consumption</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=9" title="Edit section: Fructose consumption">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Non-alcoholic and alcoholic fatty liver disease share similar histological features, which suggests that they might share common pathogenic pathways. Fructose can cause liver inflammation and addiction similarly to ethanol by using similar metabolic pathways, unlike glucose. Therefore, some researchers argue that non-alcoholic and alcoholic fatty liver diseases are more alike than previously thought.<sup id="cite_ref-Lim2010_28-1" class="reference"><a href="#cite_note-Lim2010-28">&#91;28&#93;</a></sup><sup id="cite_ref-44" class="reference"><a href="#cite_note-44">&#91;44&#93;</a></sup> Furthermore, high fructose consumption promotes fat accumulation in the liver by stimulating <a href="/wiki/De_novo_synthesis#Fatty-acid" title="De novo synthesis"><i>de novo</i> lipogenesis</a> in the liver and reducing the <a href="/wiki/Beta-oxidation" class="mw-redirect" title="Beta-oxidation">beta-oxidation</a> of fat.<sup id="cite_ref-Marjot2020_15-4" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Unlike the sugar <a href="/wiki/Glucose" title="Glucose">glucose</a>, the enzyme <a href="/wiki/Fructokinase" title="Fructokinase">fructokinase</a> rapidly metabolizes fructose. This leads to a decreased level of intracellular <a href="/wiki/Adenosine_triphosphate" title="Adenosine triphosphate">adenosine triphosphate</a> (ATP).<sup id="cite_ref-Marjot2020_15-5" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> The decrease in ATP increases <a href="/wiki/Reactive_oxygen_species" title="Reactive oxygen species">oxidative stress</a> and impairments in proper protein synthesis and mitochondrial function in the liver.<sup id="cite_ref-Marjot2020_15-6" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Insulin_resistance">Insulin resistance</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=10" title="Edit section: Insulin resistance">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Insulin resistance contributes to the accumulation of toxic fat in the liver in several ways. First, it promotes the release of <a href="/wiki/Free_fatty_acid" class="mw-redirect" title="Free fatty acid">free fatty acids</a> (FFAs) from <a href="/wiki/Adipose_tissue" title="Adipose tissue">adipose tissue</a> into the blood. Typically, adipose tissue stores lipids in the form of <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a>, slowly releasing them into the bloodstream when insulin is low. In insulin-resistant adipose tissue, such as in people with obesity and type 2 diabetes, more triglycerides are <a href="/wiki/Lipolysis" title="Lipolysis">broken down</a> into FFAs and released into the bloodstream, promoting uptake by the liver.<sup id="cite_ref-Marjot2020_15-7" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Second, insulin promotes the production of new FFAs in the liver via <a href="/wiki/Lipogenesis" title="Lipogenesis"><i>de novo</i> lipogenesis</a>; this production of liver fats continues to be stimulated by insulin, even when other tissues are insulin-resistant.<sup id="cite_ref-Marjot2020_15-8" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> These FFAs are combined back into triglycerides in the liver, forming the major constituent of the accumulated fat in the liver.<sup id="cite_ref-Marjot2020_15-9" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> The three sources of free fatty acids that contribute to liver triglyceride accumulation include FFAs circulating in the bloodstream (59%), FFAs derived from carbohydrates such as fructose and glucose (26%), and diet (14%).<sup id="cite_ref-Marjot2020_15-10" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Despite the accumulation of triglycerides in the liver, they are not directly toxic to liver tissue.<sup id="cite_ref-Marjot2020_15-11" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Instead, alteration of the profile of the other lipid subtypes present in the liver, such as <a href="/wiki/Diacylglycerol" class="mw-redirect" title="Diacylglycerol">diacylglycerols</a>, <a href="/wiki/Phospholipid" title="Phospholipid">phospholipids</a>, <a href="/wiki/Ceramide" title="Ceramide">ceramides</a>, and free <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a>, have a more significant role in the pathogenesis of NAFLD.<sup id="cite_ref-Marjot2020_15-12" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup>
</p><p>Once NAFLD progresses in severity to the point of NASH, this promotes further insulin resistance in the adipose tissue and liver, which results in a harmful cycle of insulin resistance, liver fat accumulation, and inflammation.<sup id="cite_ref-Marjot2020_15-13" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Adipose tissue dysfunction also decreases secretion of the insulin-sensitizing <a href="/wiki/Adipokine" title="Adipokine">adipokine</a> <a href="/wiki/Adiponectin" title="Adiponectin">adiponectin</a> in people with NAFLD.<sup id="cite_ref-Marjot2020_15-14" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> Adiponectin has several properties that protect the liver.<sup id="cite_ref-Marjot2020_15-15" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> These properties include improved liver fat metabolism, decreased <i>de novo</i> lipogenesis, decreased <a href="/wiki/Gluconeogenesis" title="Gluconeogenesis">glucose production in the liver</a>, <a href="/wiki/Anti-inflammatory" title="Anti-inflammatory">anti-inflammatory</a> properties, and <a href="/wiki/Antifibrotic" class="mw-redirect" title="Antifibrotic">anti-fibrotic</a> properties.<sup id="cite_ref-Marjot2020_15-16" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> <a href="/wiki/Skeletal_muscle" title="Skeletal muscle">Skeletal muscle</a> insulin resistance may also play a role in NAFLD. Insulin-resistant skeletal muscle is not as efficient at taking up glucose from the bloodstream after a meal.<sup id="cite_ref-Marjot2020_15-17" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup> This inefficient glucose uptake promotes the redistribution of consumed carbohydrates from glucose destined for use in <a href="/wiki/Glycogen" title="Glycogen">glycogen</a> stores in the skeletal muscles to being used as a substrate for <i>de novo</i> lipogenesis in the liver.<sup id="cite_ref-Marjot2020_15-18" class="reference"><a href="#cite_note-Marjot2020-15">&#91;15&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Dysbiosis">Dysbiosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=11" title="Edit section: Dysbiosis">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Disruptions in the intestinal microbiota seem to influence NAFLD risk in several ways.<sup id="cite_ref-45" class="reference"><a href="#cite_note-45">&#91;45&#93;</a></sup> People with NASH can have elevated levels of blood ethanol and <a href="/wiki/Pseudomonadota" title="Pseudomonadota">Pseudomonadota</a> (which produce alcohol), with dysbiosis proposed as a mechanism for this elevation.<sup id="cite_ref-Leung2016_46-0" class="reference"><a href="#cite_note-Leung2016-46">&#91;46&#93;</a></sup> Alterations in the composition of the intestinal microbiota may influence NAFLD risk in several ways. These changes appear to increase the permeability of intestinal tissue, thereby facilitating increased liver exposure to harmful substances (e.g., translocated bacteria, <a href="/wiki/Lipopolysaccharide" title="Lipopolysaccharide">bacterial toxins</a>, and <a href="/wiki/Cytokine" title="Cytokine">inflammatory chemical signals</a>). The increased transport of these harmful substances to the liver promotes liver inflammation, enhances nutrient and calorie absorption, and alters <a href="/wiki/Choline" title="Choline">choline</a> metabolism.<sup id="cite_ref-Leung2016_46-1" class="reference"><a href="#cite_note-Leung2016-46">&#91;46&#93;</a></sup><sup id="cite_ref-Mehal2013_47-0" class="reference"><a href="#cite_note-Mehal2013-47">&#91;47&#93;</a></sup><sup id="cite_ref-48" class="reference"><a href="#cite_note-48">&#91;48&#93;</a></sup> Higher levels of intestinal bacteria that produce <a href="/wiki/Butyrate" class="mw-redirect" title="Butyrate">butyrate</a> may be protective.<sup id="cite_ref-Leung2016_46-2" class="reference"><a href="#cite_note-Leung2016-46">&#91;46&#93;</a></sup>
</p><p>Excessive macronutrient intake contributes to gut inflammation and perturbation of homeostasis, and micronutrients may also be involved.<sup id="cite_ref-49" class="reference"><a href="#cite_note-49">&#91;49&#93;</a></sup> In addition to reducing weight and risk factors, lifestyle changes may prompt positive changes in the gut microbiota.<sup id="cite_ref-50" class="reference"><a href="#cite_note-50">&#91;50&#93;</a></sup> In particular, diet diversity may play a role that was overlooked in animal studies, since they often compare a <a href="/wiki/Western_pattern_diet" title="Western pattern diet">Western high-fat, low-diversity diet</a> against a low-fat but higher-diversity chow.<sup id="cite_ref-Heiman2016_51-0" class="reference"><a href="#cite_note-Heiman2016-51">&#91;51&#93;</a></sup> The health benefits after bariatric surgery may also involve changes in the gut microbiota by increasing gut permeability.<sup id="cite_ref-Heiman2016_51-1" class="reference"><a href="#cite_note-Heiman2016-51">&#91;51&#93;</a></sup>
</p>
<ul class="gallery mw-gallery-traditional">
		<li class="gallerybox" style="width: 155px"><div style="width: 155px">
			<div class="thumb" style="width: 150px;"><div style="margin:15px auto;"><a href="/wiki/File:Mallory_body_high_mag_cropped_annotated.jpg" class="image" title="Mallory-Denk body"><img alt="Mallory-Denk body" src="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Mallory_body_high_mag_cropped_annotated.jpg/110px-Mallory_body_high_mag_cropped_annotated.jpg" decoding="async" width="110" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Mallory_body_high_mag_cropped_annotated.jpg/165px-Mallory_body_high_mag_cropped_annotated.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/4/4d/Mallory_body_high_mag_cropped_annotated.jpg/221px-Mallory_body_high_mag_cropped_annotated.jpg 2x" data-file-width="1118" data-file-height="1216" /></a></div></div>
			<div class="gallerytext">
<p><a href="/wiki/Mallory_body" title="Mallory body">Mallory-Denk body</a>
</p>
			</div>
		</div></li>
		<li class="gallerybox" style="width: 155px"><div style="width: 155px">
			<div class="thumb" style="width: 150px;"><div style="margin:35.5px auto;"><a href="/wiki/File:Ballooning_degeneration_high_mag_cropped_annotated.jpg" class="image" title="Ballooning degeneration"><img alt="Ballooning degeneration" src="//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Ballooning_degeneration_high_mag_cropped_annotated.jpg/120px-Ballooning_degeneration_high_mag_cropped_annotated.jpg" decoding="async" width="120" height="79" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/6/69/Ballooning_degeneration_high_mag_cropped_annotated.jpg/180px-Ballooning_degeneration_high_mag_cropped_annotated.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/69/Ballooning_degeneration_high_mag_cropped_annotated.jpg/240px-Ballooning_degeneration_high_mag_cropped_annotated.jpg 2x" data-file-width="1700" data-file-height="1124" /></a></div></div>
			<div class="gallerytext">
<p><a href="/wiki/Ballooning_degeneration" title="Ballooning degeneration">Ballooning degeneration</a>
</p>
			</div>
		</div></li>
		<li class="gallerybox" style="width: 155px"><div style="width: 155px">
			<div class="thumb" style="width: 150px;"><div style="margin:15px auto;"><a href="/wiki/File:6_Nash_8_680x512px.tif" class="image" title="NASH (inflammation) and fibrosis stage 1"><img alt="NASH (inflammation) and fibrosis stage 1" src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7b/6_Nash_8_680x512px.tif/lossy-page1-120px-6_Nash_8_680x512px.tif.jpg" decoding="async" width="120" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7b/6_Nash_8_680x512px.tif/lossy-page1-180px-6_Nash_8_680x512px.tif.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7b/6_Nash_8_680x512px.tif/lossy-page1-240px-6_Nash_8_680x512px.tif.jpg 2x" data-file-width="500" data-file-height="500" /></a></div></div>
			<div class="gallerytext">
<p>NASH (inflammation) and fibrosis stage 1
</p>
			</div>
		</div></li>
		<li class="gallerybox" style="width: 155px"><div style="width: 155px">
			<div class="thumb" style="width: 150px;"><div style="margin:15px auto;"><a href="/wiki/File:2_NASH_09_680x512px.tif" class="image" title="NASH (inflammation) and fibrosis stage 2"><img alt="NASH (inflammation) and fibrosis stage 2" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/2_NASH_09_680x512px.tif/lossy-page1-120px-2_NASH_09_680x512px.tif.jpg" decoding="async" width="120" height="120" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9c/2_NASH_09_680x512px.tif/lossy-page1-180px-2_NASH_09_680x512px.tif.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9c/2_NASH_09_680x512px.tif/lossy-page1-240px-2_NASH_09_680x512px.tif.jpg 2x" data-file-width="500" data-file-height="500" /></a></div></div>
			<div class="gallerytext">
<p>NASH (inflammation) and fibrosis stage 2
</p>
			</div>
		</div></li>
		<li class="gallerybox" style="width: 155px"><div style="width: 155px">
			<div class="thumb" style="width: 150px;"><div style="margin:35px auto;"><a href="/wiki/File:Lobular_necro-inflammation_--_high_mag.jpg" class="image" title="Lobular inflammation"><img alt="Lobular inflammation" src="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Lobular_necro-inflammation_--_high_mag.jpg/120px-Lobular_necro-inflammation_--_high_mag.jpg" decoding="async" width="120" height="80" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/5/59/Lobular_necro-inflammation_--_high_mag.jpg/180px-Lobular_necro-inflammation_--_high_mag.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/5/59/Lobular_necro-inflammation_--_high_mag.jpg/240px-Lobular_necro-inflammation_--_high_mag.jpg 2x" data-file-width="4272" data-file-height="2848" /></a></div></div>
			<div class="gallerytext">
<p>Lobular inflammation
</p>
			</div>
		</div></li>
</ul>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=12" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:312px;"><a href="/wiki/File:NAFLD_liver_progression.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b1/NAFLD_liver_progression.svg/310px-NAFLD_liver_progression.svg.png" decoding="async" width="310" height="151" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b1/NAFLD_liver_progression.svg/465px-NAFLD_liver_progression.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b1/NAFLD_liver_progression.svg/620px-NAFLD_liver_progression.svg.png 2x" data-file-width="3014" data-file-height="1469" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:NAFLD_liver_progression.svg" class="internal" title="Enlarge"></a></div>Stages of progression of non-alcoholic fatty liver disease</div></div></div>
<p>NAFLD is defined by evidence of <a href="/wiki/Fatty_liver" class="mw-redirect" title="Fatty liver">fatty liver</a> without another factor that could explain the liver fat accumulation, such as <a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">excessive alcohol use</a> (&gt;21 <a href="/wiki/Standard_drink" title="Standard drink">standard drinks</a>/week for men and &gt;14 for women in the USA; &gt;30&#160;g daily for men and &gt;20&#160;g for women in UK and EU, &gt;140&#160;g/week for men and &gt;70&#160;g/week for women in Asia-Pacific and most <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">NIH</a> clinical studies), <a href="/wiki/Hepatotoxicity#Steatosis" title="Hepatotoxicity">drug-induced steatosis</a>, chronic hepatitis&#160;C, heredity or by deficiencies in <a href="/wiki/Parenteral_nutrition" title="Parenteral nutrition">parenteral nutrition</a> such as <a href="/wiki/Choline" title="Choline">choline</a> and endocrine conditions. If any of these factors are observed, an investigation into alternative causes of fatty liver unrelated to NAFLD is recommended. A history of chronic alcohol usage is an important consideration.<sup id="cite_ref-ICD11_2-5" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AASLD2018_4-10" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-7" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-NICE2016_12-1" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-EASL2016_14-3" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p><p>NAFLD comprises two histological categories: NAFL, and the more aggressive form NASH. The presence of at least 5% <a href="/wiki/Fatty_liver" class="mw-redirect" title="Fatty liver">fatty liver</a> is common to both NAFL and NASH, but the features of substantial lobular inflammation and hepatocyte injuries such as ballooning or Mallory hyaline only occur in NASH. The majority of NAFL cases show minimal or no inflammation.<sup id="cite_ref-ICD11_2-6" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AASLD2018_4-11" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-8" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> Pericentral and perisinusoidal fibrosis occur more often in adult-onset NASH, whereas portal fibrosis is more common in children with the disorder. NASH represents a more advanced stage of NAFL and is associated with poor outcomes such as cardiovascular events, cirrhosis, or hepatocellular carcinoma. ICD-11 does not use the term NAFL as it was deemed confusing with the family of disorders NAFLD. The preferred descriptions are instead: NAFLD without NASH or simple steatosis and "NASH". Also, the modifier with or without fibrosis or cirrhosis completes the diagnostic description.<sup id="cite_ref-ICD11_2-7" class="reference"><a href="#cite_note-ICD11-2">&#91;2&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-9" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Blood_tests">Blood tests</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=13" title="Edit section: Blood tests">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Elevated <a href="/wiki/Liver_enzyme" class="mw-redirect" title="Liver enzyme">liver enzymes</a> are common. According to <a href="/wiki/National_Institute_for_Health_and_Care_Excellence" title="National Institute for Health and Care Excellence">National Institute for Health and Care Excellence</a> (NICE) guidelines, it is disadvised to test enzymes levels to rule out NAFLD, as they are often within the normal range even in advanced disease.<sup id="cite_ref-Nature2016_9-2" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-2" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-Younossi2017_20-8" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup>
</p><p>Blood tests that are useful to confirm diagnosis or rule out others include <a href="/wiki/Erythrocyte_sedimentation_rate" title="Erythrocyte sedimentation rate">erythrocyte sedimentation rate</a>, <a href="/wiki/Glucose" title="Glucose">glucose</a>, <a href="/wiki/Human_serum_albumin" title="Human serum albumin">albumin</a>, and <a href="/wiki/Kidney_function" class="mw-redirect" title="Kidney function">kidney function</a>. Because the liver is important for making proteins used in <a href="/wiki/Coagulation" title="Coagulation">blood clotting</a>, coagulation-related studies are often carried out, especially the INR (<a href="/wiki/International_normalized_ratio" class="mw-redirect" title="International normalized ratio">international normalized ratio</a>). In people with fatty liver with associated inflammatory injury (steatohepatitis) blood tests are usually used to rule out viral <a href="/wiki/Hepatitis" title="Hepatitis">hepatitis</a> (hepatitis&#160;A, B, C and <a href="/wiki/Herpesvirus" class="mw-redirect" title="Herpesvirus">herpesviruses</a> such as <a href="/wiki/Epstein%E2%80%93Barr_virus" title="Epstein–Barr virus">Epstein–Barr virus</a> or <a href="/wiki/Human_cytomegalovirus" class="mw-redirect" title="Human cytomegalovirus">cytomegalovirus</a>), <a href="/wiki/Rubella" title="Rubella">rubella</a>, and autoimmune diseases. <a href="/wiki/Hypothyroidism" title="Hypothyroidism">Low thyroid activity</a> is more prevalent in people with NASH, which would be detected by determining the <a href="/wiki/Thyroid-stimulating_hormone" title="Thyroid-stimulating hormone">thyroid-stimulating hormone</a>.<sup id="cite_ref-Liangpunsakul2003_52-0" class="reference"><a href="#cite_note-Liangpunsakul2003-52">&#91;52&#93;</a></sup> Some biomarker-based blood tests have been developed and may be useful for diagnosis.<sup id="cite_ref-Musso2010_53-0" class="reference"><a href="#cite_note-Musso2010-53">&#91;53&#93;</a></sup>
</p><p>Although blood tests cannot diagnose NAFLD, circulating serum biomarkers of liver fibrosis can give moderate estimates in the diagnosis of liver fibrosis and cirrhosis. The ratio of the <a href="/wiki/Transaminase" title="Transaminase">transaminase</a> liver enzyme <a href="/wiki/Aspartate_aminotransferase" class="mw-redirect" title="Aspartate aminotransferase">aspartate aminotransferase</a> (AST) to <a href="/wiki/Platelet" title="Platelet">platelets</a> in the blood, known as the AST/platelet ratio index (APRI score), and Fibrotest are recommended as the preferred noninvasive tests for cirrhosis by the Asian-Pacific Association for Study of the Liver (APASL).<sup id="cite_ref-APASL2016_54-0" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> Several other scores such as FIB-4 score and NAFLD fibrosis score can also reflect the burden of the fibrosis in the liver,<sup id="cite_ref-55" class="reference"><a href="#cite_note-55">&#91;55&#93;</a></sup> and previous studies have confirmed that these score can predict future development of mortality and liver cancer.<sup id="cite_ref-56" class="reference"><a href="#cite_note-56">&#91;56&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Imaging">Imaging</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=14" title="Edit section: Imaging">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:352px;"><a href="/wiki/File:MRI_Liversteatosis.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/MRI_Liversteatosis.jpg/350px-MRI_Liversteatosis.jpg" decoding="async" width="350" height="185" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/3/37/MRI_Liversteatosis.jpg/525px-MRI_Liversteatosis.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/3/37/MRI_Liversteatosis.jpg/700px-MRI_Liversteatosis.jpg 2x" data-file-width="1351" data-file-height="715" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:MRI_Liversteatosis.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a> of a healthy liver (top row) and one with severe steatosis (bottom row)</div></div></div>
<p>A liver <a href="/wiki/Medical_ultrasound" title="Medical ultrasound">ultrasound</a> scan or <a href="/wiki/MRI" class="mw-redirect" title="MRI">magnetic resonance imaging</a> (MRI) can diagnose steatosis,<sup id="cite_ref-57" class="reference"><a href="#cite_note-57">&#91;57&#93;</a></sup> but not fibrosis and confirmation of early cirrhosis detection by ultrasound by other diagnostic methods is recommended.<sup id="cite_ref-APASL2016_54-1" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> The <a href="/wiki/European_Association_for_the_Study_of_the_Liver" title="European Association for the Study of the Liver">European Association for the Study of the Liver</a> (EASL) recommends screening for steatosis whenever NAFLD is suspected as this is a strong predictor of the disease evolution and predicts future type 2 diabetes, cardiovascular events, and <a href="/wiki/Hypertension" title="Hypertension">hypertension</a>.<sup id="cite_ref-EASL2016_14-4" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> These non-invasive methods can be used for NAFLD screening but are not accepted as a substitute for liver biopsy in NAFLD nor NASH clinical trials, as only a liver biopsy can define liver pathology.<sup id="cite_ref-AsiaPacific2017-1_6-10" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-3" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>Ultrasound presented average sensitivity and specificity for diagnosing the disease in children, while in the adult population, sensitivity and specificity were significantly higher. Proton density fat fraction magnetic resonance imaging has been increasingly used for the diagnosis of steatosis in pediatric patients. Elastography is an effective tool for staging liver fibrosis and discriminating NASH from NAFLD in children.<sup id="cite_ref-58" class="reference"><a href="#cite_note-58">&#91;58&#93;</a></sup>
</p><p><a href="/wiki/CT_scan" title="CT scan">CT scans</a> and MRIs are more accurate in detecting cirrhosis than conventional ultrasound.<sup id="cite_ref-APASL2016_54-2" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> <a href="/wiki/Transient_elastography" class="mw-redirect" title="Transient elastography">Transient elastography</a> is recommended for the initial assessment of liver fibrosis and cirrhosis and helps to predict complications and prognosis, but the interpretation of results is carefully weighed in the presence of limiting factors, such as steatosis, high BMI, lower degrees of hepatic fibrosis and narrow spaces between the ribs (intercostal spaces). However, transient elastography can fail for people with pre-hepatic <a href="/wiki/Portal_hypertension" title="Portal hypertension">portal hypertension</a>. Transient elastography is not considered to be a replacement for liver biopsy.<sup id="cite_ref-APASL2016_54-3" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup>
</p><p><a href="/wiki/Magnetic_resonance_elastography" title="Magnetic resonance elastography">Magnetic resonance elastography</a> (MRE) is an emerging method that can accurately assess hepatic fibrosis and is recommended by the APASL.<sup id="cite_ref-APASL2016_54-4" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> MRE possesses a good sensitivity to quantify hepatic fat and excellent accuracy to detect fibrosis in NAFLD regardless of BMI and inflammation and is suggested as a more reliable alternative to diagnose NAFLD and its progression to NASH compared to ultrasound and blood tests.<sup id="cite_ref-AlKhater2015_23-1" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup><sup id="cite_ref-Wong2018_27-2" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup><sup id="cite_ref-EURORADIOSINGH2015_59-0" class="reference"><a href="#cite_note-EURORADIOSINGH2015-59">&#91;59&#93;</a></sup><sup id="cite_ref-60" class="reference"><a href="#cite_note-60">&#91;60&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Liver_biopsy">Liver biopsy</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=15" title="Edit section: Liver biopsy">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Human_liver_biopsy_sample.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Human_liver_biopsy_sample.jpg/220px-Human_liver_biopsy_sample.jpg" decoding="async" width="220" height="141" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Human_liver_biopsy_sample.jpg/330px-Human_liver_biopsy_sample.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/d/d7/Human_liver_biopsy_sample.jpg/440px-Human_liver_biopsy_sample.jpg 2x" data-file-width="4703" data-file-height="3017" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Human_liver_biopsy_sample.jpg" class="internal" title="Enlarge"></a></div>A small quantity of tissue is sampled from the liver when doing a <a href="/wiki/Liver_biopsy" title="Liver biopsy">biopsy</a>, which is then examined under a microscope</div></div></div>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Non-alcoholic_fatty_liver_disease1.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/8/83/Non-alcoholic_fatty_liver_disease1.jpg/220px-Non-alcoholic_fatty_liver_disease1.jpg" decoding="async" width="220" height="164" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/8/83/Non-alcoholic_fatty_liver_disease1.jpg/330px-Non-alcoholic_fatty_liver_disease1.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/8/83/Non-alcoholic_fatty_liver_disease1.jpg/440px-Non-alcoholic_fatty_liver_disease1.jpg 2x" data-file-width="3460" data-file-height="2572" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Non-alcoholic_fatty_liver_disease1.jpg" class="internal" title="Enlarge"></a></div><a href="/wiki/Micrograph" title="Micrograph">Micrograph</a> of non-alcoholic fatty liver disease, demonstrating marked <a href="/wiki/Steatosis" title="Steatosis">steatosis</a> (fat in liver cells appears white; connective tissue, blue). <a href="/wiki/Trichrome_stain" class="mw-redirect" title="Trichrome stain">Trichrome stain</a></div></div></div>
<p>A <a href="/wiki/Liver_biopsy" title="Liver biopsy">liver biopsy</a> (tissue examination) is the only test widely accepted (gold standard) as definitively diagnosing and distinguishing NAFLD (including NAFL and NASH) from other forms of liver disease and can be used to assess the severity of the inflammation and resultant fibrosis. However, since most people affected by NAFLD are likely to be asymptomatic, liver biopsy presents too high a risk for routine diagnosis, so other methods are preferred, such as liver <a href="/wiki/Ultrasonography" class="mw-redirect" title="Ultrasonography">ultrasonography</a> or liver <a href="/wiki/Magnetic_resonance_imaging" title="Magnetic resonance imaging">MRI</a>. For young people, guidelines recommend liver ultrasonography, but biopsy remains the best evidence.<sup id="cite_ref-AASLD2018_4-12" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-11" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-NICE2016_12-3" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-AlKhater2015_23-2" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup> Liver biopsy is also the gold standard to detect hepatic fibrosis and assess its progression.<sup id="cite_ref-APASL2016_54-5" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> Routine liver function blood tests are not sensitive enough to detect NAFLD, and biopsy is the only procedure that can reliably differentiate NAFL from NASH.<sup id="cite_ref-EASL2016_14-5" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p><p>There are several liver biopsy techniques available to obtain liver tissue. Percutaneous liver biopsy remains the most common practice. Biopsies can also be performed via the transvenous route, either during surgery or by <a href="/wiki/Laparoscopy" title="Laparoscopy">laparoscopy</a>, especially for people with contraindications to a percutaneous approach. The liver biopsy can also be image-guided, in real-time or not, which is recommended for some clinical situations such as people with known intra-hepatic lesions, previous intra-abdominal surgery who may have adhesions, a small liver that is difficult to percuss, obese people and people with evident ascites. Vital signs must be monitored frequently afterward (at least every 15 minutes in the hour following the biopsy).<sup id="cite_ref-APASL2016_54-6" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup>
</p><p>According to AASLD guidelines, a liver biopsy may be considered in people with NAFLD who are at increased risk of having steatohepatitis with or without advanced fibrosis, but only when all other competing chronic liver diseases are excluded (such as alcoholic liver disease). The presence of metabolic syndrome, NAFLD Fibrosis Score (FIB-4), or liver stiffness (as measured by Vibration-controlled transient elastography or <a href="/wiki/Magnetic_resonance_elastography" title="Magnetic resonance elastography">MRE</a>) can identify the individuals who are at higher risk of steatohepatitis or advanced fibrosis.<sup id="cite_ref-AASLD2018_4-13" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>The AASLD and ICD-11 consider that clinically useful pathology reporting distinguishes "between NAFL (steatosis), NAFL with inflammation and NASH (steatosis with lobular and portal inflammation and hepatocellular ballooning)" with the presence or absence of fibrosis being described and optionally comment on severity.<sup id="cite_ref-AASLD2018_4-14" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-12" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> The EASL recommends the Fatty Liver Inhibition of Progression (FLIP) algorithm to grade the ballooning and classify NAFLD-associated liver injury, and the use of the NAFLD Activity Score (NAS) to grade the severity of NASH rather than for its diagnosis. They also consider the steatosis, activity, and fibrosis (SAF) score to be an accurate and reproducible scoring system.<sup id="cite_ref-EASL2016_14-6" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> The AASLD recommends the use of the NAS scoring system with or without the SAF score if deemed appropriate.<sup id="cite_ref-AASLD2018_4-15" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> The Asia-Pacific Working Group on NAFLD disadvises the use of NAS, as it is considered uninformative for NAFLD and inappropriate to diagnose NASH.<sup id="cite_ref-AsiaPacific2017-2_10-4" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>For liver fibrosis assessment, percutaneous liver biopsy, with or without image guidance, is contraindicated in uncooperative people.<sup id="cite_ref-APASL2016_54-7" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup> Transjugular liver biopsy is indicated for any person with diffuse liver disease who needs a biopsy but has a contraindication to percutaneous biopsy or needs a hemodynamic evaluation for diagnostic purposes. A transvenous liver biopsy is recommended instead of a percutaneous approach in people with clinically evident ascites, although percutaneous biopsy is an acceptable alternative approach after the removal of ascites.<sup id="cite_ref-APASL2016_54-8" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Management">Management</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=16" title="Edit section: Management">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>NAFLD warrants treatment regardless of whether the affected person is overweight or not.<sup id="cite_ref-AsiaPacific2017-1_6-13" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> NAFLD is a <a href="/wiki/Preventable_causes_of_death" title="Preventable causes of death">preventable cause of death</a>.<sup id="cite_ref-EASL2019_19-2" class="reference"><a href="#cite_note-EASL2019-19">&#91;19&#93;</a></sup> Guidelines are available from the <a href="/wiki/American_Association_for_the_Study_of_Liver_Diseases" title="American Association for the Study of Liver Diseases">American Association for the Study of Liver Diseases</a> (AASLD), <a href="/wiki/American_Association_of_Clinical_Endocrinologists" title="American Association of Clinical Endocrinologists">American Association of Clinical Endocrinologists</a> (AACE) <a href="/wiki/National_Institute_for_Health_and_Care_Excellence" title="National Institute for Health and Care Excellence">National Institute for Health and Care Excellence</a> (NICE), the <a href="/wiki/European_Association_for_the_Study_of_the_Liver" title="European Association for the Study of the Liver">European Association for the Study of the Liver</a> (EASL), and the Asia-Pacific Working Party on NAFLD.<sup id="cite_ref-AASLD2018_4-16" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-1_6-14" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-5" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-NICE2016_12-4" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-EASL2016_14-7" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-AACE2016_61-0" class="reference"><a href="#cite_note-AACE2016-61">&#91;61&#93;</a></sup><sup id="cite_ref-62" class="reference"><a href="#cite_note-62">&#91;62&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=17" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Weight loss is the most effective treatment for NAFLD. A loss of 4% to 10% body weight is recommended, with 10% to 40% weight loss completely reversing NASH without cirrhosis. A structured weight loss program helps people with NAFLD lose more weight compared with advice alone. This type of program also leads to improvements in NAFLD measured using blood tests, ultrasound, imaging, or liver biopsies. Although fibrosis improves with lifestyle interventions and weight loss, there is limited evidence for cirrhosis improvement.<sup id="cite_ref-AsiaPacific2017-1_6-15" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-6" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-AACE2016_61-1" class="reference"><a href="#cite_note-AACE2016-61">&#91;61&#93;</a></sup><sup id="cite_ref-:2_63-0" class="reference"><a href="#cite_note-:2-63">&#91;63&#93;</a></sup>
</p><p>A combination of improved diet and exercise, rather than either alone, appears to best help manage NAFLD and reduce insulin resistance.<sup id="cite_ref-AASLD2018_4-17" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-BMJKENNEALLY2017_11-1" class="reference"><a href="#cite_note-BMJKENNEALLY2017-11">&#91;11&#93;</a></sup><sup id="cite_ref-EASL2016_14-8" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-64" class="reference"><a href="#cite_note-64">&#91;64&#93;</a></sup><sup id="cite_ref-RomeroGomez2017_65-0" class="reference"><a href="#cite_note-RomeroGomez2017-65">&#91;65&#93;</a></sup> Motivational support, such as with <a href="/wiki/Cognitive_behavioral_therapy" title="Cognitive behavioral therapy">cognitive behavioral therapy</a>, is helpful, as most people with NAFLD do not perceive their condition as a disease, and thus have a low motivation to change.<sup id="cite_ref-AASLD2018_4-18" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Nature2016_9-3" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-5" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-EASL2016_14-9" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-HEPAMARCHESINI2016_35-1" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup>
</p><p>Higher-intensity behavioral weight loss therapies (diet and exercise combined) may produce more weight loss than lower-intensity ones. A 2019 systematic review suggested a change of guidelines to recommend these therapies for NAFLD management. Weight loss is associated with improvements in biomarkers, NAFLD grade, and reduced chances of NASH, but its effect on long-term health was not known.<sup id="cite_ref-:2_63-1" class="reference"><a href="#cite_note-:2-63">&#91;63&#93;</a></sup>
</p><p>2021 meta-analyses of trials over periods of 1 to 28 months found limited evidence to indicate that lifestyle modifications and <a href="/wiki/Dietary_supplement" title="Dietary supplement">nutritional supplementation</a> have an effect on mortality, liver cirrhosis, liver decompensation, liver transplantation, and <a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">hepatocellular carcinoma</a> in people with non-alcohol-related fatty liver disease; authors said that it was unlikely that differences in clinical outcomes would become apparent in trials with less than 5 years to 10 years of follow‐up, and that sample sizes needed to be much larger than had been used.<sup id="cite_ref-66" class="reference"><a href="#cite_note-66">&#91;66&#93;</a></sup><sup id="cite_ref-67" class="reference"><a href="#cite_note-67">&#91;67&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Diet">Diet</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=18" title="Edit section: Diet">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Treatment of NAFLD typically involves <a href="/wiki/Medical_nutrition_therapy" class="mw-redirect" title="Medical nutrition therapy">counseling to improve nutrition</a> and <a href="/wiki/Calorie_restriction" title="Calorie restriction">calorie restriction</a>.<sup id="cite_ref-Nature2016_9-4" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-AACE2016_61-2" class="reference"><a href="#cite_note-AACE2016-61">&#91;61&#93;</a></sup><sup id="cite_ref-Rusu2014_68-0" class="reference"><a href="#cite_note-Rusu2014-68">&#91;68&#93;</a></sup> People with NAFLD can benefit from a moderate to low-carbohydrate diet and a low-fat diet.<sup id="cite_ref-Nature2016_9-5" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-69" class="reference"><a href="#cite_note-69">&#91;69&#93;</a></sup> The Mediterranean diet also showed promising results in a 6-week study with a reduction of NASH induced inflammation and fibrosis, independently from weight loss.<sup id="cite_ref-Nature2016_9-6" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-EASL2016_14-10" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-RomeroGomez2017_65-1" class="reference"><a href="#cite_note-RomeroGomez2017-65">&#91;65&#93;</a></sup><sup id="cite_ref-70" class="reference"><a href="#cite_note-70">&#91;70&#93;</a></sup> Tentative evidence supports dietary interventions in individuals with fatty liver who are not overweight.<sup id="cite_ref-:1_71-0" class="reference"><a href="#cite_note-:1-71">&#91;71&#93;</a></sup>
</p><p>The EASL recommends <a href="/wiki/Calorie_restriction" title="Calorie restriction">energy restriction</a> of 500–1000&#160;<a href="/wiki/Calorie" title="Calorie">kcal</a> per week less than the normal daily diet, a target of 7–10% weight loss for obese/overweight NAFLD, a low- to moderate-fat, and moderate- to high-carbohydrate diet, or a low-carbohydrate ketogenic or high-protein diet such as the Mediterranean diet, and avoiding all beverages and food containing fructose.<sup id="cite_ref-EASL2016_14-11" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p><p>Alcohol is an aggravating factor, and the AASLD recommends that people with NAFLD or NASH avoid alcohol consumption.<sup id="cite_ref-AASLD2018_4-19" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Nature2016_9-7" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-6" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-pmid25274101_72-0" class="reference"><a href="#cite_note-pmid25274101-72">&#91;72&#93;</a></sup> The EASL allows alcohol consumption below 30g/day for men and 20g/day for women.<sup id="cite_ref-EASL2016_14-12" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> The role of <a href="/wiki/Coffee" title="Coffee">coffee</a> consumption for NAFLD treatment is unclear though some studies indicate that regular coffee consumption may have protective effects.<sup id="cite_ref-EASL2016_14-13" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-Tomic2018_73-0" class="reference"><a href="#cite_note-Tomic2018-73">&#91;73&#93;</a></sup><sup id="cite_ref-Wijarnpreecha2017_74-0" class="reference"><a href="#cite_note-Wijarnpreecha2017-74">&#91;74&#93;</a></sup>
</p><p>Herbal compounds such as <a href="/wiki/Silymarin" class="mw-redirect" title="Silymarin">silymarin</a> (a <a href="/wiki/Milk_thistle" class="mw-redirect" title="Milk thistle">milk thistle</a> seed extract),<sup id="cite_ref-75" class="reference"><a href="#cite_note-75">&#91;75&#93;</a></sup> <a href="/wiki/Curcumin" title="Curcumin">curcumin, a turmeric extract</a>,<sup id="cite_ref-76" class="reference"><a href="#cite_note-76">&#91;76&#93;</a></sup> and <a href="/wiki/Green_tea" title="Green tea">green tea</a> appear to improve NAFLD biomarkers and reduce the grade of NAFLD.<sup id="cite_ref-Bagherniya2018_41-1" class="reference"><a href="#cite_note-Bagherniya2018-41">&#91;41&#93;</a></sup> Studies suggest an association between <a href="/wiki/Gut_flora" class="mw-redirect" title="Gut flora">microscopic organisms that inhabit the gut</a> (microbiota) and NAFLD. Reviews reported the use of <a href="/wiki/Probiotic" title="Probiotic">probiotics</a> and <a href="/wiki/Synbiotics" title="Synbiotics">synbiotics</a> (combinations of probiotics and <a href="/wiki/Prebiotic_(nutrition)" title="Prebiotic (nutrition)">prebiotics</a>) were associated with improvement in liver-specific markers of hepatic inflammation, measurements of liver stiffness, and steatosis in persons with NAFLD.<sup id="cite_ref-77" class="reference"><a href="#cite_note-77">&#91;77&#93;</a></sup><sup id="cite_ref-78" class="reference"><a href="#cite_note-78">&#91;78&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Vitamin_E">Vitamin E</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=19" title="Edit section: Vitamin E">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<p><a href="/wiki/Vitamin_E" title="Vitamin E">Vitamin E</a> does not improve established liver fibrosis in those with NAFLD but seems to improve certain markers of liver function and reduces inflammation and fattiness of the liver in some people with NAFLD.<sup id="cite_ref-AASLD2018_4-20" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Nature2016_9-8" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-7" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> The Asia-Pacific Work Group advises that Vitamin E may improve liver condition and aminotransferase levels, but only in adults without diabetes or cirrhosis who have NASH.<sup id="cite_ref-AsiaPacific2017-2_10-7" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> The NICE guidelines recommend Vitamin E as an option for children and adults with NAFLD with advanced liver fibrosis, regardless of whether the person has diabetes mellitus.<sup id="cite_ref-Nature2016_9-9" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-8" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Red_yeast_rice">Red yeast rice</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=20" title="Edit section: Red yeast rice">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<style data-mw-deduplicate="TemplateStyles:r1033289096">.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}</style><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Red_yeast_rice#Safety" title="Red yeast rice">Red yeast rice §&#160;Safety</a></div>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1033289096"><div role="note" class="hatnote navigation-not-searchable">Main article: <a href="/wiki/Red_yeast_rice#Red_yeast_rice_and_statin_drugs" title="Red yeast rice">Red yeast rice §&#160;Red yeast rice and statin drugs</a></div>
<p>The genum of mold <i><a href="/wiki/Aspergillus" title="Aspergillus">Aspergillus</a></i> and/or <i><a href="/wiki/Monascus" title="Monascus">Monascus</a></i> are used in the fabrication of <a href="/wiki/Red_yeast_rice" title="Red yeast rice">red yeast rice</a> to stimulate the production of <a href="/wiki/Lovastatin" title="Lovastatin">lovastatin</a>, where lovastatin and other <a href="/wiki/Statin" title="Statin">statins</a> inhibit the total <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> and <a href="/wiki/LDL-cholesterol" class="mw-redirect" title="LDL-cholesterol">LDL cholesterol</a> synthesis by blocking action of the enzyme <a href="/wiki/HMG-CoA_reductase" title="HMG-CoA reductase">HMG-CoA reductase</a>.
</p><p>The safety of red yeast rice has not yet been established as studies found that some commercial supplements contain high levels of <a href="/wiki/Toxin" title="Toxin">toxin</a> <a href="/wiki/Citrinin" title="Citrinin">citrinin</a>.<sup id="cite_ref-Gordon2010_79-0" class="reference"><a href="#cite_note-Gordon2010-79">&#91;79&#93;</a></sup>
</p><p>There are reports in the literature of muscle <a href="/wiki/Myopathy" title="Myopathy">myopathy</a> and liver damage resulting from red yeast rice usage.<sup id="cite_ref-80" class="reference"><a href="#cite_note-80">&#91;80&#93;</a></sup><sup id="cite_ref-81" class="reference"><a href="#cite_note-81">&#91;81&#93;</a></sup>
</p>
<h4><span class="mw-headline" id="Essential_phospholipids">Essential phospholipids</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=21" title="Edit section: Essential phospholipids">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<style data-mw-deduplicate="TemplateStyles:r1097763485">.mw-parser-output .ambox{border:1px solid #a2a9b1;border-left:10px solid #36c;background-color:#fbfbfb;box-sizing:border-box}.mw-parser-output .ambox+link+.ambox,.mw-parser-output .ambox+link+style+.ambox,.mw-parser-output .ambox+link+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+style+.ambox,.mw-parser-output .ambox+.mw-empty-elt+link+link+.ambox{margin-top:-1px}html body.mediawiki .mw-parser-output .ambox.mbox-small-left{margin:4px 1em 4px 0;overflow:hidden;width:238px;border-collapse:collapse;font-size:88%;line-height:1.25em}.mw-parser-output .ambox-speedy{border-left:10px solid #b32424;background-color:#fee7e6}.mw-parser-output .ambox-delete{border-left:10px solid #b32424}.mw-parser-output .ambox-content{border-left:10px solid #f28500}.mw-parser-output .ambox-style{border-left:10px solid #fc3}.mw-parser-output .ambox-move{border-left:10px solid #9932cc}.mw-parser-output .ambox-protection{border-left:10px solid #a2a9b1}.mw-parser-output .ambox .mbox-text{border:none;padding:0.25em 0.5em;width:100%}.mw-parser-output .ambox .mbox-image{border:none;padding:2px 0 2px 0.5em;text-align:center}.mw-parser-output .ambox .mbox-imageright{border:none;padding:2px 0.5em 2px 0;text-align:center}.mw-parser-output .ambox .mbox-empty-cell{border:none;padding:0;width:1px}.mw-parser-output .ambox .mbox-image-div{width:52px}html.client-js body.skin-minerva .mw-parser-output .mbox-text-span{margin-left:23px!important}@media(min-width:720px){.mw-parser-output .ambox{margin:0 10%}}</style><table class="box-One_source plainlinks metadata ambox ambox-content ambox-one_source" role="presentation"><tbody><tr><td class="mbox-image"><div class="mbox-image-div"><img alt="Question book-new.svg" src="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/50px-Question_book-new.svg.png" decoding="async" width="50" height="39" srcset="//upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/75px-Question_book-new.svg.png 1.5x, //upload.wikimedia.org/wikipedia/en/thumb/9/99/Question_book-new.svg/100px-Question_book-new.svg.png 2x" data-file-width="512" data-file-height="399" /></div></td><td class="mbox-text"><div class="mbox-text-span">This section <b>relies largely or entirely upon a <a href="/wiki/Wikipedia:Identifying_reliable_sources" class="mw-redirect" title="Wikipedia:Identifying reliable sources">single source</a></b>.<span class="hide-when-compact"> Relevant discussion may be found on the <a href="/wiki/Talk:Non-alcoholic_fatty_liver_disease##" title="Talk:Non-alcoholic fatty liver disease">talk page</a>. Please help <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit">improve this article</a> by introducing <a href="/wiki/Wikipedia:Citing_sources" title="Wikipedia:Citing sources">citations</a> to additional sources at this section.</span>  <span class="date-container"><i>(<span class="date">August 2022</span>)</i></span><span class="hide-when-compact"><i> (<small><a href="/wiki/Help:Maintenance_template_removal" title="Help:Maintenance template removal">Learn how and when to remove this template message</a></small>)</i></span></div></td></tr></tbody></table>
<p>Research shows that essential phospholipids from <a href="/wiki/Soy_lecithin" class="mw-redirect" title="Soy lecithin">soy lecithin</a> (Latin: <b>phospholipida sojae praeparata</b>), <a href="/wiki/Polyenylphosphatidylcholine" class="mw-redirect" title="Polyenylphosphatidylcholine">polyenylphosphatidylcholine</a> being the active component, has a well-established mode of action, therapeutic effectiveness, and lack of toxicity, which ensures clinically relevant efficacy-to-safety ratio. It influences membrane- dependent cellular functions and shows anti-inflammatory, antioxidant, antifibrogenic, anti apoptotic, membrane-protective, and lipid-regulating effects. Due to its positive effects on membrane composition and functions, it accelerates the improvement or normalization of subjective symptoms; pathological, clinical, and biochemical findings; hepatic imaging; and liver histology. It is justified to administer EPL together with other therapeutic measurements in the liver.<sup id="cite_ref-82" class="reference"><a href="#cite_note-82">&#91;82&#93;</a></sup>
</p><p>The usual dosage for adults and children older than 12 years of age (and of at least 43&#160;kg of weight) is 600&#160;mg three times a day.
</p>
<h4><span class="mw-headline" id="Choline">Choline</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=22" title="Edit section: Choline">edit</a><span class="mw-editsection-bracket">]</span></span></h4>
<link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1097763485"><table class="box-Expand_section plainlinks metadata ambox mbox-small-left ambox-content" role="presentation"><tbody><tr><td class="mbox-image"><a href="/wiki/File:Wiki_letter_w_cropped.svg" class="image"><img alt="[icon]" src="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png" decoding="async" width="20" height="14" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x" data-file-width="44" data-file-height="31" /></a></td><td class="mbox-text"><div class="mbox-text-span">This section <b>needs expansion</b>. You can help by <a class="external text" href="https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=">adding to it</a>.  <span class="date-container"><i>(<span class="date">January 2022</span>)</i></span></div></td></tr></tbody></table>
<p>Low <a href="/wiki/Choline" title="Choline">choline</a> intake is significantly associated with the increased prevalence of NAFLD.
</p>
<h3><span class="mw-headline" id="Physical_activity">Physical activity</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=23" title="Edit section: Physical activity">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Weight loss may improve NAFLD and is recommended particularly for obese or overweight people;<sup id="cite_ref-USDietaryGuidelines2015_83-0" class="reference"><a href="#cite_note-USDietaryGuidelines2015-83">&#91;83&#93;</a></sup><sup id="cite_ref-AACAHA2019_84-0" class="reference"><a href="#cite_note-AACAHA2019-84">&#91;84&#93;</a></sup><sup id="cite_ref-USGuidelines2013_85-0" class="reference"><a href="#cite_note-USGuidelines2013-85">&#91;85&#93;</a></sup> similar <a href="/wiki/Physical_activity" title="Physical activity">physical activities</a> and diets are advisable for overweight people with NAFLD as for other obese and overweight people.<sup id="cite_ref-NICE2016_12-9" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-RomeroGomez2017_65-2" class="reference"><a href="#cite_note-RomeroGomez2017-65">&#91;65&#93;</a></sup> Although physical activity is less important for weight loss than dietary adaptations (to reduce caloric intake),<sup id="cite_ref-HEPAMARCHESINI2016_35-2" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup> the NICE advises physical activity to reduce liver fat even if there is no overall bodyweight reduction.<sup id="cite_ref-Nature2016_9-10" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-10" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> Weight loss, through <a href="/wiki/Exercise" title="Exercise">exercise</a> or diet, is the most effective way to reduce liver fat and help NASH and fibrosis remission.<sup id="cite_ref-HEPAMARCHESINI2016_35-3" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup> Exercise alone can prevent or reduce hepatic steatosis, but it remains unknown whether it can improve all other aspects of the liver; hence a combined approach with diet and exercise is advised.<sup id="cite_ref-AASLD2018_4-21" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-BMJKENNEALLY2017_11-2" class="reference"><a href="#cite_note-BMJKENNEALLY2017-11">&#91;11&#93;</a></sup> <a href="/wiki/Aerobic_exercise" title="Aerobic exercise">Aerobic exercise</a> may be more effective than resistance training, although there are contradictory results.<sup id="cite_ref-Nature2016_9-11" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-86" class="reference"><a href="#cite_note-86">&#91;86&#93;</a></sup> Vigorous training is preferable to moderate training, as only the high-intensity exercise reduced the chances of NAFLD developing into NASH or advanced fibrosis.<sup id="cite_ref-Nature2016_9-12" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-87" class="reference"><a href="#cite_note-87">&#91;87&#93;</a></sup> The EASL recommends between 150 and 200&#160;min/week in 3 to 5 sessions of moderate-intensity aerobic physical activity or resistance training. Since both effectively reduce liver fat, a pragmatic approach to the choice of physical activity that accounts for the individual's preferences for what they can maintain in the long-term is preferred. Any engagement in physical activity or increase over previous levels is better than remaining sedentary.<sup id="cite_ref-EASL2016_14-14" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Medication">Medication</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=24" title="Edit section: Medication">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Treatment with medications is primarily aimed at improving liver disease and is generally limited to those with biopsy-proven NASH and fibrosis.<sup id="cite_ref-AASLD2018_4-22" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-NICE2016_12-11" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-EASL2016_14-15" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p><p>No medicines specifically for NAFLD or NASH had received approval, as of 2018<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit">&#91;update&#93;</a></sup>, although <a href="/wiki/Anti-diabetic_drug" class="mw-redirect" title="Anti-diabetic drug">anti-diabetic medications</a> may help in liver fat loss. While many treatments appear to improve biochemical markers such as <a href="/wiki/Alanine_transaminase" title="Alanine transaminase">alanine transaminase</a> levels, most do not reverse <a href="/wiki/Histological" class="mw-redirect" title="Histological">histological</a> abnormalities or improve outcomes.<sup id="cite_ref-AASLD2018_4-23" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-8" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-88" class="reference"><a href="#cite_note-88">&#91;88&#93;</a></sup>
</p><p>Insulin sensitizers (<a href="/wiki/Metformin" title="Metformin">metformin</a> and <a href="/wiki/Thiazolidinedione" title="Thiazolidinedione">thiazolidinediones</a>, such as <a href="/wiki/Pioglitazone" title="Pioglitazone">pioglitazone</a>) and <a href="/wiki/Liraglutide" title="Liraglutide">liraglutide</a> are not specifically recommended for NAFLD as they do not directly improve the liver condition. They can be indicated for diabetic individuals, after a careful assessment of risks, to reduce insulin resistance and risks of complications.<sup id="cite_ref-AASLD2018_4-24" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-9" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> Indeed, the side effects associated with thiazolidinedione medications, which include <a href="/wiki/Osteopenia" title="Osteopenia">osteopenia</a>, increased fracture risk, fluid retention, <a href="/wiki/Congestive_heart_failure" class="mw-redirect" title="Congestive heart failure">congestive heart failure</a>, <a href="/wiki/Bladder_cancer" title="Bladder cancer">bladder cancer</a>, and long-term weight gain, have limited their adoption.<sup id="cite_ref-Nature2016_9-13" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-Raziel2015_89-0" class="reference"><a href="#cite_note-Raziel2015-89">&#91;89&#93;</a></sup><sup id="cite_ref-90" class="reference"><a href="#cite_note-90">&#91;90&#93;</a></sup> Due to these side effects, the AASLD recommends the use of pioglitazone only for individuals with biopsy-proven NASH, and the Asia-Pacific Work Group recommends them only for individuals with NAFLD with known diabetic issues. However, the AASLD advises against the use of metformin as studies were inconclusive about the improvement of the liver's histological condition. Although there was an improvement in insulin resistance and serum aminotransferases, this did not translate into NASH improvements.<sup id="cite_ref-AASLD2018_4-25" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> The NICE provides similar guidelines to the AASLD regarding pioglitazone and recommends it be administered in secondary care to adults with advanced liver fibrosis irrespective of whether or not they have diabetes.<sup id="cite_ref-NICE2016_12-12" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup>
</p><p><a href="/wiki/Statin" title="Statin">Statin</a> medications appear to improve liver histology and markers of liver biochemistry in people with NAFLD. Since people with NAFLD are at a higher risk of cardiovascular disease, statin treatment is indicated. People with NAFLD are not at higher risk for serious liver injury from statins, according to AASLD and EASL. However, even if statins are safe to use in people with NASH cirrhosis, the AASLD suggests avoiding them in people with decompensated cirrhosis.<sup id="cite_ref-AASLD2018_4-26" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-EASL2016_14-16" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-Chalasani2012_91-0" class="reference"><a href="#cite_note-Chalasani2012-91">&#91;91&#93;</a></sup> Guidelines recommend statins to treat <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> for people with NAFLD. According to NICE guidelines, statins can continue unless liver enzyme levels double within three months of starting statins.<sup id="cite_ref-NICE2016_12-13" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> Treatment with <a href="/wiki/Pentoxifylline" title="Pentoxifylline">pentoxifylline</a> is not recommended.<sup id="cite_ref-AsiaPacific2017-2_10-10" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>As of 2018, neither the AASLD nor the Asia-Pacific Working Group recommends <a href="/wiki/Obeticholic_acid" title="Obeticholic acid">obeticholic acid</a> or <a href="/wiki/Elafibranor" title="Elafibranor">elafibranor</a> due to inconsistent results for NASH treatment and concerns about safety.<sup id="cite_ref-AASLD2018_4-27" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-11" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p><a href="/wiki/Omega-3_fatty_acid" title="Omega-3 fatty acid">Omega-3 fatty acids</a> may reduce liver fat and improve blood lipid profile but do not seem to improve liver histology (fibrosis, cirrhosis, cancer).<sup id="cite_ref-AsiaPacific2017-2_10-12" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> The NICE does not recommend omega-3 fatty acid supplementation since randomized trials were inconclusive.<sup id="cite_ref-Nature2016_9-14" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-NICE2016_12-14" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> Previous <a href="/wiki/Systematic_review" title="Systematic review">systematic reviews</a> found that omega-3 fatty acid supplementation in those with NAFLD/NASH using doses of one &#160;gram daily or more (median dose four &#160;grams/day with median treatment duration six &#160;months) has been associated with improvements in liver fat.<sup id="cite_ref-HEPAMARCHESINI2016_35-4" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup><sup id="cite_ref-Parker2012_92-0" class="reference"><a href="#cite_note-Parker2012-92">&#91;92&#93;</a></sup> According to AASLD guidelines, "omega-3 fatty acids should not be used as a specific treatment of NAFLD or NASH, but they may be considered to treat <a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">hypertriglyceridemia</a> for patients with NAFLD".<sup id="cite_ref-AASLD2018_4-28" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Surgery">Surgery</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=25" title="Edit section: Surgery">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tleft"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:Bariatric_surgery_in_NAFLD.jpg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Bariatric_surgery_in_NAFLD.jpg/220px-Bariatric_surgery_in_NAFLD.jpg" decoding="async" width="220" height="98" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Bariatric_surgery_in_NAFLD.jpg/330px-Bariatric_surgery_in_NAFLD.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/7/7d/Bariatric_surgery_in_NAFLD.jpg/440px-Bariatric_surgery_in_NAFLD.jpg 2x" data-file-width="554" data-file-height="246" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:Bariatric_surgery_in_NAFLD.jpg" class="internal" title="Enlarge"></a></div>For <a href="/wiki/Classification_of_obesity#BMI" title="Classification of obesity">severely</a> <a href="/wiki/Obesity" title="Obesity">obese</a> individuals with NAFLD or NASH, <a href="/wiki/Bariatric_surgery" title="Bariatric surgery">bariatric surgery</a> improves or cures the liver disease if there is no <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> nor <a href="/wiki/Liver_cancer" title="Liver cancer">liver cancer</a>.</div></div></div>
<p><a href="/wiki/Bariatric_surgery" title="Bariatric surgery">Bariatric surgery</a> is an effective method for obese and diabetic individuals with NAFLD to induce weight loss and reduce or resolve NASH inflammation, including fibrosis, and improve longevity.<sup id="cite_ref-Nature2016_9-15" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup><sup id="cite_ref-AsiaPacific2017-2_10-13" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-EASL2016_14-17" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup><sup id="cite_ref-HEPAMARCHESINI2016_35-5" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup><sup id="cite_ref-93" class="reference"><a href="#cite_note-93">&#91;93&#93;</a></sup><sup id="cite_ref-Fakhry2019_94-0" class="reference"><a href="#cite_note-Fakhry2019-94">&#91;94&#93;</a></sup> For the AASLD, bariatric surgery can be considered only for NASH on a case-by-case basis by an experienced bariatric surgery program.<sup id="cite_ref-AASLD2018_4-29" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> Indeed, some individuals might develop new or worsened features of NAFLD.<sup id="cite_ref-Fakhry2019_94-1" class="reference"><a href="#cite_note-Fakhry2019-94">&#91;94&#93;</a></sup>
</p><p>About 92% of people with NAFLD saw an improvement in steatosis and 70% a complete resolution after bariatric surgery.<sup id="cite_ref-95" class="reference"><a href="#cite_note-95">&#91;95&#93;</a></sup>
</p><p>A preoperative diet such as a <a href="/wiki/Calorie_restriction" title="Calorie restriction">low-calorie diet</a> or a <a href="/wiki/Very-low-calorie_diet" title="Very-low-calorie diet">very-low-calorie diet</a> is usually recommended to reduce liver volume by 16–20%. Preoperative weight loss is the only factor associated with postoperative weight loss.<sup id="cite_ref-ERAS2016_96-0" class="reference"><a href="#cite_note-ERAS2016-96">&#91;96&#93;</a></sup><sup id="cite_ref-Holderbaum2018_97-0" class="reference"><a href="#cite_note-Holderbaum2018-97">&#91;97&#93;</a></sup> Preoperative weight loss can reduce operative time and hospital stay,<sup id="cite_ref-ERAS2016_96-1" class="reference"><a href="#cite_note-ERAS2016-96">&#91;96&#93;</a></sup><sup id="cite_ref-98" class="reference"><a href="#cite_note-98">&#91;98&#93;</a></sup><sup id="cite_ref-Roman2019_99-0" class="reference"><a href="#cite_note-Roman2019-99">&#91;99&#93;</a></sup> although there is insufficient evidence whether preoperative weight loss reduces long-term morbidity or complications.<sup id="cite_ref-Roman2019_99-1" class="reference"><a href="#cite_note-Roman2019-99">&#91;99&#93;</a></sup><sup id="cite_ref-100" class="reference"><a href="#cite_note-100">&#91;100&#93;</a></sup> Weight loss and decreases in liver size may be independent of the amount of calorie restriction.<sup id="cite_ref-Holderbaum2018_97-1" class="reference"><a href="#cite_note-Holderbaum2018-97">&#91;97&#93;</a></sup>
</p><p>The APWG on NAFLD recommends bariatric surgery as a treatment option for those with class II obesity (<a href="/wiki/Body_mass_index" title="Body mass index">BMI</a> &gt;32.5&#160;kg/m<sup>2</sup> for Asians, 35&#160;kg/m<sup>2</sup> for Caucasians). They consider its effects on improving liver-related complications as unproven yet, but it effectively increases longevity by improving cardiovascular factors.<sup id="cite_ref-AsiaPacific2017-2_10-14" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>Surgery carries more risks for individuals with NASH cirrhosis, with a review estimating overall morbidity to be 21%. For people with NAFLD who have undifferentiated cirrhosis, the APWG recommends an investigation to determine the cause of the cirrhosis as well as the person's liver function and whether they have portal hypertension.<sup id="cite_ref-AsiaPacific2017-2_10-15" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Screening">Screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=26" title="Edit section: Screening">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Cardiovascular system screening is considered mandatory by the EASL, as NAFLD outcomes often result in <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular complications</a>,<sup id="cite_ref-EASL2016_14-18" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> which can manifest as subclinical <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>, the cause of the majority of NAFLD-related deaths.<sup id="cite_ref-Byrne2015_39-1" class="reference"><a href="#cite_note-Byrne2015-39">&#91;39&#93;</a></sup><sup id="cite_ref-101" class="reference"><a href="#cite_note-101">&#91;101&#93;</a></sup> People with NAFLD are at high risk for cardiovascular morbidity and mortality, and "aggressive modification of <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a> risk factors is warranted in all patients with NAFLD," according to AASLD.<sup id="cite_ref-AASLD2018_4-30" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>The AASLD further recommends for people with a cirrhotic NASH to be systematically screened for <a href="/wiki/Gastric_varices" title="Gastric varices">gastric</a> and <a href="/wiki/Esophageal_varices" title="Esophageal varices">esophageal varices</a> and <a href="/wiki/Liver_cancer" title="Liver cancer">liver cancer</a>. They do not recommend routine liver biopsies and screening for liver cancer for non-cirrhotic people with NASH, but such screening sometimes occurs on a case-by-case basis.<sup id="cite_ref-AASLD2018_4-31" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>Also, people with NAFLD may be considered for screening for <a href="/wiki/Hepatocellular_carcinoma" title="Hepatocellular carcinoma">hepatocellular carcinoma</a> (liver cancer) and gastroesophageal varices. The NICE advises regular screening of NAFLD for advanced liver fibrosis every three years to adults and every two years for children using the enhanced liver fibrosis (ELF) blood test.<sup id="cite_ref-NICE2016_12-15" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> Follow-up is recommended for people with obesity and insulin resistance using the <a href="/wiki/Homeostatic_model_assessment" title="Homeostatic model assessment">homeostasis model assessment of insulin resistance</a> (HOMA-IR). People with NASH with fibrosis and hypertension merit closer monitoring as there is a higher risk of disease progression.<sup id="cite_ref-EASL2016_14-19" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Transplantation">Transplantation</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=27" title="Edit section: Transplantation">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>NAFLD is the second most common indication for liver transplantation in the US and Europe as of 2017.<sup id="cite_ref-AsiaPacific2017-2_10-16" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> NAFLD/NASH is expected to become the leading cause of liver transplantation by 2020.<sup id="cite_ref-102" class="reference"><a href="#cite_note-102">&#91;102&#93;</a></sup>
</p><p>For people with NASH and end-stage liver disease, liver failure, or liver cancer, <a href="/wiki/Liver_transplantation" title="Liver transplantation">liver transplantation</a> is an accepted procedure according to the EASL.<sup id="cite_ref-EASL2016_14-20" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> People with NASH cirrhosis NASH who are being considered for a liver transplant warrant systematic evaluation for cardiovascular diseases (whether the symptoms are apparent or not).<sup id="cite_ref-AASLD2018_4-32" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>The overall survival is comparable to transplantation following other diseases.<sup id="cite_ref-AsiaPacific2017-2_10-17" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup><sup id="cite_ref-EASL2016_14-21" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> People with NASH cirrhosis who undergo liver transplantation are more likely to die post-transplant because of cardiovascular disease or <a href="/wiki/Chronic_kidney_disease" title="Chronic kidney disease">chronic kidney disease</a>. These people with NASH are often older and are thus more prone to these complications.<sup id="cite_ref-AsiaPacific2017-2_10-18" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> For these reasons and others, individuals with morbid obesity (<a href="/wiki/Body_mass_index" title="Body mass index">BMI</a> ≥ 40&#160;kg/m<sup>2</sup>) and NASH with cirrhosis may be considered unfit for liver transplantation until they follow lifestyle modifications to reduce bodyweight.<sup id="cite_ref-AsiaPacific2017-2_10-19" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> Diabetic people with poor glycemic control are at similar risks, and optimal glycemic control is essential before attempting transplantation.<sup id="cite_ref-AsiaPacific2017-2_10-20" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>The Asia Pacific Working Group guidelines recommend healthcare providers discuss lifestyle modifications before and after transplantation to reduce potential surgery risks and to assist with NAFLD management after the transplant.<sup id="cite_ref-AsiaPacific2017-2_10-21" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>Simultaneous bariatric surgery and liver transplantation were performed in exceptional circumstances.<sup id="cite_ref-AsiaPacific2017-2_10-22" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>After transplantation, liver biopsy is the best method to monitor the evolution of post-transplant fibrosis, with significant fibrosis or portal hypertension one year after transplantation predicting rapid progression and graft loss and indicating the need for urgent intervention.<sup id="cite_ref-APASL2016_54-9" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Related_complications">Related complications</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=28" title="Edit section: Related complications">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>There is no special treatment for liver cancer associated with NAFLD/NASH and are treated according to general guidelines on liver cancers.<sup id="cite_ref-AsiaPacific2017-2_10-23" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Prognosis">Prognosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=29" title="Edit section: Prognosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The average progression rate from one stage of liver fibrosis to the next in humans with NASH is estimated to be seven years, compared to 14&#160;years with NAFLD. The course of progression varies with different clinical manifestations among individuals.<sup id="cite_ref-Younossi2017_20-9" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Friedman2018_22-4" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup><sup id="cite_ref-103" class="reference"><a href="#cite_note-103">&#91;103&#93;</a></sup> Fibrosis in humans with NASH progressed more rapidly than in humans with NAFLD.<sup id="cite_ref-Nature2016_9-16" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup> Obesity predicts a worse long-term outcome than for lean individuals.<sup id="cite_ref-autogenerated1_104-0" class="reference"><a href="#cite_note-autogenerated1-104">&#91;104&#93;</a></sup><sup id="cite_ref-105" class="reference"><a href="#cite_note-105">&#91;105&#93;</a></sup> In the Asia-Pacific region, about 25% of NAFLD cases progress to NASH under three years, but only a low proportion (3.7%) develop advanced liver fibrosis.<sup id="cite_ref-AsiaPacific2017-1_6-16" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> An international study showed that people with NAFLD had a 10-year survival rate of 81.5%.<sup id="cite_ref-AASLD2018_4-33" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup>
</p><p>NAFLD is a risk factor for fibrosis, hypertension, chronic kidney disease, <a href="/wiki/Atrial_fibrillation" title="Atrial fibrillation">atrial fibrillation</a>, myocardial infarction, ischemic <a href="/wiki/Stroke" title="Stroke">stroke</a>, and death from cardiovascular causes based on very-low to low-quality evidence from observational studies.<sup id="cite_ref-NICE2016_12-16" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup><sup id="cite_ref-106" class="reference"><a href="#cite_note-106">&#91;106&#93;</a></sup> Although NAFLD can cause <a href="/wiki/Cirrhosis" title="Cirrhosis">cirrhosis</a> and <a href="/wiki/Liver_failure" title="Liver failure">liver failure</a> and liver cancer, most deaths among people with NAFLD are attributable to cardiovascular disease.<sup id="cite_ref-Byrne2015_39-2" class="reference"><a href="#cite_note-Byrne2015-39">&#91;39&#93;</a></sup> According to a <a href="/wiki/Meta-analysis" title="Meta-analysis">meta-analysis</a> of 34,000 people with NAFLD over seven years, these individuals have a 65% increased risk of developing fatal or nonfatal <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular events</a> when compared to those without NAFLD.<sup id="cite_ref-Friedman2018_22-5" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup>
</p><p>NAFLD and NASH increase the risk of liver cancer. Cirrhosis and liver cancer induced by NAFLD were the second cause of liver transplantation in the US in 2017. Liver cancer develops in NASH in the absence of cirrhosis in 45% in the cases,<sup id="cite_ref-107" class="reference"><a href="#cite_note-107">&#91;107&#93;</a></sup> and people with NASH cirrhosis have an increased risk of liver cancer. The rate of liver cancer associated with NASH increased fourfold between 2002 and 2012 in the US, which is more than any other cause of liver cancer. NAFLD constitutes the third most common risk factor for liver cancer.<sup id="cite_ref-108" class="reference"><a href="#cite_note-108">&#91;108&#93;</a></sup> NAFLD and NASH were found to worsen with cirrhosis in respectively 2–3% and 15–20% of the people over a 10–20 year period.<sup id="cite_ref-Nature2016_9-17" class="reference"><a href="#cite_note-Nature2016-9">&#91;9&#93;</a></sup> Cirrhosis is found in only about 50% of people with NAFLD and with liver cancer, so that liver cancer and cirrhosis are not always linked.<sup id="cite_ref-AsiaPacific2017-2_10-24" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup>
</p><p>NAFLD may be a precursor of metabolic syndrome, although a bidirectional influence is possible.<sup id="cite_ref-109" class="reference"><a href="#cite_note-109">&#91;109&#93;</a></sup><sup id="cite_ref-110" class="reference"><a href="#cite_note-110">&#91;110&#93;</a></sup><sup id="cite_ref-111" class="reference"><a href="#cite_note-111">&#91;111&#93;</a></sup> The presence and stage of fibrosis are the strongest prognostic factors for liver-related events and mortality, in particular for NAFLD.<sup id="cite_ref-Younossi2017_20-10" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=30" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright"><div class="thumbinner" style="width:222px;"><a href="/wiki/File:NAFLD-prevalence-2019.svg" class="image"><img src="//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/NAFLD-prevalence-2019.svg/220px-NAFLD-prevalence-2019.svg.png" decoding="async" width="220" height="194" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/f/f4/NAFLD-prevalence-2019.svg/330px-NAFLD-prevalence-2019.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/f/f4/NAFLD-prevalence-2019.svg/440px-NAFLD-prevalence-2019.svg.png 2x" data-file-width="376" data-file-height="331" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/wiki/File:NAFLD-prevalence-2019.svg" class="internal" title="Enlarge"></a></div>Non-alcoholic fatty liver disease prevalence in 2019</div></div></div>
<p>NAFLD incidence is rapidly rising, along with obesity and diabetes, and has become the most common cause of liver disease in developed countries, for adults, teenagers, and children.<sup id="cite_ref-EASL2019_19-3" class="reference"><a href="#cite_note-EASL2019-19">&#91;19&#93;</a></sup><sup id="cite_ref-Younossi2017_20-11" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> The percentage of people with NAFLD ranges from 9 to 36.9% in different parts of the world.<sup id="cite_ref-Omagari2002_112-0" class="reference"><a href="#cite_note-Omagari2002-112">&#91;112&#93;</a></sup><sup id="cite_ref-Hilden1977_113-0" class="reference"><a href="#cite_note-Hilden1977-113">&#91;113&#93;</a></sup> Approximately 20% of the United States and 25% of the Asia-Pacific populations have non-alcoholic fatty liver.<sup id="cite_ref-AsiaPacific2017-1_6-17" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-Rinella2015_17-1" class="reference"><a href="#cite_note-Rinella2015-17">&#91;17&#93;</a></sup> Similar prevalence can be found in Europe, although less data is available.<sup id="cite_ref-Younossi2017_20-12" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> NAFLD is the most common in the Middle East (32%) and South America (30%), while Africa has the lowest rates (13%).<sup id="cite_ref-AASLD2018_4-34" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-Younossi2017_20-13" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup> Compared to the 2000s, NAFL and NASH respectively increased 2-fold and 2.5-fold in the 2010s in the USA.<sup id="cite_ref-Kabbany2017_114-0" class="reference"><a href="#cite_note-Kabbany2017-114">&#91;114&#93;</a></sup>
</p><p>NAFLD and NASH are more prevalent in Hispanics - which can be attributed to high rates of obesity and type 2 diabetes in Hispanic populations, intermediate in Whites, and lowest in Blacks.<sup id="cite_ref-Rich2018_18-1" class="reference"><a href="#cite_note-Rich2018-18">&#91;18&#93;</a></sup><sup id="cite_ref-Younossi2017_20-14" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Flegal2002_115-0" class="reference"><a href="#cite_note-Flegal2002-115">&#91;115&#93;</a></sup> NAFLD was observed to be twice as prevalent in men as women.<sup id="cite_ref-AASLD2018_4-35" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> For <a href="/wiki/Obesity" title="Obesity">severely obese</a> individuals, the prevalence of NAFLD rises over 90%, and for those with <a href="/wiki/Diabetes" title="Diabetes">diabetes</a>, over 60%, and up to 20% for normal-weight people.<sup id="cite_ref-Younossi2017_20-15" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Younossi2019_21-1" class="reference"><a href="#cite_note-Younossi2019-21">&#91;21&#93;</a></sup> NAFLD is present in 65% to 90% of people that had bariatric surgery, and up to 75% of them have NASH.<sup id="cite_ref-AsiaPacific2017-2_10-25" class="reference"><a href="#cite_note-AsiaPacific2017-2-10">&#91;10&#93;</a></sup> Ultrasonography and proton NMR spectroscopy studies suggest about 25% of the population seems to be affected by NAFLD or NASH.<sup id="cite_ref-AsiaPacific2017-1_6-18" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-Younossi2017_20-16" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup>
</p><p>Although the disease is commonly associated with obesity, a significant proportion of those affected are normal weight or lean. Lean NAFLD affects between 10 and 20% of Americans and Europeans, and approximately 25% of the Asians, although some countries have a higher incidence (e.g., India has a very high proportion of lean NAFLD and almost no obese NAFLD). PNPLA3 may be relevant for the progression of NAFLD in lean people. Thus, people with NAFLD deserve consideration for treatment regardless of the presence or absence of obesity.<sup id="cite_ref-AsiaPacific2017-1_6-19" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup><sup id="cite_ref-Younossi2017_20-17" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-HEPAMARCHESINI2016_35-6" class="reference"><a href="#cite_note-HEPAMARCHESINI2016-35">&#91;35&#93;</a></sup><sup id="cite_ref-autogenerated1_104-1" class="reference"><a href="#cite_note-autogenerated1-104">&#91;104&#93;</a></sup>
</p><p>In children ages 1 to 19, the prevalence was found to be approximately 8% in the general population up to 34% in studies with data from child obesity clinics.<sup id="cite_ref-PLOSONEANDERSON2015_116-0" class="reference"><a href="#cite_note-PLOSONEANDERSON2015-116">&#91;116&#93;</a></sup>
</p><p>The majority of cryptogenic cirrhosis is believed to be due to NASH.<sup id="cite_ref-AsiaPacific2017-1_6-20" class="reference"><a href="#cite_note-AsiaPacific2017-1-6">&#91;6&#93;</a></sup> NAFLD prevalence is expected to increase steadily,<sup id="cite_ref-EASL2019-policy_117-0" class="reference"><a href="#cite_note-EASL2019-policy-117">&#91;117&#93;</a></sup> from 25% in 2018 to a projected 33.5% of people with NAFLD globally in 2030, and from 20% to a projected 27% of those with NAFLD will progress to NASH.<sup id="cite_ref-Estes2018_118-0" class="reference"><a href="#cite_note-Estes2018-118">&#91;118&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="History">History</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=31" title="Edit section: History">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The first acknowledged case of obesity-related non-alcoholic fatty liver was observed in 1952 by Samuel Zelman.<sup id="cite_ref-Zelman1952_119-0" class="reference"><a href="#cite_note-Zelman1952-119">&#91;119&#93;</a></sup><sup id="cite_ref-Ludwig1997_120-0" class="reference"><a href="#cite_note-Ludwig1997-120">&#91;120&#93;</a></sup> Zelman started investigating after observing a fatty liver in a hospital employee who drank more than twenty bottles of Coca-Cola a day. He then went on to design a trial for a year and a half on 20 obese people who were not alcoholic, finding that about half of them had substantially fatty livers.<sup id="cite_ref-Zelman1952_119-1" class="reference"><a href="#cite_note-Zelman1952-119">&#91;119&#93;</a></sup> Fatty liver was, however, linked to diabetes since at least 1784<sup id="cite_ref-Rabinowitch1948_121-0" class="reference"><a href="#cite_note-Rabinowitch1948-121">&#91;121&#93;</a></sup> — an observation picked up again in the 1930s.<sup id="cite_ref-Hanssen1936_122-0" class="reference"><a href="#cite_note-Hanssen1936-122">&#91;122&#93;</a></sup> Studies in experimental animals implicated <a href="/wiki/Choline" title="Choline">choline</a> inadequacy in the 1920s and excess sugar consumption in 1949.<sup id="cite_ref-Best1948_123-0" class="reference"><a href="#cite_note-Best1948-123">&#91;123&#93;</a></sup>
</p><p>The name "non-alcoholic steatohepatitis" (NASH) was later defined in 1980 by Jurgen Ludwig and his colleagues from the <a href="/wiki/Mayo_Clinic" title="Mayo Clinic">Mayo Clinic</a><sup id="cite_ref-Ludwig1980_124-0" class="reference"><a href="#cite_note-Ludwig1980-124">&#91;124&#93;</a></sup> to raise awareness of the existence of this pathology, as similar reports previously were dismissed as "patients' lies".<sup id="cite_ref-Ludwig1997_120-1" class="reference"><a href="#cite_note-Ludwig1997-120">&#91;120&#93;</a></sup> This paper was mostly ignored at the time but eventually came to be seen as a landmark paper, and starting in the mid-1990s, the condition began to be intensively studied, with a series of international meetings being held on the topic since 1998.<sup id="cite_ref-Farrell2006_125-0" class="reference"><a href="#cite_note-Farrell2006-125">&#91;125&#93;</a></sup> The broader NAFLD term started to be used around 2002.<sup id="cite_ref-Farrell2006_125-1" class="reference"><a href="#cite_note-Farrell2006-125">&#91;125&#93;</a></sup><sup id="cite_ref-126" class="reference"><a href="#cite_note-126">&#91;126&#93;</a></sup> Diagnostic criteria began to be worked out, and in 2005 the Pathology Committee of the NIH NASH Clinical Research Network proposed the NAS scoring system.<sup id="cite_ref-Farrell2006_125-2" class="reference"><a href="#cite_note-Farrell2006-125">&#91;125&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Society_and_culture">Society and culture</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=32" title="Edit section: Society and culture">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Political_recommendations">Political recommendations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=33" title="Edit section: Political recommendations">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>EASL recommends Europe's public health authorities to "restrict advertising and marketing of sugar-sweetened beverages and industrially processed foods high in saturated fat, sugar, and salt", as well as "fiscal measures to discourage the consumption of sugar-sweetened beverages and legislation to ensure that the food industry improves labeling and the composition of processed foods", as well as "public awareness campaigns on liver disease, highlighting that it is not only linked to excessive consumption of alcohol".<sup id="cite_ref-EASL2019-policy_117-1" class="reference"><a href="#cite_note-EASL2019-policy-117">&#91;117&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Lobbying">Lobbying</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=34" title="Edit section: Lobbying">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>In France, the French syndicate of non-alcoholic beverages "Boissons Rafraîchissantes de France" (that included <a href="/wiki/Soft_drink" title="Soft drink">soft drink</a> producers such as Coca-Cola France, Orangina, PepsiCo France) was denounced by the French journal <i><a href="https://fr.wikipedia.org/wiki/Canard_Enchain%C3%A9" class="extiw" title="fr:Canard Enchainé">fr:Canard Enchainé</a></i> for misleading consumers using a communication on their website titled "Better understanding the NASH pathology",<sup id="cite_ref-127" class="reference"><a href="#cite_note-127">&#91;127&#93;</a></sup> explaining that "NASH pathology is sometimes called the soda illness by language abuse or an unfortunate semantic shortcut, as it is not directly linked to the consumption of non-alcoholic beverages". This page and others on the same website, such as one titled "Say no to disinformation," were since then removed.<sup id="cite_ref-128" class="reference"><a href="#cite_note-128">&#91;128&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Children">Children</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=35" title="Edit section: Children">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Pediatric NAFLD was first reported in 1983.<sup id="cite_ref-Moran1983_129-0" class="reference"><a href="#cite_note-Moran1983-129">&#91;129&#93;</a></sup><sup id="cite_ref-Temple2016_130-0" class="reference"><a href="#cite_note-Temple2016-130">&#91;130&#93;</a></sup> It is the most common chronic liver disease among children and adolescents since at least 2007, affecting 10 to 20% of them in the US in 2016.<sup id="cite_ref-Younossi2017_20-18" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-Temple2016_130-1" class="reference"><a href="#cite_note-Temple2016-130">&#91;130&#93;</a></sup><sup id="cite_ref-Papandreou07_131-0" class="reference"><a href="#cite_note-Papandreou07-131">&#91;131&#93;</a></sup> NAFLD is associated with <a href="/wiki/Metabolic_syndrome" title="Metabolic syndrome">metabolic syndrome</a>, which is a cluster of risk factors that contribute to the development of cardiovascular disease and type 2 diabetes mellitus. Studies have demonstrated that abdominal obesity and insulin resistance, in particular, are significant contributors to the development of NAFLD.<sup id="cite_ref-Cortez1999_132-0" class="reference"><a href="#cite_note-Cortez1999-132">&#91;132&#93;</a></sup><sup id="cite_ref-Marchesini2001_133-0" class="reference"><a href="#cite_note-Marchesini2001-133">&#91;133&#93;</a></sup><sup id="cite_ref-Nobili06_134-0" class="reference"><a href="#cite_note-Nobili06-134">&#91;134&#93;</a></sup><sup id="cite_ref-Pagano2002_135-0" class="reference"><a href="#cite_note-Pagano2002-135">&#91;135&#93;</a></sup><sup id="cite_ref-Schwimmer2008_136-0" class="reference"><a href="#cite_note-Schwimmer2008-136">&#91;136&#93;</a></sup> Coexisting liver diseases, such as <a href="/wiki/Hepatitis_C" title="Hepatitis C">hepatitis C</a> and cardiovascular diseases such as atherosclerosis, are also associated with an increased risk of NAFLD.<sup id="cite_ref-AlKhater2015_23-3" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup><sup id="cite_ref-Byrne2015_39-3" class="reference"><a href="#cite_note-Byrne2015-39">&#91;39&#93;</a></sup> Some children were diagnosed as early as two years old, with a mean age of diagnosis between 11 and 13 years old.<sup id="cite_ref-Temple2016_130-2" class="reference"><a href="#cite_note-Temple2016-130">&#91;130&#93;</a></sup> The mean age is usually above 10 years, as children can also report <a href="/wiki/Non-specific_symptoms" class="mw-redirect" title="Non-specific symptoms">non-specific symptoms</a> and are thus difficult to diagnose for NAFLD.<sup id="cite_ref-Temple2016_130-3" class="reference"><a href="#cite_note-Temple2016-130">&#91;130&#93;</a></sup>
</p><p>Boys are more likely to be diagnosed with NAFLD than girls.<sup id="cite_ref-AlKhater2015_23-4" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup><sup id="cite_ref-PLOSONEANDERSON2015_116-1" class="reference"><a href="#cite_note-PLOSONEANDERSON2015-116">&#91;116&#93;</a></sup> Overweight, or even weight gain, in childhood and adolescence, is associated with an increased risk of NAFLD later in life, with adult NAFLD predicted in a 31-year follow-up study by risk factors during childhood including BMI, plasma insulin levels, male sex, genetic background (PNPLA3 and TM6SF2 variants) and low birth weight, an emerging risk factor for adulthood NAFLD.<sup id="cite_ref-Younossi2017_20-19" class="reference"><a href="#cite_note-Younossi2017-20">&#91;20&#93;</a></sup><sup id="cite_ref-AlKhater2015_23-5" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup> In a study, simple steatosis was present in up to 45% in children with a clinical suspicion of NAFLD.<sup id="cite_ref-AlKhater2015_23-6" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup> Children with simple steatosis have a worse prognosis than adults, with significantly more of them progressing from NAFLD to NASH compared to adults. Indeed, 17-25% of children with NAFLD develop a NASH in general, and up to 83% for children with severe obesity (versus 29% for adults), further suggesting that hepatic fibrosis seems to follow a more aggressive clinical course in children compared to adults.<sup id="cite_ref-Temple2016_130-4" class="reference"><a href="#cite_note-Temple2016-130">&#91;130&#93;</a></sup>
</p><p>Early diagnosis of NAFLD in children may help prevent the development of liver disease during adulthood.<sup id="cite_ref-Nobili06_134-1" class="reference"><a href="#cite_note-Nobili06-134">&#91;134&#93;</a></sup><sup id="cite_ref-Roberts07_137-0" class="reference"><a href="#cite_note-Roberts07-137">&#91;137&#93;</a></sup> This is challenging as most children with NAFLD are asymptomatic, with only 42-59% showing abdominal pain.<sup id="cite_ref-AlKhater2015_23-7" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup><sup id="cite_ref-Roberts07_137-1" class="reference"><a href="#cite_note-Roberts07-137">&#91;137&#93;</a></sup> Other symptoms might be present, such as right upper quadrant pain or <a href="/wiki/Acanthosis_nigricans" title="Acanthosis nigricans">acanthosis nigricans</a>, the latter of which is often present in children with NASH. <a href="/wiki/Hepatomegaly" title="Hepatomegaly">An enlarged liver</a> occurs in 30–40% of children with NAFLD.<sup id="cite_ref-AlKhater2015_23-8" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup>
</p><p>The AASLD recommends a diagnostic liver biopsy in children when the diagnosis is unclear or before starting a potentially hepatotoxic medical therapy.<sup id="cite_ref-AASLD2018_4-36" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup> The EASL suggests using fibrosis tests such as <a href="/wiki/Elastography" title="Elastography">elastography</a>, <a href="/wiki/Acoustic_radiation_force_impulse_imaging" class="mw-redirect" title="Acoustic radiation force impulse imaging">acoustic radiation force impulse imaging</a>, and serum biomarkers to reduce the number of biopsies.<sup id="cite_ref-EASL2016_14-22" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> In follow up, NICE guidelines recommend that healthcare providers offer children regular NAFLD screening for advanced liver fibrosis every two years using the enhanced liver fibrosis (ELF) blood test.<sup id="cite_ref-NICE2016_12-17" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> Several studies also suggest <a href="/wiki/Magnetic_resonance_elastography" title="Magnetic resonance elastography">magnetic resonance elastography</a> as an alternative to the less reliable ultrasonography.<sup id="cite_ref-AlKhater2015_23-9" class="reference"><a href="#cite_note-AlKhater2015-23">&#91;23&#93;</a></sup>
</p><p>Intensive lifestyle modifications, including physical activity and dietary changes, are the first line of treatment according to AASLD and EASL as it improves the liver histology and aminotransferase levels. In terms of pharmacological treatment, the AASLD and EASL do not recommend metformin, but vitamin E may improve liver health for some children.<sup id="cite_ref-AASLD2018_4-37" class="reference"><a href="#cite_note-AASLD2018-4">&#91;4&#93;</a></sup><sup id="cite_ref-EASL2016_14-23" class="reference"><a href="#cite_note-EASL2016-14">&#91;14&#93;</a></sup> The NICE advises the use of vitamin E for children with advanced liver fibrosis, whether they have diabetes or not.<sup id="cite_ref-NICE2016_12-18" class="reference"><a href="#cite_note-NICE2016-12">&#91;12&#93;</a></sup> The only treatment shown to be effective in childhood NAFLD is weight loss.<sup id="cite_ref-138" class="reference"><a href="#cite_note-138">&#91;138&#93;</a></sup>
</p><p>Some evidence indicates that maternal undernutrition or overnutrition increases a child's susceptibility to NASH and hastens its progression.<sup id="cite_ref-139" class="reference"><a href="#cite_note-139">&#91;139&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=36" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<h3><span class="mw-headline" id="Diagnosis_and_biomarkers">Diagnosis and biomarkers</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=37" title="Edit section: Diagnosis and biomarkers">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Since a NAFLD diagnosis based on a liver biopsy is invasive and makes it difficult to estimate epidemiology, it is a high research priority to find accurate, inexpensive, and noninvasive methods of diagnosing and monitoring NAFLD disease and its progression.<sup id="cite_ref-Wong2018_27-3" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup><sup id="cite_ref-LIVERINTARAUJO2018_140-0" class="reference"><a href="#cite_note-LIVERINTARAUJO2018-140">&#91;140&#93;</a></sup> The search for these <a href="/wiki/Biomarkers" class="mw-redirect" title="Biomarkers">biomarkers</a> of NAFLD, NAFL, and NASH involves <a href="/wiki/Lipidomics" title="Lipidomics">lipidomics</a>, <a href="/wiki/Medical_imaging" title="Medical imaging">medical imaging</a>, <a href="/wiki/Proteomics" title="Proteomics">proteomics</a>, blood tests, and scoring systems.<sup id="cite_ref-Wong2018_27-4" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup>
</p><p>According to a review, proton density fat fraction estimation by magnetic resonance imaging (MRI-PDFF) may be considered the most accurate and even <a href="/wiki/Gold_standard_(test)" title="Gold standard (test)">gold standard test</a> to quantify hepatic steatosis. They recommend ultrasound-based transient elastography to accurately diagnose both fibrosis and cirrhosis in a routine clinical setting, with more objectivity than ultrasonography but with lower accuracy than magnetic resonance elastography; and plasma cytokeratin 18 (CK18) fragment levels to be a moderately accurate biomarker of steatohepatitis.<sup id="cite_ref-Wong2018_27-5" class="reference"><a href="#cite_note-Wong2018-27">&#91;27&#93;</a></sup> However, transient elastography can fail for people with pre-hepatic portal hypertension.<sup id="cite_ref-APASL2016_54-10" class="reference"><a href="#cite_note-APASL2016-54">&#91;54&#93;</a></sup>
</p>
<h3><span class="mw-headline" id="Medication_development">Medication development</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=38" title="Edit section: Medication development">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Medication development for NASH is very active and advancing rapidly. New medications are being designed to target various intrahepatic sites, from regulating lipids and glucose homeostasis to oxidant stress and mitochondrial targets in hepatocytes, inflammatory signals on hepatocytes, and intracellular targets related to <a href="/wiki/Hepatic_stellate_cell" title="Hepatic stellate cell">hepatic stellate cell</a> activation and fibrogenesis.<sup id="cite_ref-Friedman2018_22-6" class="reference"><a href="#cite_note-Friedman2018-22">&#91;22&#93;</a></sup> As of 2021<sup class="plainlinks noexcerpt noprint asof-tag update" style="display:none;"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit">&#91;update&#93;</a></sup>, <a href="/wiki/Pivotal_trial" title="Pivotal trial">pivotal trials</a> are underway for <a href="/wiki/Obeticholic_acid" title="Obeticholic acid">obeticholic acid</a> (<a href="/wiki/Farnesoid_X_receptor" title="Farnesoid X receptor">FXR</a> agonist), Resmetirom (<a href="/wiki/Thyroid_hormone_receptor_beta" title="Thyroid hormone receptor beta">THRβ</a> agonist), belapectin (<a href="/wiki/Galectin-3" title="Galectin-3">Galectin-3</a> inhibitor), and Aramchol (<a href="/wiki/Stearoyl-CoA_desaturase-1" class="mw-redirect" title="Stearoyl-CoA desaturase-1">SCD1</a> inhibitor).<sup id="cite_ref-141" class="reference"><a href="#cite_note-141">&#91;141&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="See_also">See also</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=39" title="Edit section: See also">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a href="/wiki/Foie_gras" title="Foie gras">Foie gras</a>, fatty liver induced in poultry, with pathophysiology homologous to that of NAFLD in humans</li></ul>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=40" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<style data-mw-deduplicate="TemplateStyles:r1011085734">.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}</style><div class="reflist">
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-MAFLD-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-MAFLD_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-MAFLD_1-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><style data-mw-deduplicate="TemplateStyles:r1133582631">.mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style><cite id="CITEREFEslamSanyalGeorgean_international_consensus_panel.2020" class="citation journal cs1">Eslam, M; Sanyal, AJ; George, J; an international consensus panel. (7 February 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2019.11.312">"MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease"</a>. <i>Gastroenterology</i>. <b>158</b> (7): 1999–2014.e1. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2019.11.312">10.1053/j.gastro.2019.11.312</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32044314">32044314</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=MAFLD%3A+A+consensus-driven+proposed+nomenclature+for+metabolic+associated+fatty+liver+disease.&amp;rft.volume=158&amp;rft.issue=7&amp;rft.pages=1999-2014.e1&amp;rft.date=2020-02-07&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2019.11.312&amp;rft_id=info%3Apmid%2F32044314&amp;rft.aulast=Eslam&amp;rft.aufirst=M&amp;rft.au=Sanyal%2C+AJ&amp;rft.au=George%2C+J&amp;rft.au=an+international+consensus+panel.&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1053%252Fj.gastro.2019.11.312&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-ICD11-2"><span class="mw-cite-backlink">^ <a href="#cite_ref-ICD11_2-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ICD11_2-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ICD11_2-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ICD11_2-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-ICD11_2-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-ICD11_2-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-ICD11_2-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-ICD11_2-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1912806631">"DB92 Non-alcoholic fatty liver disease"</a>. <i>WHO</i>. WHO. 18 June 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">2 October</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=WHO&amp;rft.atitle=DB92+Non-alcoholic+fatty+liver+disease&amp;rft.date=2018-06-18&amp;rft_id=https%3A%2F%2Ficd.who.int%2Fbrowse11%2Fl-m%2Fen%23%2Fhttp%3A%2F%2Fid.who.int%2Ficd%2Fentity%2F1912806631&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-NIH2016-3"><span class="mw-cite-backlink">^ <a href="#cite_ref-NIH2016_3-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NIH2016_3-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NIH2016_3-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NIH2016_3-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NIH2016_3-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NIH2016_3-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NIH2016_3-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NIH2016_3-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NIH2016_3-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NIH2016_3-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.niddk.nih.gov/health-information/liver-disease/nafld-nash/all-content">"Nonalcoholic Fatty Liver Disease &amp; NASH"</a>. <i>National Institute of Diabetes and Digestive and Kidney Diseases</i>. 7 November 2018<span class="reference-accessdate">. Retrieved <span class="nowrap">2 April</span> 2020</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=National+Institute+of+Diabetes+and+Digestive+and+Kidney+Diseases&amp;rft.atitle=Nonalcoholic+Fatty+Liver+Disease+%26+NASH&amp;rft.date=2018-11-07&amp;rft_id=https%3A%2F%2Fwww.niddk.nih.gov%2Fhealth-information%2Fliver-disease%2Fnafld-nash%2Fall-content&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AASLD2018-4"><span class="mw-cite-backlink">^ <a href="#cite_ref-AASLD2018_4-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-25"><sup><i><b>z</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-26"><sup><i><b>aa</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-27"><sup><i><b>ab</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-28"><sup><i><b>ac</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-29"><sup><i><b>ad</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-30"><sup><i><b>ae</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-31"><sup><i><b>af</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-32"><sup><i><b>ag</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-33"><sup><i><b>ah</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-34"><sup><i><b>ai</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-35"><sup><i><b>aj</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-36"><sup><i><b>ak</b></i></sup></a> <a href="#cite_ref-AASLD2018_4-37"><sup><i><b>al</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChalasaniYounossiLavineCharlton2018" class="citation journal cs1">Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M,  et&#160;al. (January 2018). <a rel="nofollow" class="external text" href="https://scholarworks.iupui.edu/bitstream/1805/14037/1/chalasani_2017_diagnosis.pdf">"The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases"</a> <span class="cs1-format">(PDF)</span>. <i>Hepatology</i> (Professional society guidelines). <b>67</b> (1): 328–357. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.29367">10.1002/hep.29367</a></span>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/1805%2F14037">1805/14037</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28714183">28714183</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=The+diagnosis+and+management+of+nonalcoholic+fatty+liver+disease%3A+Practice+guidance+from+the+American+Association+for+the+Study+of+Liver+Diseases&amp;rft.volume=67&amp;rft.issue=1&amp;rft.pages=328-357&amp;rft.date=2018-01&amp;rft_id=info%3Ahdl%2F1805%2F14037&amp;rft_id=info%3Apmid%2F28714183&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.29367&amp;rft.aulast=Chalasani&amp;rft.aufirst=N&amp;rft.au=Younossi%2C+Z&amp;rft.au=Lavine%2C+JE&amp;rft.au=Charlton%2C+M&amp;rft.au=Cusi%2C+K&amp;rft.au=Rinella%2C+M&amp;rft.au=Harrison%2C+SA&amp;rft.au=Brunt%2C+EM&amp;rft.au=Sanyal%2C+AJ&amp;rft_id=https%3A%2F%2Fscholarworks.iupui.edu%2Fbitstream%2F1805%2F14037%2F1%2Fchalasani_2017_diagnosis.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-5">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJensenAbdelmalekSullivanNadeau2018" class="citation journal cs1">Jensen, Thomas; Abdelmalek, Manal F.; Sullivan, Shelby; Nadeau, Kristen J.; Green, Melanie; Roncol, Carlos; Nakagawa, Takahiko; Kuwabara, Masanari; Sato, Yuka; Kang, Duk-Hee; Tolan, Dean R.; Sanchez-Lozada, Laura G; Rosen, Hugo R.; Lanaspa, Miguel A.; Diehl, Anna Mae; Johnson, Richard J. (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893377">"Fructose and Sugar: A Major Mediator of Nonalcoholic Fatty Liver Disease"</a>. <i>HHS Author Manuscripts</i>. <b>68</b> (5): 1063–1075. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2018.01.019">10.1016/j.jhep.2018.01.019</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893377">5893377</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29408694">29408694</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=HHS+Author+Manuscripts&amp;rft.atitle=Fructose+and+Sugar%3A+A+Major+Mediator+of+Nonalcoholic+Fatty+Liver+Disease&amp;rft.volume=68&amp;rft.issue=5&amp;rft.pages=1063-1075&amp;rft.date=2018&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5893377%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29408694&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2018.01.019&amp;rft.aulast=Jensen&amp;rft.aufirst=Thomas&amp;rft.au=Abdelmalek%2C+Manal+F.&amp;rft.au=Sullivan%2C+Shelby&amp;rft.au=Nadeau%2C+Kristen+J.&amp;rft.au=Green%2C+Melanie&amp;rft.au=Roncol%2C+Carlos&amp;rft.au=Nakagawa%2C+Takahiko&amp;rft.au=Kuwabara%2C+Masanari&amp;rft.au=Sato%2C+Yuka&amp;rft.au=Kang%2C+Duk-Hee&amp;rft.au=Tolan%2C+Dean+R.&amp;rft.au=Sanchez-Lozada%2C+Laura+G&amp;rft.au=Rosen%2C+Hugo+R.&amp;rft.au=Lanaspa%2C+Miguel+A.&amp;rft.au=Diehl%2C+Anna+Mae&amp;rft.au=Johnson%2C+Richard+J.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5893377&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AsiaPacific2017-1-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-AsiaPacific2017-1_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-1_6-20"><sup><i><b>u</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWongChanChitturiChawla2018" class="citation journal cs1">Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A,  et&#160;al. (January 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjgh.13857">"Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment"</a>. <i>Journal of Gastroenterology and Hepatology</i> (Professional society guidelines). <b>33</b> (1): 70–85. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjgh.13857">10.1111/jgh.13857</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28670712">28670712</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Gastroenterology+and+Hepatology&amp;rft.atitle=Asia-Pacific+Working+Party+on+Non-alcoholic+Fatty+Liver+Disease+guidelines+2017-Part+1%3A+Definition%2C+risk+factors+and+assessment&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=70-85&amp;rft.date=2018-01&amp;rft_id=info%3Adoi%2F10.1111%2Fjgh.13857&amp;rft_id=info%3Apmid%2F28670712&amp;rft.aulast=Wong&amp;rft.aufirst=VW&amp;rft.au=Chan%2C+WK&amp;rft.au=Chitturi%2C+S&amp;rft.au=Chawla%2C+Y&amp;rft.au=Dan%2C+YY&amp;rft.au=Duseja%2C+A&amp;rft.au=Fan%2C+J&amp;rft.au=Goh%2C+KL&amp;rft.au=Hamaguchi%2C+M&amp;rft.au=Hashimoto%2C+E&amp;rft.au=Kim%2C+SU&amp;rft.au=Lesmana%2C+LA&amp;rft.au=Lin%2C+YC&amp;rft.au=Liu%2C+CJ&amp;rft.au=Ni%2C+YH&amp;rft.au=Sollano%2C+J&amp;rft.au=Wong%2C+SK&amp;rft.au=Wong%2C+GL&amp;rft.au=Chan%2C+HL&amp;rft.au=Farrell%2C+G&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fjgh.13857&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AFP2013-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-AFP2013_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AFP2013_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AFP2013_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AFP2013_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AFP2013_7-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFIserRyan2013" class="citation journal cs1">Iser D, Ryan M (July 2013). "Fatty liver disease--a practical guide for GPs". <i>Australian Family Physician</i>. <b>42</b> (7): 444–7. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23826593">23826593</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Australian+Family+Physician&amp;rft.atitle=Fatty+liver+disease--a+practical+guide+for+GPs&amp;rft.volume=42&amp;rft.issue=7&amp;rft.pages=444-7&amp;rft.date=2013-07&amp;rft_id=info%3Apmid%2F23826593&amp;rft.aulast=Iser&amp;rft.aufirst=D&amp;rft.au=Ryan%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDulai_S.SinghPetelSoni2017" class="citation journal cs1">Dulai S., Parambir; Singh, Siddgarth; Petel, Janki; Soni, Meera; Prokop, Larry J.; Younossi, Zobair; Sebastiani, Giada; Ekstedt, Mattias; Hagstrom, Hannes; Nasr, Patrik; Stal, Per; Wong, Vincent Wai-Sun; Kechagias, Stergios; Hultcrantz, Rolf; Loomba, Rohit (2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397356">"Increased risk of mortality by fibrosis stage in non-alcoholic fatty liver disease: Systematic Review and Meta-analysis"</a>. <i>HHS Author Manuscripts</i>. <b>65</b> (5): 1557–1565. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.29085">10.1002/hep.29085</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5397356">5397356</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28130788">28130788</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=HHS+Author+Manuscripts&amp;rft.atitle=Increased+risk+of+mortality+by+fibrosis+stage+in+non-alcoholic+fatty+liver+disease%3A+Systematic+Review+and+Meta-analysis&amp;rft.volume=65&amp;rft.issue=5&amp;rft.pages=1557-1565&amp;rft.date=2017&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5397356%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28130788&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.29085&amp;rft.aulast=Dulai+S.&amp;rft.aufirst=Parambir&amp;rft.au=Singh%2C+Siddgarth&amp;rft.au=Petel%2C+Janki&amp;rft.au=Soni%2C+Meera&amp;rft.au=Prokop%2C+Larry+J.&amp;rft.au=Younossi%2C+Zobair&amp;rft.au=Sebastiani%2C+Giada&amp;rft.au=Ekstedt%2C+Mattias&amp;rft.au=Hagstrom%2C+Hannes&amp;rft.au=Nasr%2C+Patrik&amp;rft.au=Stal%2C+Per&amp;rft.au=Wong%2C+Vincent+Wai-Sun&amp;rft.au=Kechagias%2C+Stergios&amp;rft.au=Hultcrantz%2C+Rolf&amp;rft.au=Loomba%2C+Rohit&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5397356&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nature2016-9"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nature2016_9-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nature2016_9-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Nature2016_9-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Nature2016_9-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Nature2016_9-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Nature2016_9-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Nature2016_9-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Nature2016_9-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Nature2016_9-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Nature2016_9-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Nature2016_9-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Nature2016_9-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Nature2016_9-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Nature2016_9-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Nature2016_9-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Nature2016_9-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Nature2016_9-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Nature2016_9-17"><sup><i><b>r</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRinellaSanyal2016" class="citation journal cs1">Rinella ME, Sanyal AJ (April 2016). "Management of NAFLD: a stage-based approach". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>13</b> (4): 196–205. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2016.3">10.1038/nrgastro.2016.3</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26907882">26907882</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:26643913">26643913</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=Management+of+NAFLD%3A+a+stage-based+approach&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=196-205&amp;rft.date=2016-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A26643913%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26907882&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2016.3&amp;rft.aulast=Rinella&amp;rft.aufirst=ME&amp;rft.au=Sanyal%2C+AJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AsiaPacific2017-2-10"><span class="mw-cite-backlink">^ <a href="#cite_ref-AsiaPacific2017-2_10-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-23"><sup><i><b>x</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-24"><sup><i><b>y</b></i></sup></a> <a href="#cite_ref-AsiaPacific2017-2_10-25"><sup><i><b>z</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChitturiWongChanWong2018" class="citation journal cs1">Chitturi S, Wong VW, Chan WK, Wong GL, Wong SK, Sollano J,  et&#160;al. (January 2018). "The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups". <i>Journal of Gastroenterology and Hepatology</i> (Professional society guidelines). <b>33</b> (1): 86–98. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fjgh.13856">10.1111/jgh.13856</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28692197">28692197</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:29648173">29648173</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Gastroenterology+and+Hepatology&amp;rft.atitle=The+Asia-Pacific+Working+Party+on+Non-alcoholic+Fatty+Liver+Disease+guidelines+2017-Part+2%3A+Management+and+special+groups&amp;rft.volume=33&amp;rft.issue=1&amp;rft.pages=86-98&amp;rft.date=2018-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A29648173%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28692197&amp;rft_id=info%3Adoi%2F10.1111%2Fjgh.13856&amp;rft.aulast=Chitturi&amp;rft.aufirst=S&amp;rft.au=Wong%2C+VW&amp;rft.au=Chan%2C+WK&amp;rft.au=Wong%2C+GL&amp;rft.au=Wong%2C+SK&amp;rft.au=Sollano%2C+J&amp;rft.au=Ni%2C+YH&amp;rft.au=Liu%2C+CJ&amp;rft.au=Lin%2C+YC&amp;rft.au=Lesmana%2C+LA&amp;rft.au=Kim%2C+SU&amp;rft.au=Hashimoto%2C+E&amp;rft.au=Hamaguchi%2C+M&amp;rft.au=Goh%2C+KL&amp;rft.au=Fan%2C+J&amp;rft.au=Duseja%2C+A&amp;rft.au=Dan%2C+YY&amp;rft.au=Chawla%2C+Y&amp;rft.au=Farrell%2C+G&amp;rft.au=Chan%2C+HL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-BMJKENNEALLY2017-11"><span class="mw-cite-backlink">^ <a href="#cite_ref-BMJKENNEALLY2017_11-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BMJKENNEALLY2017_11-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BMJKENNEALLY2017_11-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKenneallySierMoore2017" class="citation journal cs1">Kenneally S, Sier JH, Moore JB (1 June 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508801">"Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review"</a>. <i>BMJ Open Gastroenterology</i>. <b>4</b> (1): e000139. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmjgast-2017-000139">10.1136/bmjgast-2017-000139</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508801">5508801</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28761689">28761689</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ+Open+Gastroenterology&amp;rft.atitle=Efficacy+of+dietary+and+physical+activity+intervention+in+non-alcoholic+fatty+liver+disease%3A+a+systematic+review&amp;rft.volume=4&amp;rft.issue=1&amp;rft.pages=e000139&amp;rft.date=2017-06-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5508801%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28761689&amp;rft_id=info%3Adoi%2F10.1136%2Fbmjgast-2017-000139&amp;rft.aulast=Kenneally&amp;rft.aufirst=S&amp;rft.au=Sier%2C+JH&amp;rft.au=Moore%2C+JB&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5508801&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-NICE2016-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-NICE2016_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICE2016_12-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NICE2016_12-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-NICE2016_12-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-NICE2016_12-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-NICE2016_12-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-NICE2016_12-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-NICE2016_12-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-NICE2016_12-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-NICE2016_12-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-NICE2016_12-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-NICE2016_12-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-NICE2016_12-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-NICE2016_12-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-NICE2016_12-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-NICE2016_12-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-NICE2016_12-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-NICE2016_12-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-NICE2016_12-18"><sup><i><b>s</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://www.nice.org.uk/guidance/ng49">"NG49: Non-alcoholic fatty liver disease (NAFLD): assessment and management | Guidance and guidelines"</a>. NICE. July 2016.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=NG49%3A+Non-alcoholic+fatty+liver+disease+%28NAFLD%29%3A+assessment+and+management+%7C+Guidance+and+guidelines&amp;rft.pub=NICE&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2Fng49&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span>  <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGlenFlorosDayPryke2016" class="citation journal cs1">Glen J, Floros L, Day C, Pryke R (September 2016). "Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance". <i>BMJ</i> (National guidelines). <b>354</b>: i4428. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.i4428">10.1136/bmj.i4428</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27605111">27605111</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:32302328">32302328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMJ&amp;rft.atitle=Non-alcoholic+fatty+liver+disease+%28NAFLD%29%3A+summary+of+NICE+guidance&amp;rft.volume=354&amp;rft.pages=i4428&amp;rft.date=2016-09&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A32302328%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27605111&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.i4428&amp;rft.aulast=Glen&amp;rft.aufirst=J&amp;rft.au=Floros%2C+L&amp;rft.au=Day%2C+C&amp;rft.au=Pryke%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Tilg2016-13"><span class="mw-cite-backlink">^ <a href="#cite_ref-Tilg2016_13-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Tilg2016_13-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTilgMoschenRoden2017" class="citation journal cs1">Tilg H, Moschen AR, Roden M (January 2017). "NAFLD and diabetes mellitus". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>14</b> (1): 32–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2016.147">10.1038/nrgastro.2016.147</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27729660">27729660</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:22213841">22213841</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=NAFLD+and+diabetes+mellitus&amp;rft.volume=14&amp;rft.issue=1&amp;rft.pages=32-42&amp;rft.date=2017-01&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A22213841%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27729660&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2016.147&amp;rft.aulast=Tilg&amp;rft.aufirst=H&amp;rft.au=Moschen%2C+AR&amp;rft.au=Roden%2C+M&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-EASL2016-14"><span class="mw-cite-backlink">^ <a href="#cite_ref-EASL2016_14-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EASL2016_14-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EASL2016_14-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-EASL2016_14-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-EASL2016_14-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-EASL2016_14-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-EASL2016_14-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-EASL2016_14-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-EASL2016_14-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-EASL2016_14-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-EASL2016_14-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-EASL2016_14-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-EASL2016_14-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-EASL2016_14-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-EASL2016_14-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-EASL2016_14-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-EASL2016_14-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-EASL2016_14-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-EASL2016_14-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-EASL2016_14-19"><sup><i><b>t</b></i></sup></a> <a href="#cite_ref-EASL2016_14-20"><sup><i><b>u</b></i></sup></a> <a href="#cite_ref-EASL2016_14-21"><sup><i><b>v</b></i></sup></a> <a href="#cite_ref-EASL2016_14-22"><sup><i><b>w</b></i></sup></a> <a href="#cite_ref-EASL2016_14-23"><sup><i><b>x</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEuropean_Association_for_the_Study_of_the_Liver_(EASL)European_Association_for_the_Study_of_Diabetes_(EASD)European_Association_for_the_Study_of_Obesity_(EASO)2016" class="citation journal cs1">European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO) (June 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2015.11.004">"EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease"</a>. <i>Journal of Hepatology</i> (Professional society guidelines). <b>64</b> (6): 1388–402. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2015.11.004">10.1016/j.jhep.2015.11.004</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27062661">27062661</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=EASL-EASD-EASO+Clinical+Practice+Guidelines+for+the+management+of+non-alcoholic+fatty+liver+disease&amp;rft.volume=64&amp;rft.issue=6&amp;rft.pages=1388-402&amp;rft.date=2016-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2015.11.004&amp;rft_id=info%3Apmid%2F27062661&amp;rft.au=European+Association+for+the+Study+of+the+Liver+%28EASL%29&amp;rft.au=European+Association+for+the+Study+of+Diabetes+%28EASD%29&amp;rft.au=European+Association+for+the+Study+of+Obesity+%28EASO%29&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2015.11.004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span>
<ul><li>Lay summary in: <link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation journal cs1 cs1-prop-foreign-lang-source">Spahr L, Goossens N (25 January 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.53738%2FREVMED.2017.13.547.0215">"La stéatopathie non alcoolique"</a>. <i>Revue Médicale Suisse</i> (in French). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.53738%2FREVMED.2017.13.547.0215">10.53738/REVMED.2017.13.547.0215</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Revue+M%C3%A9dicale+Suisse&amp;rft.atitle=La+st%C3%A9atopathie+non+alcoolique&amp;rft.date=2017-01-25&amp;rft_id=info%3Adoi%2F10.53738%2FREVMED.2017.13.547.0215&amp;rft.aulast=Spahr&amp;rft.aufirst=L&amp;rft.au=Goossens%2C+N&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.53738%252FREVMED.2017.13.547.0215&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></li></ul>
</span></li>
<li id="cite_note-Marjot2020-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Marjot2020_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Marjot2020_15-18"><sup><i><b>s</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarjotMoollaCobboldHodson2020" class="citation journal cs1">Marjot, T; Moolla, A; Cobbold, JF; Hodson, L; Tomlinson, JW (January 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fendrev%2Fbnz009">"Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management"</a>. <i>Endocrine Reviews</i>. <b>41</b> (1): bnz009. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1210%2Fendrev%2Fbnz009">10.1210/endrev/bnz009</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31629366">31629366</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+Reviews&amp;rft.atitle=Nonalcoholic+Fatty+Liver+Disease+in+Adults%3A+Current+Concepts+in+Etiology%2C+Outcomes%2C+and+Management&amp;rft.volume=41&amp;rft.issue=1&amp;rft.pages=bnz009&amp;rft.date=2020-01&amp;rft_id=info%3Adoi%2F10.1210%2Fendrev%2Fbnz009&amp;rft_id=info%3Apmid%2F31629366&amp;rft.aulast=Marjot&amp;rft.aufirst=T&amp;rft.au=Moolla%2C+A&amp;rft.au=Cobbold%2C+JF&amp;rft.au=Hodson%2C+L&amp;rft.au=Tomlinson%2C+JW&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1210%252Fendrev%252Fbnz009&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Younossi2016-16"><span class="mw-cite-backlink">^ <a href="#cite_ref-Younossi2016_16-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Younossi2016_16-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYounossiKoenigAbdelatifFazel2016" class="citation journal cs1">Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (July 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.28431">"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes"</a>. <i>Hepatology</i>. <b>64</b> (1): 73–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.28431">10.1002/hep.28431</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26707365">26707365</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Global+epidemiology+of+nonalcoholic+fatty+liver+disease-Meta-analytic+assessment+of+prevalence%2C+incidence%2C+and+outcomes&amp;rft.volume=64&amp;rft.issue=1&amp;rft.pages=73-84&amp;rft.date=2016-07&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.28431&amp;rft_id=info%3Apmid%2F26707365&amp;rft.aulast=Younossi&amp;rft.aufirst=ZM&amp;rft.au=Koenig%2C+AB&amp;rft.au=Abdelatif%2C+D&amp;rft.au=Fazel%2C+Y&amp;rft.au=Henry%2C+L&amp;rft.au=Wymer%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhep.28431&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Rinella2015-17"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rinella2015_17-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rinella2015_17-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRinella2015" class="citation journal cs1">Rinella ME (June 2015). "Nonalcoholic fatty liver disease: a systematic review". <i>JAMA</i> (Systematic review). <b>313</b> (22): 2263–73. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.2015.5370">10.1001/jama.2015.5370</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F1636665">2318/1636665</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26057287">26057287</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Nonalcoholic+fatty+liver+disease%3A+a+systematic+review&amp;rft.volume=313&amp;rft.issue=22&amp;rft.pages=2263-73&amp;rft.date=2015-06&amp;rft_id=info%3Ahdl%2F2318%2F1636665&amp;rft_id=info%3Apmid%2F26057287&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.2015.5370&amp;rft.aulast=Rinella&amp;rft.aufirst=ME&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Rich2018-18"><span class="mw-cite-backlink">^ <a href="#cite_ref-Rich2018_18-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Rich2018_18-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRichOjiMuftiBrowning2018" class="citation journal cs1">Rich NE, Oji S, Mufti AR, Browning JD, Parikh ND, Odewole M,  et&#160;al. (February 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794571">"Racial and Ethnic Disparities in Nonalcoholic Fatty Liver Disease Prevalence, Severity, and Outcomes in the United States: A Systematic Review and Meta-analysis"</a>. <i>Clinical Gastroenterology and Hepatology</i>. <b>16</b> (2): 198–210.e2. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2017.09.041">10.1016/j.cgh.2017.09.041</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794571">5794571</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28970148">28970148</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Gastroenterology+and+Hepatology&amp;rft.atitle=Racial+and+Ethnic+Disparities+in+Nonalcoholic+Fatty+Liver+Disease+Prevalence%2C+Severity%2C+and+Outcomes+in+the+United+States%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=16&amp;rft.issue=2&amp;rft.pages=198-210.e2&amp;rft.date=2018-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5794571%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28970148&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cgh.2017.09.041&amp;rft.aulast=Rich&amp;rft.aufirst=NE&amp;rft.au=Oji%2C+S&amp;rft.au=Mufti%2C+AR&amp;rft.au=Browning%2C+JD&amp;rft.au=Parikh%2C+ND&amp;rft.au=Odewole%2C+M&amp;rft.au=Mayo%2C+H&amp;rft.au=Singal%2C+AG&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5794571&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-EASL2019-19"><span class="mw-cite-backlink">^ <a href="#cite_ref-EASL2019_19-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EASL2019_19-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-EASL2019_19-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-EASL2019_19-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20191005233915/https://easl.eu/press-release/easl-nafld-obesity-epidemic-europe/">"Obesity epidemic results in Non-Alcoholic Fatty Liver Disease (NAFLD) becoming the most common cause of liver disease in Europe"</a>. <i>EASL-The Home of Hepatology</i>. 25 September 2019. Archived from <a rel="nofollow" class="external text" href="https://easl.eu/press-release/easl-nafld-obesity-epidemic-europe/">the original</a> on 5 October 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">5 October</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=EASL-The+Home+of+Hepatology.&amp;rft.atitle=Obesity+epidemic+results+in+Non-Alcoholic+Fatty+Liver+Disease+%28NAFLD%29+becoming+the+most+common+cause+of+liver+disease+in+Europe.&amp;rft.date=2019-09-25&amp;rft_id=https%3A%2F%2Feasl.eu%2Fpress-release%2Feasl-nafld-obesity-epidemic-europe%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Younossi2017-20"><span class="mw-cite-backlink">^ <a href="#cite_ref-Younossi2017_20-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-10"><sup><i><b>k</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-11"><sup><i><b>l</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-12"><sup><i><b>m</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-13"><sup><i><b>n</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-14"><sup><i><b>o</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-15"><sup><i><b>p</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-16"><sup><i><b>q</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-17"><sup><i><b>r</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-18"><sup><i><b>s</b></i></sup></a> <a href="#cite_ref-Younossi2017_20-19"><sup><i><b>t</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYounossiAnsteeMariettiHardy2018" class="citation journal cs1">Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M,  et&#160;al. (January 2018). "Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>15</b> (1): 11–20. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2017.109">10.1038/nrgastro.2017.109</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F1659230">2318/1659230</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28930295">28930295</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31345431">31345431</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=Global+burden+of+NAFLD+and+NASH%3A+trends%2C+predictions%2C+risk+factors+and+prevention&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=11-20&amp;rft.date=2018-01&amp;rft_id=info%3Ahdl%2F2318%2F1659230&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31345431%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28930295&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2017.109&amp;rft.aulast=Younossi&amp;rft.aufirst=Z&amp;rft.au=Anstee%2C+QM&amp;rft.au=Marietti%2C+M&amp;rft.au=Hardy%2C+T&amp;rft.au=Henry%2C+L&amp;rft.au=Eslam%2C+M&amp;rft.au=George%2C+J&amp;rft.au=Bugianesi%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Younossi2019-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-Younossi2019_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Younossi2019_21-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYounossi2019" class="citation journal cs1">Younossi ZM (March 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2018.10.033">"Non-alcoholic fatty liver disease - A global public health perspective"</a>. <i>Journal of Hepatology</i>. <b>70</b> (3): 531–544. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2018.10.033">10.1016/j.jhep.2018.10.033</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30414863">30414863</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Non-alcoholic+fatty+liver+disease+-+A+global+public+health+perspective&amp;rft.volume=70&amp;rft.issue=3&amp;rft.pages=531-544&amp;rft.date=2019-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2018.10.033&amp;rft_id=info%3Apmid%2F30414863&amp;rft.aulast=Younossi&amp;rft.aufirst=ZM&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2018.10.033&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Friedman2018-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-Friedman2018_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-Friedman2018_22-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFriedmanNeuschwander-TetriRinellaSanyal2018" class="citation journal cs1">Friedman SL, Neuschwander-Tetri BA, Rinella M, Sanyal AJ (July 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553468">"Mechanisms of NAFLD development and therapeutic strategies"</a>. <i>Nature Medicine</i>. <b>24</b> (7): 908–922. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41591-018-0104-9">10.1038/s41591-018-0104-9</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553468">6553468</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29967350">29967350</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Medicine&amp;rft.atitle=Mechanisms+of+NAFLD+development+and+therapeutic+strategies&amp;rft.volume=24&amp;rft.issue=7&amp;rft.pages=908-922&amp;rft.date=2018-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6553468%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29967350&amp;rft_id=info%3Adoi%2F10.1038%2Fs41591-018-0104-9&amp;rft.aulast=Friedman&amp;rft.aufirst=SL&amp;rft.au=Neuschwander-Tetri%2C+BA&amp;rft.au=Rinella%2C+M&amp;rft.au=Sanyal%2C+AJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6553468&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AlKhater2015-23"><span class="mw-cite-backlink">^ <a href="#cite_ref-AlKhater2015_23-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-AlKhater2015_23-9"><sup><i><b>j</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAlKhater2015" class="citation journal cs1">AlKhater SA (May 2015). "Paediatric non-alcoholic fatty liver disease: an overview". <i>Obesity Reviews</i>. <b>16</b> (5): 393–405. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fobr.12271">10.1111/obr.12271</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25753407">25753407</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39735609">39735609</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Obesity+Reviews&amp;rft.atitle=Paediatric+non-alcoholic+fatty+liver+disease%3A+an+overview&amp;rft.volume=16&amp;rft.issue=5&amp;rft.pages=393-405&amp;rft.date=2015-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39735609%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F25753407&amp;rft_id=info%3Adoi%2F10.1111%2Fobr.12271&amp;rft.aulast=AlKhater&amp;rft.aufirst=SA&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Musso2013-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-Musso2013_24-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMussoCassaderOlivettiRosina2013" class="citation journal cs1">Musso G, Cassader M, Olivetti C, Rosina F, Carbone G, Gambino R (May 2013). "Association of obstructive sleep apnea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis". <i>Obesity Reviews</i>. <b>14</b> (5): 417–31. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fobr.12020">10.1111/obr.12020</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F127880">2318/127880</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23387384">23387384</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:31153416">31153416</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Obesity+Reviews&amp;rft.atitle=Association+of+obstructive+sleep+apnea+with+the+presence+and+severity+of+non-alcoholic+fatty+liver+disease.+A+systematic+review+and+meta-analysis&amp;rft.volume=14&amp;rft.issue=5&amp;rft.pages=417-31&amp;rft.date=2013-05&amp;rft_id=info%3Ahdl%2F2318%2F127880&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A31153416%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23387384&amp;rft_id=info%3Adoi%2F10.1111%2Fobr.12020&amp;rft.aulast=Musso&amp;rft.aufirst=G&amp;rft.au=Cassader%2C+M&amp;rft.au=Olivetti%2C+C&amp;rft.au=Rosina%2C+F&amp;rft.au=Carbone%2C+G&amp;rft.au=Gambino%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-25">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSinghHussainAntony2021" class="citation journal cs1">Singh, A.; Hussain, S.; Antony, B. (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011308">"Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: A comprehensive systematic review and meta-analysis"</a>. <i>Diabetes &amp; Metabolic Syndrome</i>. <b>15</b> (3): 813–822. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dsx.2021.03.019">10.1016/j.dsx.2021.03.019</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011308">8011308</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33862417">33862417</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes+%26+Metabolic+Syndrome&amp;rft.atitle=Non-alcoholic+fatty+liver+disease+and+clinical+outcomes+in+patients+with+COVID-19%3A+A+comprehensive+systematic+review+and+meta-analysis&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=813-822&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8011308%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F33862417&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dsx.2021.03.019&amp;rft.aulast=Singh&amp;rft.aufirst=A.&amp;rft.au=Hussain%2C+S.&amp;rft.au=Antony%2C+B.&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8011308&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-26">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBallestriNascimbeniBaldelliMarrazzo2017" class="citation journal cs1">Ballestri S, Nascimbeni F, Baldelli E, Marrazzo A, Romagnoli D, Lonardo A (June 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487879">"NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk"</a>. <i>Advances in Therapy</i>. <b>34</b> (6): 1291–1326. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12325-017-0556-1">10.1007/s12325-017-0556-1</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487879">5487879</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28526997">28526997</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Therapy&amp;rft.atitle=NAFLD+as+a+Sexual+Dimorphic+Disease%3A+Role+of+Gender+and+Reproductive+Status+in+the+Development+and+Progression+of+Nonalcoholic+Fatty+Liver+Disease+and+Inherent+Cardiovascular+Risk&amp;rft.volume=34&amp;rft.issue=6&amp;rft.pages=1291-1326&amp;rft.date=2017-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5487879%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28526997&amp;rft_id=info%3Adoi%2F10.1007%2Fs12325-017-0556-1&amp;rft.aulast=Ballestri&amp;rft.aufirst=S&amp;rft.au=Nascimbeni%2C+F&amp;rft.au=Baldelli%2C+E&amp;rft.au=Marrazzo%2C+A&amp;rft.au=Romagnoli%2C+D&amp;rft.au=Lonardo%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5487879&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Wong2018-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-Wong2018_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Wong2018_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Wong2018_27-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Wong2018_27-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Wong2018_27-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Wong2018_27-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWongAdamsde_LédinghenWong2018" class="citation journal cs1">Wong VW, Adams LA, de Lédinghen V, Wong GL, Sookoian S (August 2018). "Noninvasive biomarkers in NAFLD and NASH - current progress and future promise". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>15</b> (8): 461–478. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41575-018-0014-9">10.1038/s41575-018-0014-9</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29844588">29844588</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:44102990">44102990</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=Noninvasive+biomarkers+in+NAFLD+and+NASH+-+current+progress+and+future+promise&amp;rft.volume=15&amp;rft.issue=8&amp;rft.pages=461-478&amp;rft.date=2018-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A44102990%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29844588&amp;rft_id=info%3Adoi%2F10.1038%2Fs41575-018-0014-9&amp;rft.aulast=Wong&amp;rft.aufirst=VW&amp;rft.au=Adams%2C+LA&amp;rft.au=de+L%C3%A9dinghen%2C+V&amp;rft.au=Wong%2C+GL&amp;rft.au=Sookoian%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Lim2010-28"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lim2010_28-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lim2010_28-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLimMietus-SnyderValenteSchwarz2010" class="citation journal cs1">Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH (May 2010). "The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>7</b> (5): 251–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2010.41">10.1038/nrgastro.2010.41</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20368739">20368739</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:2483983">2483983</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=The+role+of+fructose+in+the+pathogenesis+of+NAFLD+and+the+metabolic+syndrome&amp;rft.volume=7&amp;rft.issue=5&amp;rft.pages=251-64&amp;rft.date=2010-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A2483983%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F20368739&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2010.41&amp;rft.aulast=Lim&amp;rft.aufirst=JS&amp;rft.au=Mietus-Snyder%2C+M&amp;rft.au=Valente%2C+A&amp;rft.au=Schwarz%2C+JM&amp;rft.au=Lustig%2C+RH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Wree2013-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wree2013_29-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWreeBroderickCanbayHoffman2013" class="citation journal cs1">Wree A, Broderick L, Canbay A, Hoffman HM, Feldstein AE (November 2013). "From NAFLD to NASH to cirrhosis-new insights into disease mechanisms". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>10</b> (11): 627–36. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2013.149">10.1038/nrgastro.2013.149</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23958599">23958599</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:6899033">6899033</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=From+NAFLD+to+NASH+to+cirrhosis-new+insights+into+disease+mechanisms&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=627-36&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A6899033%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23958599&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2013.149&amp;rft.aulast=Wree&amp;rft.aufirst=A&amp;rft.au=Broderick%2C+L&amp;rft.au=Canbay%2C+A&amp;rft.au=Hoffman%2C+HM&amp;rft.au=Feldstein%2C+AE&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLeermakersMoreiraKiefte-de_JongDarweesh2015" class="citation journal cs1">Leermakers ET, Moreira EM, Kiefte-de Jong JC, Darweesh SK, Visser T, Voortman T,  et&#160;al. (August 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fnutrit%2Fnuv010">"Effects of choline on health across the life course: a systematic review"</a>. <i>Nutrition Reviews</i>. <b>73</b> (8): 500–22. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fnutrit%2Fnuv010">10.1093/nutrit/nuv010</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26108618">26108618</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nutrition+Reviews&amp;rft.atitle=Effects+of+choline+on+health+across+the+life+course%3A+a+systematic+review&amp;rft.volume=73&amp;rft.issue=8&amp;rft.pages=500-22&amp;rft.date=2015-08&amp;rft_id=info%3Adoi%2F10.1093%2Fnutrit%2Fnuv010&amp;rft_id=info%3Apmid%2F26108618&amp;rft.aulast=Leermakers&amp;rft.aufirst=ET&amp;rft.au=Moreira%2C+EM&amp;rft.au=Kiefte-de+Jong%2C+JC&amp;rft.au=Darweesh%2C+SK&amp;rft.au=Visser%2C+T&amp;rft.au=Voortman%2C+T&amp;rft.au=Bautista%2C+PK&amp;rft.au=Chowdhury%2C+R&amp;rft.au=Gorman%2C+D&amp;rft.au=Bramer%2C+WM&amp;rft.au=Felix%2C+JF&amp;rft.au=Franco%2C+OH&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1093%252Fnutrit%252Fnuv010&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFIvancovsky-WajcmanFliss-IsakovGrinshpanSalomone2022" class="citation journal cs1">Ivancovsky-Wajcman, Dana; Fliss-Isakov, Naomi; Grinshpan, Laura Sol; Salomone, Federico; Lazarus, Jeffrey V.; Webb, Muriel; Shibolet, Oren; Kariv, Revital; Zelber-Sagi, Shira (2022-08-27). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459934">"High Meat Consumption Is Prospectively Associated with the Risk of Non-Alcoholic Fatty Liver Disease and Presumed Significant Fibrosis"</a>. <i>Nutrients</i>. <b>14</b> (17): 3533. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fnu14173533">10.3390/nu14173533</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/2072-6643">2072-6643</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459934">9459934</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/36079791">36079791</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nutrients&amp;rft.atitle=High+Meat+Consumption+Is+Prospectively+Associated+with+the+Risk+of+Non-Alcoholic+Fatty+Liver+Disease+and+Presumed+Significant+Fibrosis&amp;rft.volume=14&amp;rft.issue=17&amp;rft.pages=3533&amp;rft.date=2022-08-27&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9459934%23id-name%3DPMC&amp;rft.issn=2072-6643&amp;rft_id=info%3Apmid%2F36079791&amp;rft_id=info%3Adoi%2F10.3390%2Fnu14173533&amp;rft.aulast=Ivancovsky-Wajcman&amp;rft.aufirst=Dana&amp;rft.au=Fliss-Isakov%2C+Naomi&amp;rft.au=Grinshpan%2C+Laura+Sol&amp;rft.au=Salomone%2C+Federico&amp;rft.au=Lazarus%2C+Jeffrey+V.&amp;rft.au=Webb%2C+Muriel&amp;rft.au=Shibolet%2C+Oren&amp;rft.au=Kariv%2C+Revital&amp;rft.au=Zelber-Sagi%2C+Shira&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC9459934&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-32">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiZhengRayamajhiThapa2022" class="citation journal cs1">Li, Huiping; Zheng, Xiaoxi; Rayamajhi, Sabina; Thapa, Amrish; Meng, Ge; Zhang, Qing; Liu, Li; Wu, Hongmei; Gu, Yeqing; Zhang, Shunming; Zhang, Tingjing; Wang, Xuena; Dong, Jun; Cao, Zhixia; Zhang, Xu (2022-02-28). "Organ meat consumption and risk of nonalcoholic fatty liver disease: the TCLSIH study". <i>The British Journal of Nutrition</i>: 1–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS0007114522000629">10.1017/S0007114522000629</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1475-2662">1475-2662</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/35225189">35225189</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:247156762">247156762</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Nutrition&amp;rft.atitle=Organ+meat+consumption+and+risk+of+nonalcoholic+fatty+liver+disease%3A+the+TCLSIH+study&amp;rft.pages=1-21&amp;rft.date=2022-02-28&amp;rft.issn=1475-2662&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A247156762%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F35225189&amp;rft_id=info%3Adoi%2F10.1017%2FS0007114522000629&amp;rft.aulast=Li&amp;rft.aufirst=Huiping&amp;rft.au=Zheng%2C+Xiaoxi&amp;rft.au=Rayamajhi%2C+Sabina&amp;rft.au=Thapa%2C+Amrish&amp;rft.au=Meng%2C+Ge&amp;rft.au=Zhang%2C+Qing&amp;rft.au=Liu%2C+Li&amp;rft.au=Wu%2C+Hongmei&amp;rft.au=Gu%2C+Yeqing&amp;rft.au=Zhang%2C+Shunming&amp;rft.au=Zhang%2C+Tingjing&amp;rft.au=Wang%2C+Xuena&amp;rft.au=Dong%2C+Jun&amp;rft.au=Cao%2C+Zhixia&amp;rft.au=Zhang%2C+Xu&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-33">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTannéGagnadouxChazouillèresFleury2005" class="citation journal cs1">Tanné F, Gagnadoux F, Chazouillères O, Fleury B, Wendum D, Lasnier E,  et&#160;al. (June 2005). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.20725">"Chronic liver injury during obstructive sleep apnea"</a>. <i>Hepatology</i>. <b>41</b> (6): 1290–1296. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.20725">10.1002/hep.20725</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15915459">15915459</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Chronic+liver+injury+during+obstructive+sleep+apnea&amp;rft.volume=41&amp;rft.issue=6&amp;rft.pages=1290-1296&amp;rft.date=2005-06&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.20725&amp;rft_id=info%3Apmid%2F15915459&amp;rft.aulast=Tann%C3%A9&amp;rft.aufirst=F&amp;rft.au=Gagnadoux%2C+F&amp;rft.au=Chazouill%C3%A8res%2C+O&amp;rft.au=Fleury%2C+B&amp;rft.au=Wendum%2C+D&amp;rft.au=Lasnier%2C+E&amp;rft.au=Lebeau%2C+B&amp;rft.au=Poupon%2C+R&amp;rft.au=Serfaty%2C+L&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhep.20725&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-34">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWangGaoHeBao2020" class="citation journal cs1">Wang H, Gao Q, He S, Bao Y, Sun H, Meng L,  et&#160;al. (June 2020). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283303">"Self-reported snoring is associated with nonalcoholic fatty liver disease"</a>. <i>Scientific Reports</i>. <b>10</b> (1): 9267. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2020NatSR..10.9267W">2020NatSR..10.9267W</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41598-020-66208-1">10.1038/s41598-020-66208-1</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283303">7283303</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32518245">32518245</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scientific+Reports&amp;rft.atitle=Self-reported+snoring+is+associated+with+nonalcoholic+fatty+liver+disease&amp;rft.volume=10&amp;rft.issue=1&amp;rft.pages=9267&amp;rft.date=2020-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7283303%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F32518245&amp;rft_id=info%3Adoi%2F10.1038%2Fs41598-020-66208-1&amp;rft_id=info%3Abibcode%2F2020NatSR..10.9267W&amp;rft.aulast=Wang&amp;rft.aufirst=H&amp;rft.au=Gao%2C+Q&amp;rft.au=He%2C+S&amp;rft.au=Bao%2C+Y&amp;rft.au=Sun%2C+H&amp;rft.au=Meng%2C+L&amp;rft.au=Liang%2C+J&amp;rft.au=Sun%2C+C&amp;rft.au=Chen%2C+S&amp;rft.au=Cao%2C+L&amp;rft.au=Huang%2C+W&amp;rft.au=Zhang%2C+Y&amp;rft.au=Huang%2C+J&amp;rft.au=Wu%2C+S&amp;rft.au=Wang%2C+T&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7283303&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-HEPAMARCHESINI2016-35"><span class="mw-cite-backlink">^ <a href="#cite_ref-HEPAMARCHESINI2016_35-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-HEPAMARCHESINI2016_35-6"><sup><i><b>g</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarchesiniPettaDalle_Grave2016" class="citation journal cs1">Marchesini G, Petta S, Dalle Grave R (June 2016). "Diet, weight loss, and liver health in nonalcoholic fatty liver disease: Pathophysiology, evidence, and practice". <i>Hepatology</i>. <b>63</b> (6): 2032–43. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.28392">10.1002/hep.28392</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/10447%2F159316">10447/159316</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26663351">26663351</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:19914572">19914572</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Diet%2C+weight+loss%2C+and+liver+health+in+nonalcoholic+fatty+liver+disease%3A+Pathophysiology%2C+evidence%2C+and+practice&amp;rft.volume=63&amp;rft.issue=6&amp;rft.pages=2032-43&amp;rft.date=2016-06&amp;rft_id=info%3Ahdl%2F10447%2F159316&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A19914572%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F26663351&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.28392&amp;rft.aulast=Marchesini&amp;rft.aufirst=G&amp;rft.au=Petta%2C+S&amp;rft.au=Dalle+Grave%2C+R&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-36"><span class="mw-cite-backlink"><b><a href="#cite_ref-36">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKhanNewsome2018" class="citation journal cs1">Khan RS, Newsome PN (February 2018). "NAFLD in 2017: Novel insights into mechanisms of disease progression". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>15</b> (2): 71–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2017.181">10.1038/nrgastro.2017.181</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29300050">29300050</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:10248663">10248663</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=NAFLD+in+2017%3A+Novel+insights+into+mechanisms+of+disease+progression&amp;rft.volume=15&amp;rft.issue=2&amp;rft.pages=71-72&amp;rft.date=2018-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A10248663%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29300050&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2017.181&amp;rft.aulast=Khan&amp;rft.aufirst=RS&amp;rft.au=Newsome%2C+PN&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-37"><span class="mw-cite-backlink"><b><a href="#cite_ref-37">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNeuschwander-Tetri2017" class="citation journal cs1">Neuschwander-Tetri BA (February 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330146">"Non-alcoholic fatty liver disease"</a>. <i>BMC Medicine</i>. <b>15</b> (1): 45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1186%2Fs12916-017-0806-8">10.1186/s12916-017-0806-8</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5330146">5330146</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28241825">28241825</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=BMC+Medicine&amp;rft.atitle=Non-alcoholic+fatty+liver+disease&amp;rft.volume=15&amp;rft.issue=1&amp;rft.pages=45&amp;rft.date=2017-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5330146%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28241825&amp;rft_id=info%3Adoi%2F10.1186%2Fs12916-017-0806-8&amp;rft.aulast=Neuschwander-Tetri&amp;rft.aufirst=BA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5330146&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-38"><span class="mw-cite-backlink"><b><a href="#cite_ref-38">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDella_PepaVetraniLombardiBozzetto2017" class="citation journal cs1">Della Pepa G, Vetrani C, Lombardi G, Bozzetto L, Annuzzi G, Rivellese AA (September 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691682">"Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals"</a>. <i>Nutrients</i>. <b>9</b> (10): 1065. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fnu9101065">10.3390/nu9101065</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691682">5691682</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28954437">28954437</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nutrients&amp;rft.atitle=Isocaloric+Dietary+Changes+and+Non-Alcoholic+Fatty+Liver+Disease+in+High+Cardiometabolic+Risk+Individuals&amp;rft.volume=9&amp;rft.issue=10&amp;rft.pages=1065&amp;rft.date=2017-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5691682%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28954437&amp;rft_id=info%3Adoi%2F10.3390%2Fnu9101065&amp;rft.aulast=Della+Pepa&amp;rft.aufirst=G&amp;rft.au=Vetrani%2C+C&amp;rft.au=Lombardi%2C+G&amp;rft.au=Bozzetto%2C+L&amp;rft.au=Annuzzi%2C+G&amp;rft.au=Rivellese%2C+AA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5691682&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Byrne2015-39"><span class="mw-cite-backlink">^ <a href="#cite_ref-Byrne2015_39-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Byrne2015_39-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Byrne2015_39-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Byrne2015_39-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFByrneTargher2015" class="citation journal cs1">Byrne CD, Targher G (April 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2014.12.012">"NAFLD: a multisystem disease"</a>. <i>Journal of Hepatology</i>. <b>62</b> (1 Suppl): S47–64. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2014.12.012">10.1016/j.jhep.2014.12.012</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25920090">25920090</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=NAFLD%3A+a+multisystem+disease&amp;rft.volume=62&amp;rft.issue=1+Suppl&amp;rft.pages=S47-64&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2014.12.012&amp;rft_id=info%3Apmid%2F25920090&amp;rft.aulast=Byrne&amp;rft.aufirst=CD&amp;rft.au=Targher%2C+G&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2014.12.012&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZhangJiWangLi2018" class="citation journal cs1">Zhang X, Ji X, Wang Q, Li JZ (February 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818366">"New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD)"</a>. <i>Protein &amp; Cell</i>. <b>9</b> (2): 164–177. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs13238-017-0436-0">10.1007/s13238-017-0436-0</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818366">5818366</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28643267">28643267</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Protein+%26+Cell&amp;rft.atitle=New+insight+into+inter-organ+crosstalk+contributing+to+the+pathogenesis+of+non-alcoholic+fatty+liver+disease+%28NAFLD%29&amp;rft.volume=9&amp;rft.issue=2&amp;rft.pages=164-177&amp;rft.date=2018-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818366%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28643267&amp;rft_id=info%3Adoi%2F10.1007%2Fs13238-017-0436-0&amp;rft.aulast=Zhang&amp;rft.aufirst=X&amp;rft.au=Ji%2C+X&amp;rft.au=Wang%2C+Q&amp;rft.au=Li%2C+JZ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5818366&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Bagherniya2018-41"><span class="mw-cite-backlink">^ <a href="#cite_ref-Bagherniya2018_41-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Bagherniya2018_41-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBagherniyaNobiliBlessoSahebkar2018" class="citation journal cs1">Bagherniya M, Nobili V, Blesso CN, Sahebkar A (April 2018). "Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review". <i>Pharmacological Research</i>. <b>130</b>: 213–240. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.phrs.2017.12.020">10.1016/j.phrs.2017.12.020</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29287685">29287685</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207369426">207369426</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pharmacological+Research&amp;rft.atitle=Medicinal+plants+and+bioactive+natural+compounds+in+the+treatment+of+non-alcoholic+fatty+liver+disease%3A+A+clinical+review&amp;rft.volume=130&amp;rft.pages=213-240&amp;rft.date=2018-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207369426%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29287685&amp;rft_id=info%3Adoi%2F10.1016%2Fj.phrs.2017.12.020&amp;rft.aulast=Bagherniya&amp;rft.aufirst=M&amp;rft.au=Nobili%2C+V&amp;rft.au=Blesso%2C+CN&amp;rft.au=Sahebkar%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid31451866-42"><span class="mw-cite-backlink">^ <a href="#cite_ref-pmid31451866_42-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-pmid31451866_42-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-pmid31451866_42-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPalmerGustafsonKirklandSmith2019" class="citation journal cs1">Palmer AK, Gustafson B, Kirkland JL, Smith U (2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731336">"Cellular senescence: at the nexus between ageing and diabetes"</a>. <i><a href="/wiki/Diabetologia" title="Diabetologia">Diabetologia</a></i>. <b>62</b> (10): 1835–1841. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00125-019-4934-x">10.1007/s00125-019-4934-x</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731336">6731336</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31451866">31451866</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetologia&amp;rft.atitle=Cellular+senescence%3A+at+the+nexus+between+ageing+and+diabetes&amp;rft.volume=62&amp;rft.issue=10&amp;rft.pages=1835-1841&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6731336%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31451866&amp;rft_id=info%3Adoi%2F10.1007%2Fs00125-019-4934-x&amp;rft.aulast=Palmer&amp;rft.aufirst=AK&amp;rft.au=Gustafson%2C+B&amp;rft.au=Kirkland%2C+JL&amp;rft.au=Smith%2C+U&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6731336&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-43">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVaccaLeslieVirtueLam2020" class="citation journal cs1">Vacca, Michele; Leslie, Jack; Virtue, Samuel; Lam, Brian Y. H.; Govaere, Olivier; Tiniakos, Dina; Snow, Sophie; Davies, Susan; Petkevicius, Kasparas; Tong, Zhen; Peirce, Vivian (2020). <a rel="nofollow" class="external text" href="https://www.repository.cam.ac.uk/handle/1810/305000">"Bone morphogenetic protein 8B promotes the progression of non-alcoholic steatohepatitis"</a>. <i>Nature Metabolism</i>. <b>2</b> (6): 514–531. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs42255-020-0214-9">10.1038/s42255-020-0214-9</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/2522-5812">2522-5812</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/32694734">32694734</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:219933429">219933429</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Metabolism&amp;rft.atitle=Bone+morphogenetic+protein+8B+promotes+the+progression+of+non-alcoholic+steatohepatitis&amp;rft.volume=2&amp;rft.issue=6&amp;rft.pages=514-531&amp;rft.date=2020&amp;rft.issn=2522-5812&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A219933429%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F32694734&amp;rft_id=info%3Adoi%2F10.1038%2Fs42255-020-0214-9&amp;rft.aulast=Vacca&amp;rft.aufirst=Michele&amp;rft.au=Leslie%2C+Jack&amp;rft.au=Virtue%2C+Samuel&amp;rft.au=Lam%2C+Brian+Y.+H.&amp;rft.au=Govaere%2C+Olivier&amp;rft.au=Tiniakos%2C+Dina&amp;rft.au=Snow%2C+Sophie&amp;rft.au=Davies%2C+Susan&amp;rft.au=Petkevicius%2C+Kasparas&amp;rft.au=Tong%2C+Zhen&amp;rft.au=Peirce%2C+Vivian&amp;rft_id=https%3A%2F%2Fwww.repository.cam.ac.uk%2Fhandle%2F1810%2F305000&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-44">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLustig2010" class="citation journal cs1">Lustig RH (September 2010). "Fructose: metabolic, hedonic, and societal parallels with ethanol". <i>Journal of the American Dietetic Association</i>. <b>110</b> (9): 1307–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jada.2010.06.008">10.1016/j.jada.2010.06.008</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20800122">20800122</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Dietetic+Association&amp;rft.atitle=Fructose%3A+metabolic%2C+hedonic%2C+and+societal+parallels+with+ethanol&amp;rft.volume=110&amp;rft.issue=9&amp;rft.pages=1307-21&amp;rft.date=2010-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jada.2010.06.008&amp;rft_id=info%3Apmid%2F20800122&amp;rft.aulast=Lustig&amp;rft.aufirst=RH&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-45">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTokuhara2021" class="citation journal cs1">Tokuhara, Daisuke (2021-06-25). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267179">"Role of the Gut Microbiota in Regulating Non-alcoholic Fatty Liver Disease in Children and Adolescents"</a>. <i>Frontiers in Nutrition</i>. <b>8</b>: 700058. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3389%2Ffnut.2021.700058">10.3389/fnut.2021.700058</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267179">8267179</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34250000">34250000</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Frontiers+in+Nutrition&amp;rft.atitle=Role+of+the+Gut+Microbiota+in+Regulating+Non-alcoholic+Fatty+Liver+Disease+in+Children+and+Adolescents&amp;rft.volume=8&amp;rft.pages=700058&amp;rft.date=2021-06-25&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8267179%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34250000&amp;rft_id=info%3Adoi%2F10.3389%2Ffnut.2021.700058&amp;rft.aulast=Tokuhara&amp;rft.aufirst=Daisuke&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8267179&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Leung2016-46"><span class="mw-cite-backlink">^ <a href="#cite_ref-Leung2016_46-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Leung2016_46-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Leung2016_46-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLeungRiveraFurnessAngus2016" class="citation journal cs1">Leung C, Rivera L, Furness JB, Angus PW (July 2016). "The role of the gut microbiota in NAFLD". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>13</b> (7): 412–25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2016.85">10.1038/nrgastro.2016.85</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27273168">27273168</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:24114749">24114749</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=The+role+of+the+gut+microbiota+in+NAFLD&amp;rft.volume=13&amp;rft.issue=7&amp;rft.pages=412-25&amp;rft.date=2016-07&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A24114749%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27273168&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2016.85&amp;rft.aulast=Leung&amp;rft.aufirst=C&amp;rft.au=Rivera%2C+L&amp;rft.au=Furness%2C+JB&amp;rft.au=Angus%2C+PW&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Mehal2013-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Mehal2013_47-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMehal2013" class="citation journal cs1">Mehal WZ (November 2013). "The Gordian Knot of dysbiosis, obesity and NAFLD". <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>10</b> (11): 637–44. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2013.146">10.1038/nrgastro.2013.146</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23958600">23958600</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:20972307">20972307</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=The+Gordian+Knot+of+dysbiosis%2C+obesity+and+NAFLD&amp;rft.volume=10&amp;rft.issue=11&amp;rft.pages=637-44&amp;rft.date=2013-11&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A20972307%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F23958600&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2013.146&amp;rft.aulast=Mehal&amp;rft.aufirst=WZ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSharptonAjmeraLoomba2019" class="citation journal cs1">Sharpton SR, Ajmera V, Loomba R (January 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314895">"Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function"</a>. <i>Clinical Gastroenterology and Hepatology</i>. <b>17</b> (2): 296–306. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2018.08.065">10.1016/j.cgh.2018.08.065</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6314895">6314895</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30196156">30196156</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Gastroenterology+and+Hepatology&amp;rft.atitle=Emerging+Role+of+the+Gut+Microbiome+in+Nonalcoholic+Fatty+Liver+Disease%3A+From+Composition+to+Function&amp;rft.volume=17&amp;rft.issue=2&amp;rft.pages=296-306&amp;rft.date=2019-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6314895%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30196156&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cgh.2018.08.065&amp;rft.aulast=Sharpton&amp;rft.aufirst=SR&amp;rft.au=Ajmera%2C+V&amp;rft.au=Loomba%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6314895&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-49">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPickett-BlakelyYoungCarr2018" class="citation journal cs1">Pickett-Blakely O, Young K, Carr RM (2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170520">"Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis"</a>. <i>Cellular and Molecular Gastroenterology and Hepatology</i>. <b>6</b> (4): 451–462. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jcmgh.2018.07.004">10.1016/j.jcmgh.2018.07.004</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170520">6170520</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30294653">30294653</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cellular+and+Molecular+Gastroenterology+and+Hepatology&amp;rft.atitle=Micronutrients+in+Nonalcoholic+Fatty+Liver+Disease+Pathogenesis&amp;rft.volume=6&amp;rft.issue=4&amp;rft.pages=451-462&amp;rft.date=2018&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6170520%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30294653&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jcmgh.2018.07.004&amp;rft.aulast=Pickett-Blakely&amp;rft.aufirst=O&amp;rft.au=Young%2C+K&amp;rft.au=Carr%2C+RM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6170520&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-50">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPanasevichPepplerOertherWright2017" class="citation journal cs1">Panasevich MR, Peppler WT, Oerther DB, Wright DC, Rector RS (August 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1152%2Fphysiolgenomics.00012.2017">"Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification"</a>. <i>Physiological Genomics</i>. <b>49</b> (8): 385–399. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1152%2Fphysiolgenomics.00012.2017">10.1152/physiolgenomics.00012.2017</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28600319">28600319</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Physiological+Genomics&amp;rft.atitle=Microbiome+and+NAFLD%3A+potential+influence+of+aerobic+fitness+and+lifestyle+modification&amp;rft.volume=49&amp;rft.issue=8&amp;rft.pages=385-399&amp;rft.date=2017-08&amp;rft_id=info%3Adoi%2F10.1152%2Fphysiolgenomics.00012.2017&amp;rft_id=info%3Apmid%2F28600319&amp;rft.aulast=Panasevich&amp;rft.aufirst=MR&amp;rft.au=Peppler%2C+WT&amp;rft.au=Oerther%2C+DB&amp;rft.au=Wright%2C+DC&amp;rft.au=Rector%2C+RS&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1152%252Fphysiolgenomics.00012.2017&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Heiman2016-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-Heiman2016_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Heiman2016_51-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHeimanGreenway2016" class="citation journal cs1">Heiman ML, Greenway FL (May 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837298">"A healthy gastrointestinal microbiome is dependent on dietary diversity"</a>. <i>Molecular Metabolism</i> (Review). <b>5</b> (5): 317–320. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.molmet.2016.02.005">10.1016/j.molmet.2016.02.005</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837298">4837298</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27110483">27110483</a>. <q>Stable, diverse and healthy GI microbial ecosystems are an important component to consider when using diet to perturb physiological systems in animal models of disease, and it is an aspect often overlooked. A common model to study obesity and insulin resistance is one in which the diet is switched from a basic chow diet to a "Western" or "high fat" diet with a predominance of fat and sugar.</q></cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecular+Metabolism&amp;rft.atitle=A+healthy+gastrointestinal+microbiome+is+dependent+on+dietary+diversity&amp;rft.volume=5&amp;rft.issue=5&amp;rft.pages=317-320&amp;rft.date=2016-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4837298%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27110483&amp;rft_id=info%3Adoi%2F10.1016%2Fj.molmet.2016.02.005&amp;rft.aulast=Heiman&amp;rft.aufirst=ML&amp;rft.au=Greenway%2C+FL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4837298&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Liangpunsakul2003-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-Liangpunsakul2003_52-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLiangpunsakulChalasani2003" class="citation journal cs1">Liangpunsakul S, Chalasani N (October 2003). "Is hypothyroidism a risk factor for non-alcoholic steatohepatitis?". <i>Journal of Clinical Gastroenterology</i>. <b>37</b> (4): 340–3. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2F00004836-200310000-00014">10.1097/00004836-200310000-00014</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14506393">14506393</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:41849572">41849572</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Gastroenterology&amp;rft.atitle=Is+hypothyroidism+a+risk+factor+for+non-alcoholic+steatohepatitis%3F&amp;rft.volume=37&amp;rft.issue=4&amp;rft.pages=340-3&amp;rft.date=2003-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A41849572%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F14506393&amp;rft_id=info%3Adoi%2F10.1097%2F00004836-200310000-00014&amp;rft.aulast=Liangpunsakul&amp;rft.aufirst=S&amp;rft.au=Chalasani%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Musso2010-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-Musso2010_53-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMussoGambinoCassaderPagano2011" class="citation journal cs1">Musso G, Gambino R, Cassader M, Pagano G (December 2011). "Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity". <i>Annals of Medicine</i>. <b>43</b> (8): 617–49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F07853890.2010.518623">10.3109/07853890.2010.518623</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21039302">21039302</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:207470810">207470810</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annals+of+Medicine&amp;rft.atitle=Meta-analysis%3A+natural+history+of+non-alcoholic+fatty+liver+disease+%28NAFLD%29+and+diagnostic+accuracy+of+non-invasive+tests+for+liver+disease+severity&amp;rft.volume=43&amp;rft.issue=8&amp;rft.pages=617-49&amp;rft.date=2011-12&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A207470810%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F21039302&amp;rft_id=info%3Adoi%2F10.3109%2F07853890.2010.518623&amp;rft.aulast=Musso&amp;rft.aufirst=G&amp;rft.au=Gambino%2C+R&amp;rft.au=Cassader%2C+M&amp;rft.au=Pagano%2C+G&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-APASL2016-54"><span class="mw-cite-backlink">^ <a href="#cite_ref-APASL2016_54-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-APASL2016_54-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-APASL2016_54-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-APASL2016_54-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-APASL2016_54-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-APASL2016_54-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-APASL2016_54-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-APASL2016_54-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-APASL2016_54-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-APASL2016_54-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-APASL2016_54-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFShihaIbrahimHelmySarin2017" class="citation journal cs1">Shiha G, Ibrahim A, Helmy A, Sarin SK, Omata M, Kumar A,  et&#160;al. (January 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12072-016-9760-3">"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update"</a>. <i>Hepatology International</i> (Professional society guidelines). <b>11</b> (1): 1–30. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs12072-016-9760-3">10.1007/s12072-016-9760-3</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27714681">27714681</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology+International&amp;rft.atitle=Asian-Pacific+Association+for+the+Study+of+the+Liver+%28APASL%29+consensus+guidelines+on+invasive+and+non-invasive+assessment+of+hepatic+fibrosis%3A+a+2016+update&amp;rft.volume=11&amp;rft.issue=1&amp;rft.pages=1-30&amp;rft.date=2017-01&amp;rft_id=info%3Adoi%2F10.1007%2Fs12072-016-9760-3&amp;rft_id=info%3Apmid%2F27714681&amp;rft.aulast=Shiha&amp;rft.aufirst=G&amp;rft.au=Ibrahim%2C+A&amp;rft.au=Helmy%2C+A&amp;rft.au=Sarin%2C+SK&amp;rft.au=Omata%2C+M&amp;rft.au=Kumar%2C+A&amp;rft.au=Bernstien%2C+D&amp;rft.au=Maruyama%2C+H&amp;rft.au=Saraswat%2C+V&amp;rft.au=Chawla%2C+Y&amp;rft.au=Hamid%2C+S&amp;rft.au=Abbas%2C+Z&amp;rft.au=Bedossa%2C+P&amp;rft.au=Sakhuja%2C+P&amp;rft.au=Elmahatab%2C+M&amp;rft.au=Lim%2C+SG&amp;rft.au=Lesmana%2C+L&amp;rft.au=Sollano%2C+J&amp;rft.au=Jia%2C+JD&amp;rft.au=Abbas%2C+B&amp;rft.au=Omar%2C+A&amp;rft.au=Sharma%2C+B&amp;rft.au=Payawal%2C+D&amp;rft.au=Abdallah%2C+A&amp;rft.au=Serwah%2C+A&amp;rft.au=Hamed%2C+A&amp;rft.au=Elsayed%2C+A&amp;rft.au=AbdelMaqsod%2C+A&amp;rft.au=Hassanein%2C+T&amp;rft.au=Ihab%2C+A&amp;rft.au=GHaziuan%2C+H&amp;rft.au=Zein%2C+N&amp;rft.au=Kumar%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1007%252Fs12072-016-9760-3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-55"><span class="mw-cite-backlink"><b><a href="#cite_ref-55">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPelegIssacharSneh-ArbibShlomai2017" class="citation journal cs1">Peleg, Noam; Issachar, Assaf; Sneh-Arbib, Orly; Shlomai, Amir (October 2017). "AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease". <i>Digestive and Liver Disease</i>. <b>49</b> (10): 1133–1138. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dld.2017.05.002">10.1016/j.dld.2017.05.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28572039">28572039</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+and+Liver+Disease&amp;rft.atitle=AST+to+Platelet+Ratio+Index+and+fibrosis+4+calculator+scores+for+non-invasive+assessment+of+hepatic+fibrosis+in+patients+with+non-alcoholic+fatty+liver+disease&amp;rft.volume=49&amp;rft.issue=10&amp;rft.pages=1133-1138&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dld.2017.05.002&amp;rft_id=info%3Apmid%2F28572039&amp;rft.aulast=Peleg&amp;rft.aufirst=Noam&amp;rft.au=Issachar%2C+Assaf&amp;rft.au=Sneh-Arbib%2C+Orly&amp;rft.au=Shlomai%2C+Amir&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-56"><span class="mw-cite-backlink"><b><a href="#cite_ref-56">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPelegSneh_ArbibIssacharCohen-Naftaly2018" class="citation journal cs1">Peleg, Noam; Sneh Arbib, Orly; Issachar, Assaf; Cohen-Naftaly, Michal; Braun, Marius; Shlomai, Amir (2018-08-14).  Vespasiani-Gentilucci, Umberto (ed.). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091950">"Noninvasive scoring systems predict hepatic and extra-hepatic cancers in patients with nonalcoholic fatty liver disease"</a>. <i>PLOS ONE</i>. <b>13</b> (8): e0202393. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2018PLoSO..1302393P">2018PLoSO..1302393P</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0202393">10.1371/journal.pone.0202393</a></span>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1932-6203">1932-6203</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6091950">6091950</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30106985">30106985</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=Noninvasive+scoring+systems+predict+hepatic+and+extra-hepatic+cancers+in+patients+with+nonalcoholic+fatty+liver+disease&amp;rft.volume=13&amp;rft.issue=8&amp;rft.pages=e0202393&amp;rft.date=2018-08-14&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6091950%23id-name%3DPMC&amp;rft_id=info%3Abibcode%2F2018PLoSO..1302393P&amp;rft_id=info%3Apmid%2F30106985&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0202393&amp;rft.issn=1932-6203&amp;rft.aulast=Peleg&amp;rft.aufirst=Noam&amp;rft.au=Sneh+Arbib%2C+Orly&amp;rft.au=Issachar%2C+Assaf&amp;rft.au=Cohen-Naftaly%2C+Michal&amp;rft.au=Braun%2C+Marius&amp;rft.au=Shlomai%2C+Amir&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6091950&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-57"><span class="mw-cite-backlink"><b><a href="#cite_ref-57">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVilgrainRonotAbdel-RehimZappa2012" class="citation journal cs1">Vilgrain V, Ronot M, Abdel-Rehim M, Zappa M, d'Assignies G, Bruno O, Vullierme MP (2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.diii.2013.03.010">"Hepatic steatosis: a major trap in liver imaging"</a>. <i>Diagnostic and Interventional Imaging</i> (Tutorial). <b>94</b> (7–8): 713–27. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.diii.2013.03.010">10.1016/j.diii.2013.03.010</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/23751229">23751229</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diagnostic+and+Interventional+Imaging&amp;rft.atitle=Hepatic+steatosis%3A+a+major+trap+in+liver+imaging&amp;rft.volume=94&amp;rft.issue=7%E2%80%938&amp;rft.pages=713-27&amp;rft.date=2012&amp;rft_id=info%3Adoi%2F10.1016%2Fj.diii.2013.03.010&amp;rft_id=info%3Apmid%2F23751229&amp;rft.aulast=Vilgrain&amp;rft.aufirst=V&amp;rft.au=Ronot%2C+M&amp;rft.au=Abdel-Rehim%2C+M&amp;rft.au=Zappa%2C+M&amp;rft.au=d%27Assignies%2C+G&amp;rft.au=Bruno%2C+O&amp;rft.au=Vullierme%2C+MP&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.diii.2013.03.010&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-58"><span class="mw-cite-backlink"><b><a href="#cite_ref-58">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPapachristodoulouKavvadasKaramitsosPapamitsou2021" class="citation journal cs1">Papachristodoulou, Angeliki; Kavvadas, Dimitrios; Karamitsos, Athanasios; Papamitsou, Theodora; Chatzidimitriou, Maria; Sioga, Antonia (2021). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293345">"Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?"</a>. <i>Pediatric Reports</i>. <b>13</b> (2): 312–321. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fpediatric13020039">10.3390/pediatric13020039</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293345">8293345</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34201230">34201230</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Pediatric+Reports&amp;rft.atitle=Diagnosis+and+Staging+of+Pediatric+Non-Alcoholic+Fatty+Liver+Disease%3A+Is+Classical+Ultrasound+the+Answer%3F&amp;rft.volume=13&amp;rft.issue=2&amp;rft.pages=312-321&amp;rft.date=2021&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8293345%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F34201230&amp;rft_id=info%3Adoi%2F10.3390%2Fpediatric13020039&amp;rft.aulast=Papachristodoulou&amp;rft.aufirst=Angeliki&amp;rft.au=Kavvadas%2C+Dimitrios&amp;rft.au=Karamitsos%2C+Athanasios&amp;rft.au=Papamitsou%2C+Theodora&amp;rft.au=Chatzidimitriou%2C+Maria&amp;rft.au=Sioga%2C+Antonia&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8293345&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-EURORADIOSINGH2015-59"><span class="mw-cite-backlink"><b><a href="#cite_ref-EURORADIOSINGH2015_59-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSinghVenkateshLoombaWang2016" class="citation journal cs1">Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J,  et&#160;al. (May 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051267">"Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis"</a>. <i>European Radiology</i> (Systematic review). <b>26</b> (5): 1431–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00330-015-3949-z">10.1007/s00330-015-3949-z</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051267">5051267</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26314479">26314479</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Radiology&amp;rft.atitle=Magnetic+resonance+elastography+for+staging+liver+fibrosis+in+non-alcoholic+fatty+liver+disease%3A+a+diagnostic+accuracy+systematic+review+and+individual+participant+data+pooled+analysis&amp;rft.volume=26&amp;rft.issue=5&amp;rft.pages=1431-40&amp;rft.date=2016-05&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5051267%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26314479&amp;rft_id=info%3Adoi%2F10.1007%2Fs00330-015-3949-z&amp;rft.aulast=Singh&amp;rft.aufirst=S&amp;rft.au=Venkatesh%2C+SK&amp;rft.au=Loomba%2C+R&amp;rft.au=Wang%2C+Z&amp;rft.au=Sirlin%2C+C&amp;rft.au=Chen%2C+J&amp;rft.au=Yin%2C+M&amp;rft.au=Miller%2C+FH&amp;rft.au=Low%2C+RN&amp;rft.au=Hassanein%2C+T&amp;rft.au=Godfrey%2C+EM&amp;rft.au=Asbach%2C+P&amp;rft.au=Murad%2C+MH&amp;rft.au=Lomas%2C+DJ&amp;rft.au=Talwalkar%2C+JA&amp;rft.au=Ehman%2C+RL&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5051267&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-60"><span class="mw-cite-backlink"><b><a href="#cite_ref-60">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSrinivasa_BabuWellsTeytelboymMackey2015" class="citation journal cs1">Srinivasa Babu A, Wells ML, Teytelboym OM, Mackey JE, Miller FH, Yeh BM,  et&#160;al. (2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584553">"Elastography in Chronic Liver Disease: Modalities, Techniques, Limitations, and Future Directions"</a>. <i>Radiographics</i> (Review). <b>36</b> (7): 1987–2006. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1148%2Frg.2016160042">10.1148/rg.2016160042</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5584553">5584553</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27689833">27689833</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Radiographics&amp;rft.atitle=Elastography+in+Chronic+Liver+Disease%3A+Modalities%2C+Techniques%2C+Limitations%2C+and+Future+Directions&amp;rft.volume=36&amp;rft.issue=7&amp;rft.pages=1987-2006&amp;rft.date=2015&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5584553%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27689833&amp;rft_id=info%3Adoi%2F10.1148%2Frg.2016160042&amp;rft.aulast=Srinivasa+Babu&amp;rft.aufirst=A&amp;rft.au=Wells%2C+ML&amp;rft.au=Teytelboym%2C+OM&amp;rft.au=Mackey%2C+JE&amp;rft.au=Miller%2C+FH&amp;rft.au=Yeh%2C+BM&amp;rft.au=Ehman%2C+RL&amp;rft.au=Venkatesh%2C+SK&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5584553&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AACE2016-61"><span class="mw-cite-backlink">^ <a href="#cite_ref-AACE2016_61-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AACE2016_61-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AACE2016_61-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGarveyMechanickBrettGarber2016" class="citation journal cs1 cs1-prop-long-vol">Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM,  et&#160;al. (July 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.4158%2FEP161365.GL">"American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity"</a>. <i>Endocrine Practice</i> (Professional society guidelines). 22 Suppl 3: 1–203. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.4158%2FEP161365.GL">10.4158/EP161365.GL</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27219496">27219496</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Endocrine+Practice&amp;rft.atitle=American+Association+of+Clinical+Endocrinologists+and+American+College+of+Endocrinology+Comprehensive+Clinical+Practice+Guidelines+for+Medical+Care+of+Patients+with+Obesity&amp;rft.volume=22+Suppl+3&amp;rft.pages=1-203&amp;rft.date=2016-07&amp;rft_id=info%3Adoi%2F10.4158%2FEP161365.GL&amp;rft_id=info%3Apmid%2F27219496&amp;rft.aulast=Garvey&amp;rft.aufirst=WT&amp;rft.au=Mechanick%2C+JI&amp;rft.au=Brett%2C+EM&amp;rft.au=Garber%2C+AJ&amp;rft.au=Hurley%2C+DL&amp;rft.au=Jastreboff%2C+AM&amp;rft.au=Nadolsky%2C+K&amp;rft.au=Pessah-Pollack%2C+R&amp;rft.au=Plodkowski%2C+R&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.4158%252FEP161365.GL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-62"><span class="mw-cite-backlink"><b><a href="#cite_ref-62">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLonardoNascimbeniTargherBernardi2017" class="citation journal cs1">Lonardo A, Nascimbeni F, Targher G, Bernardi M, Bonino F, Bugianesi E,  et&#160;al. (May 2017). "AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions". <i>Digestive and Liver Disease</i> (Professional society guidelines). <b>49</b> (5): 471–483. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dld.2017.01.147">10.1016/j.dld.2017.01.147</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F1636507">2318/1636507</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28215516">28215516</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+and+Liver+Disease&amp;rft.atitle=AISF+position+paper+on+nonalcoholic+fatty+liver+disease+%28NAFLD%29%3A+Updates+and+future+directions&amp;rft.volume=49&amp;rft.issue=5&amp;rft.pages=471-483&amp;rft.date=2017-05&amp;rft_id=info%3Ahdl%2F2318%2F1636507&amp;rft_id=info%3Apmid%2F28215516&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dld.2017.01.147&amp;rft.aulast=Lonardo&amp;rft.aufirst=A&amp;rft.au=Nascimbeni%2C+F&amp;rft.au=Targher%2C+G&amp;rft.au=Bernardi%2C+M&amp;rft.au=Bonino%2C+F&amp;rft.au=Bugianesi%2C+E&amp;rft.au=Casini%2C+A&amp;rft.au=Gastaldelli%2C+A&amp;rft.au=Marchesini%2C+G&amp;rft.au=Marra%2C+F&amp;rft.au=Miele%2C+L&amp;rft.au=Morisco%2C+F&amp;rft.au=Petta%2C+S&amp;rft.au=Piscaglia%2C+F&amp;rft.au=Svegliati-Baroni%2C+G&amp;rft.au=Valenti%2C+L&amp;rft.au=Bellentani%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:2-63"><span class="mw-cite-backlink">^ <a href="#cite_ref-:2_63-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-:2_63-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKoutoukidisAstburyTudorMorris2019" class="citation journal cs1">Koutoukidis DA, Astbury NM, Tudor KE, Morris E, Henry JA, Noreik M,  et&#160;al. (July 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604126">"Association of Weight Loss Interventions With Changes in Biomarkers of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis"</a>. <i>JAMA Internal Medicine</i>. <b>179</b> (9): 1262–1271. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjamainternmed.2019.2248">10.1001/jamainternmed.2019.2248</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6604126">6604126</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31260026">31260026</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA+Internal+Medicine&amp;rft.atitle=Association+of+Weight+Loss+Interventions+With+Changes+in+Biomarkers+of+Nonalcoholic+Fatty+Liver+Disease%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=179&amp;rft.issue=9&amp;rft.pages=1262-1271&amp;rft.date=2019-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6604126%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31260026&amp;rft_id=info%3Adoi%2F10.1001%2Fjamainternmed.2019.2248&amp;rft.aulast=Koutoukidis&amp;rft.aufirst=DA&amp;rft.au=Astbury%2C+NM&amp;rft.au=Tudor%2C+KE&amp;rft.au=Morris%2C+E&amp;rft.au=Henry%2C+JA&amp;rft.au=Noreik%2C+M&amp;rft.au=Jebb%2C+SA&amp;rft.au=Aveyard%2C+P&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6604126&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-64"><span class="mw-cite-backlink"><b><a href="#cite_ref-64">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFParisGeorgeRobertsTierney2017" class="citation journal cs1">Paris T, George ES, Roberts SK, Tierney AC (August 2017). "The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review". <i>European Journal of Gastroenterology &amp; Hepatology</i>. <b>29</b> (8): 867–878. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMEG.0000000000000890">10.1097/MEG.0000000000000890</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28471823">28471823</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:13768180">13768180</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Gastroenterology+%26+Hepatology&amp;rft.atitle=The+effects+of+diet+and+lifestyle+interventions+on+insulin+resistance+in+patients+with+nonalcoholic+fatty+liver+disease%3A+a+systematic+review&amp;rft.volume=29&amp;rft.issue=8&amp;rft.pages=867-878&amp;rft.date=2017-08&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A13768180%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28471823&amp;rft_id=info%3Adoi%2F10.1097%2FMEG.0000000000000890&amp;rft.aulast=Paris&amp;rft.aufirst=T&amp;rft.au=George%2C+ES&amp;rft.au=Roberts%2C+SK&amp;rft.au=Tierney%2C+AC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-RomeroGomez2017-65"><span class="mw-cite-backlink">^ <a href="#cite_ref-RomeroGomez2017_65-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-RomeroGomez2017_65-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-RomeroGomez2017_65-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRomero-GómezZelber-SagiTrenell2017" class="citation journal cs1">Romero-Gómez M, Zelber-Sagi S, Trenell M (October 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2017.05.016">"Treatment of NAFLD with diet, physical activity and exercise"</a>. <i>Journal of Hepatology</i>. <b>67</b> (4): 829–846. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2017.05.016">10.1016/j.jhep.2017.05.016</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28545937">28545937</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Treatment+of+NAFLD+with+diet%2C+physical+activity+and+exercise&amp;rft.volume=67&amp;rft.issue=4&amp;rft.pages=829-846&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2017.05.016&amp;rft_id=info%3Apmid%2F28545937&amp;rft.aulast=Romero-G%C3%B3mez&amp;rft.aufirst=M&amp;rft.au=Zelber-Sagi%2C+S&amp;rft.au=Trenell%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2017.05.016&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-66"><span class="mw-cite-backlink"><b><a href="#cite_ref-66">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBuzzettiLindenBestMadden2021" class="citation journal cs1">Buzzetti, Elena; Linden, Audrey; Best, Lawrence MJ; Madden, Angela M; Roberts, Danielle; Chase, Thomas J G; Freeman, Suzanne C; Cooper, Nicola J; Sutton, Alex J; Fritche, Dominic; Milne, Elisabeth Jane (2021-06-11). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193812">"Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis"</a>. <i>Cochrane Database of Systematic Reviews</i>. <b>2021</b> (6): CD013156. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.cd013156.pub2">10.1002/14651858.cd013156.pub2</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1465-1858">1465-1858</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193812">8193812</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34114650">34114650</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Lifestyle+modifications+for+nonalcohol-related+fatty+liver+disease%3A+a+network+meta-analysis&amp;rft.volume=2021&amp;rft.issue=6&amp;rft.pages=CD013156&amp;rft.date=2021-06-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8193812%23id-name%3DPMC&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F34114650&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.cd013156.pub2&amp;rft.aulast=Buzzetti&amp;rft.aufirst=Elena&amp;rft.au=Linden%2C+Audrey&amp;rft.au=Best%2C+Lawrence+MJ&amp;rft.au=Madden%2C+Angela+M&amp;rft.au=Roberts%2C+Danielle&amp;rft.au=Chase%2C+Thomas+J+G&amp;rft.au=Freeman%2C+Suzanne+C&amp;rft.au=Cooper%2C+Nicola+J&amp;rft.au=Sutton%2C+Alex+J&amp;rft.au=Fritche%2C+Dominic&amp;rft.au=Milne%2C+Elisabeth+Jane&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8193812&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-67"><span class="mw-cite-backlink"><b><a href="#cite_ref-67">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKomolafeBuzzettiLindenBest2021" class="citation journal cs1">Komolafe, Oluyemi; Buzzetti, Elena; Linden, Audrey; Best, Lawrence MJ; Madden, Angela M; Roberts, Danielle; Chase, Thomas JG; Fritche, Dominic; Freeman, Suzanne C; Cooper, Nicola J; Sutton, Alex J (2021-07-19). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406904">"Nutritional supplementation for nonalcohol-related fatty liver disease: a network meta-analysis"</a>. <i>Cochrane Database of Systematic Reviews</i>. <b>2021</b> (7): CD013157. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2F14651858.cd013157.pub2">10.1002/14651858.cd013157.pub2</a>. <a href="/wiki/ISSN_(identifier)" class="mw-redirect" title="ISSN (identifier)">ISSN</a>&#160;<a rel="nofollow" class="external text" href="https://www.worldcat.org/issn/1465-1858">1465-1858</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8406904">8406904</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/34280304">34280304</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Cochrane+Database+of+Systematic+Reviews&amp;rft.atitle=Nutritional+supplementation+for+nonalcohol-related+fatty+liver+disease%3A+a+network+meta-analysis&amp;rft.volume=2021&amp;rft.issue=7&amp;rft.pages=CD013157&amp;rft.date=2021-07-19&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8406904%23id-name%3DPMC&amp;rft.issn=1465-1858&amp;rft_id=info%3Apmid%2F34280304&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.cd013157.pub2&amp;rft.aulast=Komolafe&amp;rft.aufirst=Oluyemi&amp;rft.au=Buzzetti%2C+Elena&amp;rft.au=Linden%2C+Audrey&amp;rft.au=Best%2C+Lawrence+MJ&amp;rft.au=Madden%2C+Angela+M&amp;rft.au=Roberts%2C+Danielle&amp;rft.au=Chase%2C+Thomas+JG&amp;rft.au=Fritche%2C+Dominic&amp;rft.au=Freeman%2C+Suzanne+C&amp;rft.au=Cooper%2C+Nicola+J&amp;rft.au=Sutton%2C+Alex+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC8406904&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Rusu2014-68"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rusu2014_68-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRusuEnacheJingaDragut2014" class="citation journal cs1">Rusu E, Enache G, Jinga M, Dragut R, Nan R, Popescu H,  et&#160;al. (2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556902">"Medical nutrition therapy in non-alcoholic fatty liver disease--a review of literature"</a>. <i>Journal of Medicine and Life</i>. <b>8</b> (3): 258–62. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556902">4556902</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26351523">26351523</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Medicine+and+Life&amp;rft.atitle=Medical+nutrition+therapy+in+non-alcoholic+fatty+liver+disease--a+review+of+literature&amp;rft.volume=8&amp;rft.issue=3&amp;rft.pages=258-62&amp;rft.date=2014&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4556902%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26351523&amp;rft.aulast=Rusu&amp;rft.aufirst=E&amp;rft.au=Enache%2C+G&amp;rft.au=Jinga%2C+M&amp;rft.au=Dragut%2C+R&amp;rft.au=Nan%2C+R&amp;rft.au=Popescu%2C+H&amp;rft.au=Parpala%2C+C&amp;rft.au=Homentcovschi%2C+C&amp;rft.au=Nitescu%2C+M&amp;rft.au=Stoian%2C+M&amp;rft.au=Costache%2C+A&amp;rft.au=Posea%2C+M&amp;rft.au=Rusu%2C+F&amp;rft.au=Jinga%2C+V&amp;rft.au=Mischianu%2C+D&amp;rft.au=Radulian%2C+G&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4556902&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-69"><span class="mw-cite-backlink"><b><a href="#cite_ref-69">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHsuNessKowdley2017" class="citation journal cs1">Hsu CC, Ness E, Kowdley KV (March 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347099">"Nutritional Approaches to Achieve Weight Loss in Nonalcoholic Fatty Liver Disease"</a>. <i>Advances in Nutrition</i>. <b>8</b> (2): 253–265. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3945%2Fan.116.013730">10.3945/an.116.013730</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347099">5347099</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28298270">28298270</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Advances+in+Nutrition&amp;rft.atitle=Nutritional+Approaches+to+Achieve+Weight+Loss+in+Nonalcoholic+Fatty+Liver+Disease&amp;rft.volume=8&amp;rft.issue=2&amp;rft.pages=253-265&amp;rft.date=2017-03&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5347099%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28298270&amp;rft_id=info%3Adoi%2F10.3945%2Fan.116.013730&amp;rft.aulast=Hsu&amp;rft.aufirst=CC&amp;rft.au=Ness%2C+E&amp;rft.au=Kowdley%2C+KV&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5347099&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-70"><span class="mw-cite-backlink"><b><a href="#cite_ref-70">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZelber-SagiSalomoneMlynarsky2017" class="citation journal cs1">Zelber-Sagi S, Salomone F, Mlynarsky L (July 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13435">"The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms"</a>. <i>Liver International</i>. <b>37</b> (7): 936–949. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13435">10.1111/liv.13435</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28371239">28371239</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Liver+International&amp;rft.atitle=The+Mediterranean+dietary+pattern+as+the+diet+of+choice+for+non-alcoholic+fatty+liver+disease%3A+Evidence+and+plausible+mechanisms&amp;rft.volume=37&amp;rft.issue=7&amp;rft.pages=936-949&amp;rft.date=2017-07&amp;rft_id=info%3Adoi%2F10.1111%2Fliv.13435&amp;rft_id=info%3Apmid%2F28371239&amp;rft.aulast=Zelber-Sagi&amp;rft.aufirst=S&amp;rft.au=Salomone%2C+F&amp;rft.au=Mlynarsky%2C+L&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fliv.13435&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-:1-71"><span class="mw-cite-backlink"><b><a href="#cite_ref-:1_71-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMerchant2017" class="citation journal cs1">Merchant HA (September 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615281">"Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)?"</a>. <i>Journal of Clinical Medicine</i>. <b>6</b> (9): 88. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fjcm6090088">10.3390/jcm6090088</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615281">5615281</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28925934">28925934</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Clinical+Medicine&amp;rft.atitle=Can+Diet+Help+Non-Obese+Individuals+with+Non-Alcoholic+Fatty+Liver+Disease+%28NAFLD%29%3F&amp;rft.volume=6&amp;rft.issue=9&amp;rft.pages=88&amp;rft.date=2017-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5615281%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28925934&amp;rft_id=info%3Adoi%2F10.3390%2Fjcm6090088&amp;rft.aulast=Merchant&amp;rft.aufirst=HA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5615281&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-pmid25274101-72"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid25274101_72-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVeenaMuragundlaSidgiddiSubramaniam2014" class="citation journal cs1">Veena J, Muragundla A, Sidgiddi S, Subramaniam S (December 2014). <a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS0007114514002591">"Non-alcoholic fatty liver disease: need for a balanced nutritional source"</a>. <i>The British Journal of Nutrition</i>. <b>112</b> (11): 1858–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1017%2FS0007114514002591">10.1017/S0007114514002591</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25274101">25274101</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Nutrition&amp;rft.atitle=Non-alcoholic+fatty+liver+disease%3A+need+for+a+balanced+nutritional+source&amp;rft.volume=112&amp;rft.issue=11&amp;rft.pages=1858-72&amp;rft.date=2014-12&amp;rft_id=info%3Adoi%2F10.1017%2FS0007114514002591&amp;rft_id=info%3Apmid%2F25274101&amp;rft.aulast=Veena&amp;rft.aufirst=J&amp;rft.au=Muragundla%2C+A&amp;rft.au=Sidgiddi%2C+S&amp;rft.au=Subramaniam%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1017%252FS0007114514002591&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Tomic2018-73"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tomic2018_73-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTomicKempRoberts2018" class="citation journal cs1">Tomic, D; Kemp, WW; Roberts, SK (October 2018). "Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies". <i>European Journal of Gastroenterology &amp; Hepatology</i>. <b>30</b> (10): 1103–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMEG.0000000000001235">10.1097/MEG.0000000000001235</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30113367">30113367</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:52010921">52010921</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Gastroenterology+%26+Hepatology&amp;rft.atitle=Nonalcoholic+fatty+liver+disease%3A+current+concepts%2C+epidemiology+and+management+strategies&amp;rft.volume=30&amp;rft.issue=10&amp;rft.pages=1103-15&amp;rft.date=2018-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A52010921%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30113367&amp;rft_id=info%3Adoi%2F10.1097%2FMEG.0000000000001235&amp;rft.aulast=Tomic&amp;rft.aufirst=D&amp;rft.au=Kemp%2C+WW&amp;rft.au=Roberts%2C+SK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Wijarnpreecha2017-74"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wijarnpreecha2017_74-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWijarnpreechaThongprayoonUngprasert2017" class="citation journal cs1">Wijarnpreecha, K; Thongprayoon, C; Ungprasert, P (February 2017). "Coffee consumption and risk of nonalcoholic fatty liver disease: a systematic review and meta-analysis". <i>European Journal of Gastroenterology &amp; Hepatology</i>. <b>29</b> (2): e8-12. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMEG.0000000000000776">10.1097/MEG.0000000000000776</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27824642">27824642</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23243292">23243292</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=European+Journal+of+Gastroenterology+%26+Hepatology&amp;rft.atitle=Coffee+consumption+and+risk+of+nonalcoholic+fatty+liver+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=29&amp;rft.issue=2&amp;rft.pages=e8-12&amp;rft.date=2017-02&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23243292%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F27824642&amp;rft_id=info%3Adoi%2F10.1097%2FMEG.0000000000000776&amp;rft.aulast=Wijarnpreecha&amp;rft.aufirst=K&amp;rft.au=Thongprayoon%2C+C&amp;rft.au=Ungprasert%2C+P&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-75"><span class="mw-cite-backlink"><b><a href="#cite_ref-75">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZhongFanYanFan2017" class="citation journal cs1">Zhong S, Fan Y, Yan Q, Fan X, Wu B, Han Y, Zhang Y, Chen Y, Zhang H, Niu J (December 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728929">"The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials"</a>. <i>Medicine (Baltimore)</i>. <b>96</b> (49): e9061. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMD.0000000000009061">10.1097/MD.0000000000009061</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728929">5728929</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29245314">29245314</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Medicine+%28Baltimore%29&amp;rft.atitle=The+therapeutic+effect+of+silymarin+in+the+treatment+of+nonalcoholic+fatty+disease%3A+A+meta-analysis+%28PRISMA%29+of+randomized+control+trials&amp;rft.volume=96&amp;rft.issue=49&amp;rft.pages=e9061&amp;rft.date=2017-12&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5728929%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F29245314&amp;rft_id=info%3Adoi%2F10.1097%2FMD.0000000000009061&amp;rft.aulast=Zhong&amp;rft.aufirst=S&amp;rft.au=Fan%2C+Y&amp;rft.au=Yan%2C+Q&amp;rft.au=Fan%2C+X&amp;rft.au=Wu%2C+B&amp;rft.au=Han%2C+Y&amp;rft.au=Zhang%2C+Y&amp;rft.au=Chen%2C+Y&amp;rft.au=Zhang%2C+H&amp;rft.au=Niu%2C+J&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5728929&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-76"><span class="mw-cite-backlink"><b><a href="#cite_ref-76">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJalaliMahmoodiMosallanezhadJalali2020" class="citation journal cs1">Jalali M, Mahmoodi M, Mosallanezhad Z, Jalali R, Imanieh MH, Moosavian SP (January 2020). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ctim.2019.102283">"The effects of curcumin supplementation on liver function, metabolic profile and body composition in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials"</a>. <i>Complement Ther Med</i>. <b>48</b>: 102283. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.ctim.2019.102283">10.1016/j.ctim.2019.102283</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31987259">31987259</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Complement+Ther+Med&amp;rft.atitle=The+effects+of+curcumin+supplementation+on+liver+function%2C+metabolic+profile+and+body+composition+in+patients+with+non-alcoholic+fatty+liver+disease%3A+A+systematic+review+and+meta-analysis+of+randomized+controlled+trials&amp;rft.volume=48&amp;rft.pages=102283&amp;rft.date=2020-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.ctim.2019.102283&amp;rft_id=info%3Apmid%2F31987259&amp;rft.aulast=Jalali&amp;rft.aufirst=M&amp;rft.au=Mahmoodi%2C+M&amp;rft.au=Mosallanezhad%2C+Z&amp;rft.au=Jalali%2C+R&amp;rft.au=Imanieh%2C+MH&amp;rft.au=Moosavian%2C+SP&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.ctim.2019.102283&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-77"><span class="mw-cite-backlink"><b><a href="#cite_ref-77">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSharptonMarajHarding-TheobaldVittinghoff2019" class="citation journal cs1">Sharpton SR, Maraj B, Harding-Theobald E, Vittinghoff E, Terrault NA (July 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599739">"Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression"</a>. <i>Am. J. Clin. Nutr</i>. <b>110</b> (1): 139–49. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1093%2Fajcn%2Fnqz042">10.1093/ajcn/nqz042</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6599739">6599739</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/31124558">31124558</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.atitle=Gut+microbiome-targeted+therapies+in+nonalcoholic+fatty+liver+disease%3A+a+systematic+review%2C+meta-analysis%2C+and+meta-regression&amp;rft.volume=110&amp;rft.issue=1&amp;rft.pages=139-49&amp;rft.date=2019-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6599739%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F31124558&amp;rft_id=info%3Adoi%2F10.1093%2Fajcn%2Fnqz042&amp;rft.aulast=Sharpton&amp;rft.aufirst=SR&amp;rft.au=Maraj%2C+B&amp;rft.au=Harding-Theobald%2C+E&amp;rft.au=Vittinghoff%2C+E&amp;rft.au=Terrault%2C+NA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC6599739&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-78"><span class="mw-cite-backlink"><b><a href="#cite_ref-78">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHadiMohammadiMiraghajaniGhaedi2019" class="citation journal cs1">Hadi A, Mohammadi H, Miraghajani M, Ghaedi E (2019). "Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD". <i>Critical Reviews in Food Science and Nutrition</i>. <b>59</b> (15): 2494–2505. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F10408398.2018.1458021">10.1080/10408398.2018.1458021</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29584449">29584449</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:5006292">5006292</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Critical+Reviews+in+Food+Science+and+Nutrition&amp;rft.atitle=Efficacy+of+synbiotic+supplementation+in+patients+with+nonalcoholic+fatty+liver+disease%3A+A+systematic+review+and+meta-analysis+of+clinical+trials%3A+Synbiotic+supplementation+and+NAFLD&amp;rft.volume=59&amp;rft.issue=15&amp;rft.pages=2494-2505&amp;rft.date=2019&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A5006292%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29584449&amp;rft_id=info%3Adoi%2F10.1080%2F10408398.2018.1458021&amp;rft.aulast=Hadi&amp;rft.aufirst=A&amp;rft.au=Mohammadi%2C+H&amp;rft.au=Miraghajani%2C+M&amp;rft.au=Ghaedi%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Gordon2010-79"><span class="mw-cite-backlink"><b><a href="#cite_ref-Gordon2010_79-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGordonCoopermanObermeyerBecker2010" class="citation journal cs1">Gordon RY, Cooperman T, Obermeyer W, Becker DJ (2010). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinternmed.2010.382">"Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products: Buyer Beware!"</a>. <i>Archives of Internal Medicine</i>. <b>170</b> (19): 1722–1727. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinternmed.2010.382">10.1001/archinternmed.2010.382</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/20975018">20975018</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Archives+of+Internal+Medicine&amp;rft.atitle=Marked+Variability+of+Monacolin+Levels+in+Commercial+Red+Yeast+Rice+Products%3A+Buyer+Beware%21&amp;rft.volume=170&amp;rft.issue=19&amp;rft.pages=1722-1727&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2010.382&amp;rft_id=info%3Apmid%2F20975018&amp;rft.aulast=Gordon&amp;rft.aufirst=RY&amp;rft.au=Cooperman%2C+T&amp;rft.au=Obermeyer%2C+W&amp;rft.au=Becker%2C+DJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Farchinternmed.2010.382&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-80"><span class="mw-cite-backlink"><b><a href="#cite_ref-80">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPhilibertBresJean-PastorGuy2016" class="citation journal cs1 cs1-prop-foreign-lang-source">Philibert C, Bres V, Jean-Pastor MJ, Guy C, Lebrun-Vignes B, Robin P, Pinzani V, Hillaire-Buys D (2016). "[Red yeast-rice-induced muscular injuries: Analysis of French pharmacovigilance database and literature review]". <i>Thérapie</i> (in French). <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2515%2Ftherapie%2F2015053">10.2515/therapie/2015053</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28277227">28277227</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Th%C3%A9rapie&amp;rft.atitle=%5BRed+yeast-rice-induced+muscular+injuries%3A+Analysis+of+French+pharmacovigilance+database+and+literature+review%5D&amp;rft.date=2016&amp;rft_id=info%3Adoi%2F10.2515%2Ftherapie%2F2015053&amp;rft_id=info%3Apmid%2F28277227&amp;rft.aulast=Philibert&amp;rft.aufirst=C&amp;rft.au=Bres%2C+V&amp;rft.au=Jean-Pastor%2C+MJ&amp;rft.au=Guy%2C+C&amp;rft.au=Lebrun-Vignes%2C+B&amp;rft.au=Robin%2C+P&amp;rft.au=Pinzani%2C+V&amp;rft.au=Hillaire-Buys%2C+D&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-81"><span class="mw-cite-backlink"><b><a href="#cite_ref-81">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBeckerGordonHalbertFrench2009" class="citation journal cs1">Becker DJ, Gordon RY, Halbert SC, French B, Morris PB, Rader DJ (2009). "Red yeast rice for dyslipidemia in statin-intolerant patients: a randomized trial". <i>Ann. Intern. Med</i>. <b>150</b> (12): 830–839. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.7326%2F0003-4819-150-12-200906160-00006">10.7326/0003-4819-150-12-200906160-00006</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19528562">19528562</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:46513590">46513590</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Ann.+Intern.+Med.&amp;rft.atitle=Red+yeast+rice+for+dyslipidemia+in+statin-intolerant+patients%3A+a+randomized+trial&amp;rft.volume=150&amp;rft.issue=12&amp;rft.pages=830-839&amp;rft.date=2009&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A46513590%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F19528562&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-150-12-200906160-00006&amp;rft.aulast=Becker&amp;rft.aufirst=DJ&amp;rft.au=Gordon%2C+RY&amp;rft.au=Halbert%2C+SC&amp;rft.au=French%2C+B&amp;rft.au=Morris%2C+PB&amp;rft.au=Rader%2C+DJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-82"><span class="mw-cite-backlink"><b><a href="#cite_ref-82">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGundermannGundermannDrozdzikPrasad2016" class="citation journal cs1">Gundermann, Karl-Josef; Gundermann, Simon; Drozdzik, Marek; Prasad, VG Mohan (2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861608">"Essential phospholipids in fatty liver: a scientific update"</a>. <i>Clin Exp Gastroenterol</i>. <b>9</b>: 105–117. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2147%2FCEG.S96362">10.2147/CEG.S96362</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861608">4861608</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27217791">27217791</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clin+Exp+Gastroenterol&amp;rft.atitle=Essential+phospholipids+in+fatty+liver%3A+a+scientific+update&amp;rft.volume=9&amp;rft.pages=105-117&amp;rft.date=2016&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4861608%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27217791&amp;rft_id=info%3Adoi%2F10.2147%2FCEG.S96362&amp;rft.aulast=Gundermann&amp;rft.aufirst=Karl-Josef&amp;rft.au=Gundermann%2C+Simon&amp;rft.au=Drozdzik%2C+Marek&amp;rft.au=Prasad%2C+VG+Mohan&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4861608&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-USDietaryGuidelines2015-83"><span class="mw-cite-backlink"><b><a href="#cite_ref-USDietaryGuidelines2015_83-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUS_Department_of_Health_and_Human_Services.2017" class="citation web cs1">US Department of Health and Human Services. (2017). <a rel="nofollow" class="external text" href="https://health.gov/dietaryguidelines/2015/">"2015–2020 Dietary Guidelines for Americans - health.gov"</a>. <i>health.gov</i>. Skyhorse Publishing Inc<span class="reference-accessdate">. Retrieved <span class="nowrap">30 September</span> 2019</span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=health.gov&amp;rft.atitle=2015%E2%80%932020+Dietary+Guidelines+for+Americans+-+health.gov&amp;rft.date=2017&amp;rft.au=US+Department+of+Health+and+Human+Services.&amp;rft_id=https%3A%2F%2Fhealth.gov%2Fdietaryguidelines%2F2015%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-AACAHA2019-84"><span class="mw-cite-backlink"><b><a href="#cite_ref-AACAHA2019_84-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFArnettBlumenthalAlbertBuroker2019" class="citation journal cs1">Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ,  et&#160;al. (September 2019). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734661">"2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines"</a>. <i>Circulation</i>. <b>140</b> (11): e596–e646. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIR.0000000000000678">10.1161/CIR.0000000000000678</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7734661">7734661</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30879355">30879355</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=2019+ACC%2FAHA+Guideline+on+the+Primary+Prevention+of+Cardiovascular+Disease%3A+A+Report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Clinical+Practice+Guidelines&amp;rft.volume=140&amp;rft.issue=11&amp;rft.pages=e596-e646&amp;rft.date=2019-09&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7734661%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F30879355&amp;rft_id=info%3Adoi%2F10.1161%2FCIR.0000000000000678&amp;rft.aulast=Arnett&amp;rft.aufirst=DK&amp;rft.au=Blumenthal%2C+RS&amp;rft.au=Albert%2C+MA&amp;rft.au=Buroker%2C+AB&amp;rft.au=Goldberger%2C+ZD&amp;rft.au=Hahn%2C+EJ&amp;rft.au=Himmelfarb%2C+CD&amp;rft.au=Khera%2C+A&amp;rft.au=Lloyd-Jones%2C+D&amp;rft.au=McEvoy%2C+JW&amp;rft.au=Michos%2C+ED&amp;rft.au=Miedema%2C+MD&amp;rft.au=Mu%C3%B1oz%2C+D&amp;rft.au=Smith%2C+SC&amp;rft.au=Virani%2C+SS&amp;rft.au=Williams%2C+KA&amp;rft.au=Yeboah%2C+J&amp;rft.au=Ziaeian%2C+B&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC7734661&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-USGuidelines2013-85"><span class="mw-cite-backlink"><b><a href="#cite_ref-USGuidelines2013_85-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFJensenRyanApovianArd2014" class="citation journal cs1">Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA,  et&#160;al. (June 2014). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819889">"2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society"</a>. <i>Circulation</i>. <b>129</b> (25 Suppl 2): S102-38. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2F01.cir.0000437739.71477.ee">10.1161/01.cir.0000437739.71477.ee</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5819889">5819889</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24222017">24222017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=2013+AHA%2FACC%2FTOS+guideline+for+the+management+of+overweight+and+obesity+in+adults%3A+a+report+of+the+American+College+of+Cardiology%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines+and+The+Obesity+Society&amp;rft.volume=129&amp;rft.issue=25+Suppl+2&amp;rft.pages=S102-38&amp;rft.date=2014-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5819889%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24222017&amp;rft_id=info%3Adoi%2F10.1161%2F01.cir.0000437739.71477.ee&amp;rft.aulast=Jensen&amp;rft.aufirst=MD&amp;rft.au=Ryan%2C+DH&amp;rft.au=Apovian%2C+CM&amp;rft.au=Ard%2C+JD&amp;rft.au=Comuzzie%2C+AG&amp;rft.au=Donato%2C+KA&amp;rft.au=Hu%2C+FB&amp;rft.au=Hubbard%2C+VS&amp;rft.au=Jakicic%2C+JM&amp;rft.au=Kushner%2C+RF&amp;rft.au=Loria%2C+CM&amp;rft.au=Millen%2C+BE&amp;rft.au=Nonas%2C+CA&amp;rft.au=Pi-Sunyer%2C+FX&amp;rft.au=Stevens%2C+J&amp;rft.au=Stevens%2C+VJ&amp;rft.au=Wadden%2C+TA&amp;rft.au=Wolfe%2C+BM&amp;rft.au=Yanovski%2C+SZ&amp;rft.au=Jordan%2C+HS&amp;rft.au=Kendall%2C+KA&amp;rft.au=Lux%2C+LJ&amp;rft.au=Mentor-Marcel%2C+R&amp;rft.au=Morgan%2C+LC&amp;rft.au=Trisolini%2C+MG&amp;rft.au=Wnek%2C+J&amp;rft.au=Anderson%2C+JL&amp;rft.au=Halperin%2C+JL&amp;rft.au=Albert%2C+NM&amp;rft.au=Bozkurt%2C+B&amp;rft.au=Brindis%2C+RG&amp;rft.au=Curtis%2C+LH&amp;rft.au=DeMets%2C+D&amp;rft.au=Hochman%2C+JS&amp;rft.au=Kovacs%2C+RJ&amp;rft.au=Ohman%2C+EM&amp;rft.au=Pressler%2C+SJ&amp;rft.au=Sellke%2C+FW&amp;rft.au=Shen%2C+WK&amp;rft.au=Smith%2C+SC&amp;rft.au=Tomaselli%2C+GF&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5819889&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-86"><span class="mw-cite-backlink"><b><a href="#cite_ref-86">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHashidaKawaguchiBekkiOmoto2017" class="citation journal cs1">Hashida R, Kawaguchi T, Bekki M, Omoto M, Matsuse H, Nago T,  et&#160;al. (January 2017). "Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review". <i>Journal of Hepatology</i>. <b>66</b> (1): 142–152. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2016.08.023">10.1016/j.jhep.2016.08.023</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27639843">27639843</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Aerobic+vs.+resistance+exercise+in+non-alcoholic+fatty+liver+disease%3A+A+systematic+review&amp;rft.volume=66&amp;rft.issue=1&amp;rft.pages=142-152&amp;rft.date=2017-01&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2016.08.023&amp;rft_id=info%3Apmid%2F27639843&amp;rft.aulast=Hashida&amp;rft.aufirst=R&amp;rft.au=Kawaguchi%2C+T&amp;rft.au=Bekki%2C+M&amp;rft.au=Omoto%2C+M&amp;rft.au=Matsuse%2C+H&amp;rft.au=Nago%2C+T&amp;rft.au=Takano%2C+Y&amp;rft.au=Ueno%2C+T&amp;rft.au=Koga%2C+H&amp;rft.au=George%2C+J&amp;rft.au=Shiba%2C+N&amp;rft.au=Torimura%2C+T&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-87"><span class="mw-cite-backlink"><b><a href="#cite_ref-87">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRatziu2017" class="citation journal cs1 cs1-prop-long-vol">Ratziu V (January 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13311">"Non-pharmacological interventions in non-alcoholic fatty liver disease patients"</a>. <i>Liver International</i>. 37 Suppl 1: 90–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13311">10.1111/liv.13311</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28052636">28052636</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Liver+International&amp;rft.atitle=Non-pharmacological+interventions+in+non-alcoholic+fatty+liver+disease+patients&amp;rft.volume=37+Suppl+1&amp;rft.pages=90-96&amp;rft.date=2017-01&amp;rft_id=info%3Adoi%2F10.1111%2Fliv.13311&amp;rft_id=info%3Apmid%2F28052636&amp;rft.aulast=Ratziu&amp;rft.aufirst=V&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fliv.13311&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-88"><span class="mw-cite-backlink"><b><a href="#cite_ref-88">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRatziuGoodmanSanyal2015" class="citation journal cs1">Ratziu V, Goodman Z, Sanyal A (April 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2015.02.041">"Current efforts and trends in the treatment of NASH"</a>. <i>Journal of Hepatology</i>. <b>62</b> (1 Suppl): S65–75. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2015.02.041">10.1016/j.jhep.2015.02.041</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25920092">25920092</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Current+efforts+and+trends+in+the+treatment+of+NASH&amp;rft.volume=62&amp;rft.issue=1+Suppl&amp;rft.pages=S65-75&amp;rft.date=2015-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2015.02.041&amp;rft_id=info%3Apmid%2F25920092&amp;rft.aulast=Ratziu&amp;rft.aufirst=V&amp;rft.au=Goodman%2C+Z&amp;rft.au=Sanyal%2C+A&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2015.02.041&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Raziel2015-89"><span class="mw-cite-backlink"><b><a href="#cite_ref-Raziel2015_89-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRazielSakranSzoldGoitein2015" class="citation journal cs1">Raziel A, Sakran N, Szold A, Goitein D (April 2015). <a rel="nofollow" class="external text" href="http://www.ima.org.il/FilesUpload/IMAJ/0/142/71367.pdf">"Current solutions for obesity-related liver disorders: non-alcoholic fatty liver disease and non-alcoholic steatohepatitis"</a> <span class="cs1-format">(PDF)</span>. <i>The Israel Medical Association Journal</i>. <b>17</b> (4): 234–8. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26040050">26040050</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Israel+Medical+Association+Journal&amp;rft.atitle=Current+solutions+for+obesity-related+liver+disorders%3A+non-alcoholic+fatty+liver+disease+and+non-alcoholic+steatohepatitis&amp;rft.volume=17&amp;rft.issue=4&amp;rft.pages=234-8&amp;rft.date=2015-04&amp;rft_id=info%3Apmid%2F26040050&amp;rft.aulast=Raziel&amp;rft.aufirst=A&amp;rft.au=Sakran%2C+N&amp;rft.au=Szold%2C+A&amp;rft.au=Goitein%2C+D&amp;rft_id=http%3A%2F%2Fwww.ima.org.il%2FFilesUpload%2FIMAJ%2F0%2F142%2F71367.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-90"><span class="mw-cite-backlink"><b><a href="#cite_ref-90">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="http://www.prescrire.org/fr/3/31/53765/0/NewsDetails.aspx">"Pour mieux soigner&#160;: des médicaments à écarter - actualisation&#160;2018"</a>. <i>www.prescrire.org</i>. Prescrire. 2018-01-25.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=unknown&amp;rft.jtitle=www.prescrire.org&amp;rft.atitle=Pour+mieux+soigner+%3A+des+m%C3%A9dicaments+%C3%A0+%C3%A9carter+-+actualisation+2018&amp;rft.date=2018-01-25&amp;rft_id=http%3A%2F%2Fwww.prescrire.org%2Ffr%2F3%2F31%2F53765%2F0%2FNewsDetails.aspx&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Chalasani2012-91"><span class="mw-cite-backlink"><b><a href="#cite_ref-Chalasani2012_91-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFChalasaniYounossiLavineDiehl2012" class="citation journal cs1">Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K,  et&#160;al. (June 2012). <a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2012.04.001">"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology"</a>. <i>Gastroenterology</i>. <b>142</b> (7): 1592–609. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fj.gastro.2012.04.001">10.1053/j.gastro.2012.04.001</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22656328">22656328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Gastroenterology&amp;rft.atitle=The+diagnosis+and+management+of+non-alcoholic+fatty+liver+disease%3A+practice+guideline+by+the+American+Gastroenterological+Association%2C+American+Association+for+the+Study+of+Liver+Diseases%2C+and+American+College+of+Gastroenterology&amp;rft.volume=142&amp;rft.issue=7&amp;rft.pages=1592-609&amp;rft.date=2012-06&amp;rft_id=info%3Adoi%2F10.1053%2Fj.gastro.2012.04.001&amp;rft_id=info%3Apmid%2F22656328&amp;rft.aulast=Chalasani&amp;rft.aufirst=N&amp;rft.au=Younossi%2C+Z&amp;rft.au=Lavine%2C+JE&amp;rft.au=Diehl%2C+AM&amp;rft.au=Brunt%2C+EM&amp;rft.au=Cusi%2C+K&amp;rft.au=Charlton%2C+M&amp;rft.au=Sanyal%2C+AJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1053%252Fj.gastro.2012.04.001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Parker2012-92"><span class="mw-cite-backlink"><b><a href="#cite_ref-Parker2012_92-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFParkerJohnsonBurdonCohn2012" class="citation journal cs1">Parker HM, Johnson NA, Burdon CA, Cohn JS, O'Connor HT, George J (April 2012). <a rel="nofollow" class="external text" href="http://www.journal-of-hepatology.eu/article/S0168-8278(11)00740-9/pdf">"Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis"</a>. <i>Journal of Hepatology</i> (Systematic review and meta-analysis). <b>56</b> (4): 944–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2011.08.018">10.1016/j.jhep.2011.08.018</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22023985">22023985</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Omega-3+supplementation+and+non-alcoholic+fatty+liver+disease%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=56&amp;rft.issue=4&amp;rft.pages=944-51&amp;rft.date=2012-04&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2011.08.018&amp;rft_id=info%3Apmid%2F22023985&amp;rft.aulast=Parker&amp;rft.aufirst=HM&amp;rft.au=Johnson%2C+NA&amp;rft.au=Burdon%2C+CA&amp;rft.au=Cohn%2C+JS&amp;rft.au=O%27Connor%2C+HT&amp;rft.au=George%2C+J&amp;rft_id=http%3A%2F%2Fwww.journal-of-hepatology.eu%2Farticle%2FS0168-8278%2811%2900740-9%2Fpdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-93"><span class="mw-cite-backlink"><b><a href="#cite_ref-93">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLeeDoumourasYuBrar2019" class="citation journal cs1">Lee Y, Doumouras AG, Yu J, Brar K, Banfield L, Gmora S,  et&#160;al. (May 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2018.10.017">"Complete Resolution of Nonalcoholic Fatty Liver Disease After Bariatric Surgery: A Systematic Review and Meta-analysis"</a>. <i>Clinical Gastroenterology and Hepatology</i>. <b>17</b> (6): 1040–1060.e11. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2018.10.017">10.1016/j.cgh.2018.10.017</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30326299">30326299</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Gastroenterology+and+Hepatology&amp;rft.atitle=Complete+Resolution+of+Nonalcoholic+Fatty+Liver+Disease+After+Bariatric+Surgery%3A+A+Systematic+Review+and+Meta-analysis&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=1040-1060.e11&amp;rft.date=2019-05&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cgh.2018.10.017&amp;rft_id=info%3Apmid%2F30326299&amp;rft.aulast=Lee&amp;rft.aufirst=Y&amp;rft.au=Doumouras%2C+AG&amp;rft.au=Yu%2C+J&amp;rft.au=Brar%2C+K&amp;rft.au=Banfield%2C+L&amp;rft.au=Gmora%2C+S&amp;rft.au=Anvari%2C+M&amp;rft.au=Hong%2C+D&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.cgh.2018.10.017&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Fakhry2019-94"><span class="mw-cite-backlink">^ <a href="#cite_ref-Fakhry2019_94-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Fakhry2019_94-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFakhryMhaskarSchwitallaMuradova2019" class="citation journal cs1">Fakhry TK, Mhaskar R, Schwitalla T, Muradova E, Gonzalvo JP, Murr MM (March 2019). "Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis". <i>Surgery for Obesity and Related Diseases</i>. <b>15</b> (3): 502–511. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.soard.2018.12.002">10.1016/j.soard.2018.12.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30683512">30683512</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:59275709">59275709</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Surgery+for+Obesity+and+Related+Diseases&amp;rft.atitle=Bariatric+surgery+improves+nonalcoholic+fatty+liver+disease%3A+a+contemporary+systematic+review+and+meta-analysis&amp;rft.volume=15&amp;rft.issue=3&amp;rft.pages=502-511&amp;rft.date=2019-03&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A59275709%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F30683512&amp;rft_id=info%3Adoi%2F10.1016%2Fj.soard.2018.12.002&amp;rft.aulast=Fakhry&amp;rft.aufirst=TK&amp;rft.au=Mhaskar%2C+R&amp;rft.au=Schwitalla%2C+T&amp;rft.au=Muradova%2C+E&amp;rft.au=Gonzalvo%2C+JP&amp;rft.au=Murr%2C+MM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-95"><span class="mw-cite-backlink"><b><a href="#cite_ref-95">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMummadiKasturiChennareddygariSood2008" class="citation journal cs1">Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK (December 2008). "Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis". <i>Clinical Gastroenterology and Hepatology</i>. <b>6</b> (12): 1396–402. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2008.08.012">10.1016/j.cgh.2008.08.012</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18986848">18986848</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Gastroenterology+and+Hepatology&amp;rft.atitle=Effect+of+bariatric+surgery+on+nonalcoholic+fatty+liver+disease%3A+systematic+review+and+meta-analysis&amp;rft.volume=6&amp;rft.issue=12&amp;rft.pages=1396-402&amp;rft.date=2008-12&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cgh.2008.08.012&amp;rft_id=info%3Apmid%2F18986848&amp;rft.aulast=Mummadi&amp;rft.aufirst=RR&amp;rft.au=Kasturi%2C+KS&amp;rft.au=Chennareddygari%2C+S&amp;rft.au=Sood%2C+GK&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-ERAS2016-96"><span class="mw-cite-backlink">^ <a href="#cite_ref-ERAS2016_96-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ERAS2016_96-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFThorellMacCormickAwadReynolds2016" class="citation journal cs1">Thorell A, MacCormick AD, Awad S, Reynolds N, Roulin D, Demartines N,  et&#160;al. (September 2016). <a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00268-016-3492-3">"Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations"</a>. <i>World Journal of Surgery</i> (Professional society guidelines). <b>40</b> (9): 2065–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1007%2Fs00268-016-3492-3">10.1007/s00268-016-3492-3</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26943657">26943657</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=World+Journal+of+Surgery&amp;rft.atitle=Guidelines+for+Perioperative+Care+in+Bariatric+Surgery%3A+Enhanced+Recovery+After+Surgery+%28ERAS%29+Society+Recommendations&amp;rft.volume=40&amp;rft.issue=9&amp;rft.pages=2065-83&amp;rft.date=2016-09&amp;rft_id=info%3Adoi%2F10.1007%2Fs00268-016-3492-3&amp;rft_id=info%3Apmid%2F26943657&amp;rft.aulast=Thorell&amp;rft.aufirst=A&amp;rft.au=MacCormick%2C+AD&amp;rft.au=Awad%2C+S&amp;rft.au=Reynolds%2C+N&amp;rft.au=Roulin%2C+D&amp;rft.au=Demartines%2C+N&amp;rft.au=Vignaud%2C+M&amp;rft.au=Alvarez%2C+A&amp;rft.au=Singh%2C+PM&amp;rft.au=Lobo%2C+DN&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1007%252Fs00268-016-3492-3&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Holderbaum2018-97"><span class="mw-cite-backlink">^ <a href="#cite_ref-Holderbaum2018_97-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Holderbaum2018_97-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHolderbaumCasagrandeSussenbachBuss2018" class="citation journal cs1">Holderbaum M, Casagrande DS, Sussenbach S, Buss C (February 2018). "Effects of very low calorie diets on liver size and weight loss in the preoperative period of bariatric surgery: a systematic review". <i>Surgery for Obesity and Related Diseases</i> (Systematic review). <b>14</b> (2): 237–244. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.soard.2017.09.531">10.1016/j.soard.2017.09.531</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29239795">29239795</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Surgery+for+Obesity+and+Related+Diseases&amp;rft.atitle=Effects+of+very+low+calorie+diets+on+liver+size+and+weight+loss+in+the+preoperative+period+of+bariatric+surgery%3A+a+systematic+review&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=237-244&amp;rft.date=2018-02&amp;rft_id=info%3Adoi%2F10.1016%2Fj.soard.2017.09.531&amp;rft_id=info%3Apmid%2F29239795&amp;rft.aulast=Holderbaum&amp;rft.aufirst=M&amp;rft.au=Casagrande%2C+DS&amp;rft.au=Sussenbach%2C+S&amp;rft.au=Buss%2C+C&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-98"><span class="mw-cite-backlink"><b><a href="#cite_ref-98">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLivhitsMercadoYermilovParikh2008" class="citation journal cs1">Livhits M, Mercado C, Yermilov I, Parikh JA, Dutson E, Mehran A,  et&#160;al. (2008). "Does weight loss immediately before bariatric surgery improve outcomes: a systematic review". <i>Surgery for Obesity and Related Diseases</i>. <b>5</b> (6): 713–21. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.soard.2009.08.014">10.1016/j.soard.2009.08.014</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/19879814">19879814</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Surgery+for+Obesity+and+Related+Diseases&amp;rft.atitle=Does+weight+loss+immediately+before+bariatric+surgery+improve+outcomes%3A+a+systematic+review&amp;rft.volume=5&amp;rft.issue=6&amp;rft.pages=713-21&amp;rft.date=2008&amp;rft_id=info%3Adoi%2F10.1016%2Fj.soard.2009.08.014&amp;rft_id=info%3Apmid%2F19879814&amp;rft.aulast=Livhits&amp;rft.aufirst=M&amp;rft.au=Mercado%2C+C&amp;rft.au=Yermilov%2C+I&amp;rft.au=Parikh%2C+JA&amp;rft.au=Dutson%2C+E&amp;rft.au=Mehran%2C+A&amp;rft.au=Ko%2C+CY&amp;rft.au=Gibbons%2C+MM&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Roman2019-99"><span class="mw-cite-backlink">^ <a href="#cite_ref-Roman2019_99-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Roman2019_99-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRomanMonaghanSerrainoMiller2019" class="citation journal cs1">Roman M, Monaghan A, Serraino GF, Miller D, Pathak S, Lai F,  et&#160;al. (February 2019). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fbjs.11001">"Meta-analysis of the influence of lifestyle changes for preoperative weight loss on surgical outcomes"</a>. <i>The British Journal of Surgery</i> (Meta-analysis). <b>106</b> (3): 181–189. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fbjs.11001">10.1002/bjs.11001</a></span>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<a rel="nofollow" class="external text" href="https://hdl.handle.net/2381%2F43636">2381/43636</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/30328098">30328098</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+British+Journal+of+Surgery&amp;rft.atitle=Meta-analysis+of+the+influence+of+lifestyle+changes+for+preoperative+weight+loss+on+surgical+outcomes&amp;rft.volume=106&amp;rft.issue=3&amp;rft.pages=181-189&amp;rft.date=2019-02&amp;rft_id=info%3Ahdl%2F2381%2F43636&amp;rft_id=info%3Apmid%2F30328098&amp;rft_id=info%3Adoi%2F10.1002%2Fbjs.11001&amp;rft.aulast=Roman&amp;rft.aufirst=M&amp;rft.au=Monaghan%2C+A&amp;rft.au=Serraino%2C+GF&amp;rft.au=Miller%2C+D&amp;rft.au=Pathak%2C+S&amp;rft.au=Lai%2C+F&amp;rft.au=Zaccardi%2C+F&amp;rft.au=Ghanchi%2C+A&amp;rft.au=Khunti%2C+K&amp;rft.au=Davies%2C+MJ&amp;rft.au=Murphy%2C+GJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fbjs.11001&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-100"><span class="mw-cite-backlink"><b><a href="#cite_ref-100">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCassieMenezesBirchShi2010" class="citation journal cs1">Cassie S, Menezes C, Birch DW, Shi X, Karmali S (2010). "Effect of preoperative weight loss in bariatric surgical patients: a systematic review". <i>Surgery for Obesity and Related Diseases</i> (Systematic review). <b>7</b> (6): 760–7, discussion 767. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.soard.2011.08.011">10.1016/j.soard.2011.08.011</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/21978748">21978748</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Surgery+for+Obesity+and+Related+Diseases&amp;rft.atitle=Effect+of+preoperative+weight+loss+in+bariatric+surgical+patients%3A+a+systematic+review&amp;rft.volume=7&amp;rft.issue=6&amp;rft.pages=760-7%2C+discussion+767&amp;rft.date=2010&amp;rft_id=info%3Adoi%2F10.1016%2Fj.soard.2011.08.011&amp;rft_id=info%3Apmid%2F21978748&amp;rft.aulast=Cassie&amp;rft.aufirst=S&amp;rft.au=Menezes%2C+C&amp;rft.au=Birch%2C+DW&amp;rft.au=Shi%2C+X&amp;rft.au=Karmali%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-101"><span class="mw-cite-backlink"><b><a href="#cite_ref-101">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZhouFu2017" class="citation journal cs1">Zhou, Yaoyao; Fu, Shenwen (October 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2017.07.284">"GW28-e0325 Association of non-alcoholic fatty liver disease and subclinical atherosclerosis: a systematic review and meta-analysis"</a>. <i>Journal of the American College of Cardiology</i>. <b>70</b> (16): C81. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jacc.2017.07.284">10.1016/j.jacc.2017.07.284</a></span>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+College+of+Cardiology&amp;rft.atitle=GW28-e0325+Association+of+non-alcoholic+fatty+liver+disease+and+subclinical+atherosclerosis%3A+a+systematic+review+and+meta-analysis&amp;rft.volume=70&amp;rft.issue=16&amp;rft.pages=C81&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jacc.2017.07.284&amp;rft.aulast=Zhou&amp;rft.aufirst=Yaoyao&amp;rft.au=Fu%2C+Shenwen&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jacc.2017.07.284&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-102"><span class="mw-cite-backlink"><b><a href="#cite_ref-102">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMahadyGeorge2012" class="citation journal cs1">Mahady SE, George J (August 2012). "Management of nonalcoholic steatohepatitis: an evidence-based approach". <i>Clinics in Liver Disease</i>. <b>16</b> (3): 631–45. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cld.2012.05.003">10.1016/j.cld.2012.05.003</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/22824485">22824485</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinics+in+Liver+Disease&amp;rft.atitle=Management+of+nonalcoholic+steatohepatitis%3A+an+evidence-based+approach&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=631-45&amp;rft.date=2012-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cld.2012.05.003&amp;rft_id=info%3Apmid%2F22824485&amp;rft.aulast=Mahady&amp;rft.aufirst=SE&amp;rft.au=George%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-103"><span class="mw-cite-backlink"><b><a href="#cite_ref-103">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSinghAllenWangProkop2015" class="citation journal cs1">Singh S, Allen AM, Wang Z, Prokop LJ, Murad MH, Loomba R (April 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208976">"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies"</a>. <i>Clinical Gastroenterology and Hepatology</i>. <b>13</b> (4): 643–54.e1–9, quiz e39–40. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.cgh.2014.04.014">10.1016/j.cgh.2014.04.014</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208976">4208976</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24768810">24768810</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Gastroenterology+and+Hepatology&amp;rft.atitle=Fibrosis+progression+in+nonalcoholic+fatty+liver+vs+nonalcoholic+steatohepatitis%3A+a+systematic+review+and+meta-analysis+of+paired-biopsy+studies&amp;rft.volume=13&amp;rft.issue=4&amp;rft.pages=643-54.e1-9%2C+quiz+e39-40&amp;rft.date=2015-04&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4208976%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F24768810&amp;rft_id=info%3Adoi%2F10.1016%2Fj.cgh.2014.04.014&amp;rft.aulast=Singh&amp;rft.aufirst=S&amp;rft.au=Allen%2C+AM&amp;rft.au=Wang%2C+Z&amp;rft.au=Prokop%2C+LJ&amp;rft.au=Murad%2C+MH&amp;rft.au=Loomba%2C+R&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4208976&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-autogenerated1-104"><span class="mw-cite-backlink">^ <a href="#cite_ref-autogenerated1_104-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-autogenerated1_104-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLuHuXuChen2018" class="citation journal cs1">Lu FB, Hu ED, Xu LM, Chen L, Wu JL, Li H,  et&#160;al. (May 2018). "The relationship between obesity and the severity of non-alcoholic fatty liver disease: systematic review and meta-analysis". <i>Expert Review of Gastroenterology &amp; Hepatology</i>. <b>12</b> (5): 491–502. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1080%2F17474124.2018.1460202">10.1080/17474124.2018.1460202</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29609501">29609501</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:4626474">4626474</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Expert+Review+of+Gastroenterology+%26+Hepatology&amp;rft.atitle=The+relationship+between+obesity+and+the+severity+of+non-alcoholic+fatty+liver+disease%3A+systematic+review+and+meta-analysis&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=491-502&amp;rft.date=2018-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A4626474%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F29609501&amp;rft_id=info%3Adoi%2F10.1080%2F17474124.2018.1460202&amp;rft.aulast=Lu&amp;rft.aufirst=FB&amp;rft.au=Hu%2C+ED&amp;rft.au=Xu%2C+LM&amp;rft.au=Chen%2C+L&amp;rft.au=Wu%2C+JL&amp;rft.au=Li%2C+H&amp;rft.au=Chen%2C+DZ&amp;rft.au=Chen%2C+YP&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-105"><span class="mw-cite-backlink"><b><a href="#cite_ref-105">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSookoianPirola2018" class="citation journal cs1">Sookoian S, Pirola CJ (January 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fapt.14401">"Systematic review with meta-analysis: the significance of histological disease severity in lean patients with nonalcoholic fatty liver disease"</a>. <i>Alimentary Pharmacology &amp; Therapeutics</i>. <b>47</b> (1): 16–25. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fapt.14401">10.1111/apt.14401</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29083036">29083036</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Alimentary+Pharmacology+%26+Therapeutics&amp;rft.atitle=Systematic+review+with+meta-analysis%3A+the+significance+of+histological+disease+severity+in+lean+patients+with+nonalcoholic+fatty+liver+disease&amp;rft.volume=47&amp;rft.issue=1&amp;rft.pages=16-25&amp;rft.date=2018-01&amp;rft_id=info%3Adoi%2F10.1111%2Fapt.14401&amp;rft_id=info%3Apmid%2F29083036&amp;rft.aulast=Sookoian&amp;rft.aufirst=S&amp;rft.au=Pirola%2C+CJ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fapt.14401&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-106"><span class="mw-cite-backlink"><b><a href="#cite_ref-106">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFUsmanSiddiqi2017" class="citation journal cs1">Usman MS, Siddiqi TJ (October 2017). "Emerging evidence for the association between non-alcoholic fatty liver disease and cardiac arrhythmias". <i>Digestive and Liver Disease</i>. <b>49</b> (10): 1166. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dld.2017.07.013">10.1016/j.dld.2017.07.013</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28822729">28822729</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+and+Liver+Disease&amp;rft.atitle=Emerging+evidence+for+the+association+between+non-alcoholic+fatty+liver+disease+and+cardiac+arrhythmias&amp;rft.volume=49&amp;rft.issue=10&amp;rft.pages=1166&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dld.2017.07.013&amp;rft_id=info%3Apmid%2F28822729&amp;rft.aulast=Usman&amp;rft.aufirst=MS&amp;rft.au=Siddiqi%2C+TJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-107"><span class="mw-cite-backlink"><b><a href="#cite_ref-107">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBellentani2017" class="citation journal cs1 cs1-prop-long-vol">Bellentani S (January 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13299">"The epidemiology of non-alcoholic fatty liver disease"</a>. <i>Liver International</i>. 37 Suppl 1: 81–84. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13299">10.1111/liv.13299</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28052624">28052624</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Liver+International&amp;rft.atitle=The+epidemiology+of+non-alcoholic+fatty+liver+disease&amp;rft.volume=37+Suppl+1&amp;rft.pages=81-84&amp;rft.date=2017-01&amp;rft_id=info%3Adoi%2F10.1111%2Fliv.13299&amp;rft_id=info%3Apmid%2F28052624&amp;rft.aulast=Bellentani&amp;rft.aufirst=S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fliv.13299&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-108"><span class="mw-cite-backlink"><b><a href="#cite_ref-108">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarengoRossoBugianesi2016" class="citation journal cs1">Marengo A, Rosso C, Bugianesi E (14 January 2016). "Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis". <i>Annual Review of Medicine</i>. <b>67</b> (1): 103–17. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1146%2Fannurev-med-090514-013832">10.1146/annurev-med-090514-013832</a>. <a href="/wiki/Hdl_(identifier)" class="mw-redirect" title="Hdl (identifier)">hdl</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://hdl.handle.net/2318%2F1636160">2318/1636160</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26473416">26473416</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Annual+Review+of+Medicine&amp;rft.atitle=Liver+Cancer%3A+Connections+with+Obesity%2C+Fatty+Liver%2C+and+Cirrhosis&amp;rft.volume=67&amp;rft.issue=1&amp;rft.pages=103-17&amp;rft.date=2016-01-14&amp;rft_id=info%3Ahdl%2F2318%2F1636160&amp;rft_id=info%3Apmid%2F26473416&amp;rft_id=info%3Adoi%2F10.1146%2Fannurev-med-090514-013832&amp;rft.aulast=Marengo&amp;rft.aufirst=A&amp;rft.au=Rosso%2C+C&amp;rft.au=Bugianesi%2C+E&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-109"><span class="mw-cite-backlink"><b><a href="#cite_ref-109">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLonardoBallestriMarchesiniAngulo2015" class="citation journal cs1">Lonardo A, Ballestri S, Marchesini G, Angulo P, Loria P (March 2015). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dld.2014.09.020">"Nonalcoholic fatty liver disease: a precursor of the metabolic syndrome"</a>. <i>Digestive and Liver Disease</i>. <b>47</b> (3): 181–90. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.dld.2014.09.020">10.1016/j.dld.2014.09.020</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/25739820">25739820</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Digestive+and+Liver+Disease&amp;rft.atitle=Nonalcoholic+fatty+liver+disease%3A+a+precursor+of+the+metabolic+syndrome&amp;rft.volume=47&amp;rft.issue=3&amp;rft.pages=181-90&amp;rft.date=2015-03&amp;rft_id=info%3Adoi%2F10.1016%2Fj.dld.2014.09.020&amp;rft_id=info%3Apmid%2F25739820&amp;rft.aulast=Lonardo&amp;rft.aufirst=A&amp;rft.au=Ballestri%2C+S&amp;rft.au=Marchesini%2C+G&amp;rft.au=Angulo%2C+P&amp;rft.au=Loria%2C+P&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.dld.2014.09.020&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-110"><span class="mw-cite-backlink"><b><a href="#cite_ref-110">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFYki-Järvinen2014" class="citation journal cs1">Yki-Järvinen H (November 2014). "Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome". <i>The Lancet. Diabetes &amp; Endocrinology</i>. <b>2</b> (11): 901–10. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS2213-8587%2814%2970032-4">10.1016/S2213-8587(14)70032-4</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/24731669">24731669</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+Lancet.+Diabetes+%26+Endocrinology&amp;rft.atitle=Non-alcoholic+fatty+liver+disease+as+a+cause+and+a+consequence+of+metabolic+syndrome&amp;rft.volume=2&amp;rft.issue=11&amp;rft.pages=901-10&amp;rft.date=2014-11&amp;rft_id=info%3Adoi%2F10.1016%2FS2213-8587%2814%2970032-4&amp;rft_id=info%3Apmid%2F24731669&amp;rft.aulast=Yki-J%C3%A4rvinen&amp;rft.aufirst=H&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-111"><span class="mw-cite-backlink"><b><a href="#cite_ref-111">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKatsikiPerez-MartinezAnagnostisMikhailidis2018" class="citation journal cs1">Katsiki N, Perez-Martinez P, Anagnostis P, Mikhailidis DP, Karagiannis A (2018). "Is Nonalcoholic Fatty Liver Disease Indeed the Hepatic Manifestation of Metabolic Syndrome?". <i>Current Vascular Pharmacology</i>. <b>16</b> (3): 219–227. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.2174%2F1570161115666170621075619">10.2174/1570161115666170621075619</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28669328">28669328</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Current+Vascular+Pharmacology&amp;rft.atitle=Is+Nonalcoholic+Fatty+Liver+Disease+Indeed+the+Hepatic+Manifestation+of+Metabolic+Syndrome%3F&amp;rft.volume=16&amp;rft.issue=3&amp;rft.pages=219-227&amp;rft.date=2018&amp;rft_id=info%3Adoi%2F10.2174%2F1570161115666170621075619&amp;rft_id=info%3Apmid%2F28669328&amp;rft.aulast=Katsiki&amp;rft.aufirst=N&amp;rft.au=Perez-Martinez%2C+P&amp;rft.au=Anagnostis%2C+P&amp;rft.au=Mikhailidis%2C+DP&amp;rft.au=Karagiannis%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Omagari2002-112"><span class="mw-cite-backlink"><b><a href="#cite_ref-Omagari2002_112-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFOmagariKadokawaMasudaEgawa2002" class="citation journal cs1">Omagari K, Kadokawa Y, Masuda J, Egawa I, Sawa T, Hazama H,  et&#160;al. (October 2002). "Fatty liver in non-alcoholic non-overweight Japanese adults: incidence and clinical characteristics". <i>Journal of Gastroenterology and Hepatology</i>. <b>17</b> (10): 1098–105. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1046%2Fj.1440-1746.2002.02846.x">10.1046/j.1440-1746.2002.02846.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12201871">12201871</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:23627555">23627555</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Gastroenterology+and+Hepatology&amp;rft.atitle=Fatty+liver+in+non-alcoholic+non-overweight+Japanese+adults%3A+incidence+and+clinical+characteristics&amp;rft.volume=17&amp;rft.issue=10&amp;rft.pages=1098-105&amp;rft.date=2002-10&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A23627555%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F12201871&amp;rft_id=info%3Adoi%2F10.1046%2Fj.1440-1746.2002.02846.x&amp;rft.aulast=Omagari&amp;rft.aufirst=K&amp;rft.au=Kadokawa%2C+Y&amp;rft.au=Masuda%2C+J&amp;rft.au=Egawa%2C+I&amp;rft.au=Sawa%2C+T&amp;rft.au=Hazama%2C+H&amp;rft.au=Ohba%2C+K&amp;rft.au=Isomoto%2C+H&amp;rft.au=Mizuta%2C+Y&amp;rft.au=Hayashida%2C+K&amp;rft.au=Murase%2C+K&amp;rft.au=Kadota%2C+T&amp;rft.au=Murata%2C+I&amp;rft.au=Kohno%2C+S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Hilden1977-113"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hilden1977_113-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHildenChristoffersenJuhlDalgaard1977" class="citation journal cs1">Hilden M, Christoffersen P, Juhl E, Dalgaard JB (1977). "Liver histology in a 'normal' population--examinations of 503 consecutive fatal traffic casualties". <i>Scandinavian Journal of Gastroenterology</i>. <b>12</b> (5): 593–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.3109%2F00365527709181339">10.3109/00365527709181339</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/918553">918553</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Scandinavian+Journal+of+Gastroenterology&amp;rft.atitle=Liver+histology+in+a+%27normal%27+population--examinations+of+503+consecutive+fatal+traffic+casualties&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=593-7&amp;rft.date=1977&amp;rft_id=info%3Adoi%2F10.3109%2F00365527709181339&amp;rft_id=info%3Apmid%2F918553&amp;rft.aulast=Hilden&amp;rft.aufirst=M&amp;rft.au=Christoffersen%2C+P&amp;rft.au=Juhl%2C+E&amp;rft.au=Dalgaard%2C+JB&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Kabbany2017-114"><span class="mw-cite-backlink"><b><a href="#cite_ref-Kabbany2017_114-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFKabbanyConjeevaram_SelvakumarWattLopez2017" class="citation journal cs1">Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N,  et&#160;al. (April 2017). "Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data". <i>The American Journal of Gastroenterology</i>. <b>112</b> (4): 581–587. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fajg.2017.5">10.1038/ajg.2017.5</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28195177">28195177</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:39521696">39521696</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Gastroenterology&amp;rft.atitle=Prevalence+of+Nonalcoholic+Steatohepatitis-Associated+Cirrhosis+in+the+United+States%3A+An+Analysis+of+National+Health+and+Nutrition+Examination+Survey+Data&amp;rft.volume=112&amp;rft.issue=4&amp;rft.pages=581-587&amp;rft.date=2017-04&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A39521696%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F28195177&amp;rft_id=info%3Adoi%2F10.1038%2Fajg.2017.5&amp;rft.aulast=Kabbany&amp;rft.aufirst=MN&amp;rft.au=Conjeevaram+Selvakumar%2C+PK&amp;rft.au=Watt%2C+K&amp;rft.au=Lopez%2C+R&amp;rft.au=Akras%2C+Z&amp;rft.au=Zein%2C+N&amp;rft.au=Carey%2C+W&amp;rft.au=Alkhouri%2C+N&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Flegal2002-115"><span class="mw-cite-backlink"><b><a href="#cite_ref-Flegal2002_115-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFlegalCarrollOgdenJohnson2002" class="citation journal cs1">Flegal KM, Carroll MD, Ogden CL, Johnson CL (October 2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.288.14.1723">"Prevalence and trends in obesity among US adults, 1999-2000"</a>. <i>JAMA</i>. <b>288</b> (14): 1723–7. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.288.14.1723">10.1001/jama.288.14.1723</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/12365955">12365955</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=JAMA&amp;rft.atitle=Prevalence+and+trends+in+obesity+among+US+adults%2C+1999-2000&amp;rft.volume=288&amp;rft.issue=14&amp;rft.pages=1723-7&amp;rft.date=2002-10&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.288.14.1723&amp;rft_id=info%3Apmid%2F12365955&amp;rft.aulast=Flegal&amp;rft.aufirst=KM&amp;rft.au=Carroll%2C+MD&amp;rft.au=Ogden%2C+CL&amp;rft.au=Johnson%2C+CL&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1001%252Fjama.288.14.1723&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-PLOSONEANDERSON2015-116"><span class="mw-cite-backlink">^ <a href="#cite_ref-PLOSONEANDERSON2015_116-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-PLOSONEANDERSON2015_116-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAndersonHoweJonesHiggins2015" class="citation journal cs1">Anderson EL, Howe LD, Jones HE, Higgins JP, Lawlor DA, Fraser A (29 October 2015). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626023">"The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis"</a>. <i>PLOS ONE</i>. <b>10</b> (10): e0140908. <a href="/wiki/Bibcode_(identifier)" class="mw-redirect" title="Bibcode (identifier)">Bibcode</a>:<a rel="nofollow" class="external text" href="https://ui.adsabs.harvard.edu/abs/2015PLoSO..1040908A">2015PLoSO..1040908A</a>. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1371%2Fjournal.pone.0140908">10.1371/journal.pone.0140908</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626023">4626023</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/26512983">26512983</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=PLOS+ONE&amp;rft.atitle=The+Prevalence+of+Non-Alcoholic+Fatty+Liver+Disease+in+Children+and+Adolescents%3A+A+Systematic+Review+and+Meta-Analysis&amp;rft.volume=10&amp;rft.issue=10&amp;rft.pages=e0140908&amp;rft.date=2015-10-29&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4626023%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F26512983&amp;rft_id=info%3Adoi%2F10.1371%2Fjournal.pone.0140908&amp;rft_id=info%3Abibcode%2F2015PLoSO..1040908A&amp;rft.aulast=Anderson&amp;rft.aufirst=EL&amp;rft.au=Howe%2C+LD&amp;rft.au=Jones%2C+HE&amp;rft.au=Higgins%2C+JP&amp;rft.au=Lawlor%2C+DA&amp;rft.au=Fraser%2C+A&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4626023&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-EASL2019-policy-117"><span class="mw-cite-backlink">^ <a href="#cite_ref-EASL2019-policy_117-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-EASL2019-policy_117-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEASL2019" class="citation web cs1">EASL (April 2019). <a rel="nofollow" class="external text" href="https://web.archive.org/web/20191007160746/https://easl.eu/wp-content/uploads/2019/04/EASL-POLICY-Obesity-and-NAFLD-FINAL.pdf">"Policy Statement - Obesity is feeding the rise in Non-Alcoholic Fatty Liver Disease (NAFLD) across Europe"</a> <span class="cs1-format">(PDF)</span>. Archived from <a rel="nofollow" class="external text" href="https://easl.eu/wp-content/uploads/2019/04/EASL-POLICY-Obesity-and-NAFLD-FINAL.pdf">the original</a> <span class="cs1-format">(PDF)</span> on 2019-10-07.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Policy+Statement+-+Obesity+is+feeding+the+rise+in+Non-Alcoholic+Fatty+Liver+Disease+%28NAFLD%29+across+Europe&amp;rft.date=2019-04&amp;rft.au=EASL&amp;rft_id=https%3A%2F%2Feasl.eu%2Fwp-content%2Fuploads%2F2019%2F04%2FEASL-POLICY-Obesity-and-NAFLD-FINAL.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Estes2018-118"><span class="mw-cite-backlink"><b><a href="#cite_ref-Estes2018_118-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFEstesRazaviLoombaYounossi2018" class="citation journal cs1">Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ (January 2018). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767">"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease"</a>. <i>Hepatology</i>. <b>67</b> (1): 123–133. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.29466">10.1002/hep.29466</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767767">5767767</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28802062">28802062</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Modeling+the+epidemic+of+nonalcoholic+fatty+liver+disease+demonstrates+an+exponential+increase+in+burden+of+disease&amp;rft.volume=67&amp;rft.issue=1&amp;rft.pages=123-133&amp;rft.date=2018-01&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5767767%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F28802062&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.29466&amp;rft.aulast=Estes&amp;rft.aufirst=C&amp;rft.au=Razavi%2C+H&amp;rft.au=Loomba%2C+R&amp;rft.au=Younossi%2C+Z&amp;rft.au=Sanyal%2C+AJ&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5767767&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Zelman1952-119"><span class="mw-cite-backlink">^ <a href="#cite_ref-Zelman1952_119-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Zelman1952_119-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFZelman1952" class="citation journal cs1">Zelman S (August 1952). "The liver in obesity". <i>A.M.A. Archives of Internal Medicine</i>. <b>90</b> (2): 141–56. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Farchinte.1952.00240080007002">10.1001/archinte.1952.00240080007002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/14943295">14943295</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=A.M.A.+Archives+of+Internal+Medicine&amp;rft.atitle=The+liver+in+obesity&amp;rft.volume=90&amp;rft.issue=2&amp;rft.pages=141-56&amp;rft.date=1952-08&amp;rft_id=info%3Adoi%2F10.1001%2Farchinte.1952.00240080007002&amp;rft_id=info%3Apmid%2F14943295&amp;rft.aulast=Zelman&amp;rft.aufirst=S&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Ludwig1997-120"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ludwig1997_120-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ludwig1997_120-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLudwigMcGillLindor1997" class="citation journal cs1">Ludwig J, McGill DB, Lindor KD (May 1997). "Review: nonalcoholic steatohepatitis". <i>Journal of Gastroenterology and Hepatology</i>. <b>12</b> (5): 398–403. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fj.1440-1746.1997.tb00450.x">10.1111/j.1440-1746.1997.tb00450.x</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/9195388">9195388</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:34775647">34775647</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Gastroenterology+and+Hepatology&amp;rft.atitle=Review%3A+nonalcoholic+steatohepatitis&amp;rft.volume=12&amp;rft.issue=5&amp;rft.pages=398-403&amp;rft.date=1997-05&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A34775647%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F9195388&amp;rft_id=info%3Adoi%2F10.1111%2Fj.1440-1746.1997.tb00450.x&amp;rft.aulast=Ludwig&amp;rft.aufirst=J&amp;rft.au=McGill%2C+DB&amp;rft.au=Lindor%2C+KD&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Rabinowitch1948-121"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rabinowitch1948_121-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRabinowitch1948" class="citation journal cs1">Rabinowitch IM (June 1948). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590957">"Relationship between impairment of liver function and premature development of arteriosclerosis in diabetes mellitus"</a>. <i>Canadian Medical Association Journal</i>. <b>58</b> (6): 547–56. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1590957">1590957</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18862251">18862251</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.atitle=Relationship+between+impairment+of+liver+function+and+premature+development+of+arteriosclerosis+in+diabetes+mellitus&amp;rft.volume=58&amp;rft.issue=6&amp;rft.pages=547-56&amp;rft.date=1948-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1590957%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18862251&amp;rft.aulast=Rabinowitch&amp;rft.aufirst=IM&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1590957&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Hanssen1936-122"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hanssen1936_122-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFHANSSEN1936" class="citation journal cs1">HANSSEN, PER (14 March 1936). "Enlargement of the Liver in Diabetes Mellitus". <i>Journal of the American Medical Association</i>. <b>106</b> (11): 914. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1001%2Fjama.1936.02770110030011">10.1001/jama.1936.02770110030011</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+the+American+Medical+Association&amp;rft.atitle=Enlargement+of+the+Liver+in+Diabetes+Mellitus&amp;rft.volume=106&amp;rft.issue=11&amp;rft.pages=914&amp;rft.date=1936-03-14&amp;rft_id=info%3Adoi%2F10.1001%2Fjama.1936.02770110030011&amp;rft.aulast=HANSSEN&amp;rft.aufirst=PER&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Best1948-123"><span class="mw-cite-backlink"><b><a href="#cite_ref-Best1948_123-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFBestHartroft1949" class="citation journal cs1">Best CH, Hartroft WS (November 1949). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2051633">"Liver damage produced by feeding alcohol or sugar and its prevention by choline"</a>. <i>British Medical Journal</i>. <b>2</b> (4635): 1002–6, pl. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1136%2Fbmj.2.4635.1001">10.1136/bmj.2.4635.1001</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2051633">2051633</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/15393035">15393035</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=British+Medical+Journal&amp;rft.atitle=Liver+damage+produced+by+feeding+alcohol+or+sugar+and+its+prevention+by+choline&amp;rft.volume=2&amp;rft.issue=4635&amp;rft.pages=1002-6%2C+pl&amp;rft.date=1949-11&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2051633%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F15393035&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.2.4635.1001&amp;rft.aulast=Best&amp;rft.aufirst=CH&amp;rft.au=Hartroft%2C+WS&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2051633&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Ludwig1980-124"><span class="mw-cite-backlink"><b><a href="#cite_ref-Ludwig1980_124-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFLudwigViggianoMcGillOh1980" class="citation journal cs1">Ludwig J, Viggiano TR, McGill DB, Oh BJ (July 1980). "Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease". <i>Mayo Clinic Proceedings</i>. <b>55</b> (7): 434–8. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/7382552">7382552</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Mayo+Clinic+Proceedings&amp;rft.atitle=Nonalcoholic+steatohepatitis%3A+Mayo+Clinic+experiences+with+a+hitherto+unnamed+disease&amp;rft.volume=55&amp;rft.issue=7&amp;rft.pages=434-8&amp;rft.date=1980-07&amp;rft_id=info%3Apmid%2F7382552&amp;rft.aulast=Ludwig&amp;rft.aufirst=J&amp;rft.au=Viggiano%2C+TR&amp;rft.au=McGill%2C+DB&amp;rft.au=Oh%2C+BJ&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Farrell2006-125"><span class="mw-cite-backlink">^ <a href="#cite_ref-Farrell2006_125-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Farrell2006_125-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Farrell2006_125-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFFarrellLarter2006" class="citation journal cs1">Farrell GC, Larter CZ (February 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.20973">"Nonalcoholic fatty liver disease: from steatosis to cirrhosis"</a>. <i>Hepatology</i>. <b>43</b> (2 Suppl 1): S99–S112. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.20973">10.1002/hep.20973</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16447287">16447287</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Nonalcoholic+fatty+liver+disease%3A+from+steatosis+to+cirrhosis&amp;rft.volume=43&amp;rft.issue=2+Suppl+1&amp;rft.pages=S99-S112&amp;rft.date=2006-02&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.20973&amp;rft_id=info%3Apmid%2F16447287&amp;rft.aulast=Farrell&amp;rft.aufirst=GC&amp;rft.au=Larter%2C+CZ&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhep.20973&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-126"><span class="mw-cite-backlink"><b><a href="#cite_ref-126">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFDrew2017" class="citation journal cs1">Drew L (October 2017). <a rel="nofollow" class="external text" href="https://doi.org/10.1038%2F550S101a">"Fatty liver disease: turning the tide"</a>. <i>Nature</i>. <b>550</b> (7675): S101. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1038%2F550S101a">10.1038/550S101a</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29019967">29019967</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature&amp;rft.atitle=Fatty+liver+disease%3A+turning+the+tide&amp;rft.volume=550&amp;rft.issue=7675&amp;rft.pages=S101&amp;rft.date=2017-10&amp;rft_id=info%3Adoi%2F10.1038%2F550S101a&amp;rft_id=info%3Apmid%2F29019967&amp;rft.aulast=Drew&amp;rft.aufirst=L&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1038%252F550S101a&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-127"><span class="mw-cite-backlink"><b><a href="#cite_ref-127">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation web cs1"><a rel="nofollow" class="external text" href="https://web.archive.org/web/20180425032329/http://www.boissonsrafraichissantes.com/consommation-et-nutrition/">"Consommation et Nutrition - Boissons Rafraichissantes de France"</a>. Archived from <a rel="nofollow" class="external text" href="http://www.boissonsrafraichissantes.com/consommation-et-nutrition/">the original</a> on 2018-04-25.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=unknown&amp;rft.btitle=Consommation+et+Nutrition+-+Boissons+Rafraichissantes+de+France&amp;rft_id=http%3A%2F%2Fwww.boissonsrafraichissantes.com%2Fconsommation-et-nutrition%2F&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-128"><span class="mw-cite-backlink"><b><a href="#cite_ref-128">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite class="citation news cs1">"Il était un foie le soda". No.&#160;5102. Le Canard Enchaîné. August 2018.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.atitle=Il+%C3%A9tait+un+foie+le+soda&amp;rft.issue=5102&amp;rft.date=2018-08&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Moran1983-129"><span class="mw-cite-backlink"><b><a href="#cite_ref-Moran1983_129-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMoranGhishanHalterGreene1983" class="citation journal cs1">Moran JR, Ghishan FK, Halter SA, Greene HL (June 1983). "Steatohepatitis in obese children: a cause of chronic liver dysfunction". <i>The American Journal of Gastroenterology</i>. <b>78</b> (6): 374–7. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/6859017">6859017</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=The+American+Journal+of+Gastroenterology&amp;rft.atitle=Steatohepatitis+in+obese+children%3A+a+cause+of+chronic+liver+dysfunction&amp;rft.volume=78&amp;rft.issue=6&amp;rft.pages=374-7&amp;rft.date=1983-06&amp;rft_id=info%3Apmid%2F6859017&amp;rft.aulast=Moran&amp;rft.aufirst=JR&amp;rft.au=Ghishan%2C+FK&amp;rft.au=Halter%2C+SA&amp;rft.au=Greene%2C+HL&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Temple2016-130"><span class="mw-cite-backlink">^ <a href="#cite_ref-Temple2016_130-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Temple2016_130-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Temple2016_130-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Temple2016_130-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Temple2016_130-4"><sup><i><b>e</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFTempleCorderoLiNguyen2016" class="citation journal cs1">Temple JL, Cordero P, Li J, Nguyen V, Oben JA (June 2016). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926480">"A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence"</a>. <i>International Journal of Molecular Sciences</i>. <b>17</b> (6): 947. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.3390%2Fijms17060947">10.3390/ijms17060947</a></span>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926480">4926480</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27314342">27314342</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=International+Journal+of+Molecular+Sciences&amp;rft.atitle=A+Guide+to+Non-Alcoholic+Fatty+Liver+Disease+in+Childhood+and+Adolescence&amp;rft.volume=17&amp;rft.issue=6&amp;rft.pages=947&amp;rft.date=2016-06&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4926480%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27314342&amp;rft_id=info%3Adoi%2F10.3390%2Fijms17060947&amp;rft.aulast=Temple&amp;rft.aufirst=JL&amp;rft.au=Cordero%2C+P&amp;rft.au=Li%2C+J&amp;rft.au=Nguyen%2C+V&amp;rft.au=Oben%2C+JA&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4926480&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Papandreou07-131"><span class="mw-cite-backlink"><b><a href="#cite_ref-Papandreou07_131-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPapandreouRoussoMavromichalis2007" class="citation journal cs1">Papandreou D, Rousso I, Mavromichalis I (August 2007). "Update on non-alcoholic fatty liver disease in children". <i>Clinical Nutrition</i>. <b>26</b> (4): 409–15. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.clnu.2007.02.002">10.1016/j.clnu.2007.02.002</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17449148">17449148</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Nutrition&amp;rft.atitle=Update+on+non-alcoholic+fatty+liver+disease+in+children&amp;rft.volume=26&amp;rft.issue=4&amp;rft.pages=409-15&amp;rft.date=2007-08&amp;rft_id=info%3Adoi%2F10.1016%2Fj.clnu.2007.02.002&amp;rft_id=info%3Apmid%2F17449148&amp;rft.aulast=Papandreou&amp;rft.aufirst=D&amp;rft.au=Rousso%2C+I&amp;rft.au=Mavromichalis%2C+I&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Cortez1999-132"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cortez1999_132-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFCortez-PintoCamiloBaptistaDe_Oliveira1999" class="citation journal cs1">Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC (December 1999). "Non-alcoholic fatty liver: another feature of the metabolic syndrome?". <i>Clinical Nutrition</i>. <b>18</b> (6): 353–8. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1016%2FS0261-5614%2899%2980015-6">10.1016/S0261-5614(99)80015-6</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/10634920">10634920</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Clinical+Nutrition&amp;rft.atitle=Non-alcoholic+fatty+liver%3A+another+feature+of+the+metabolic+syndrome%3F&amp;rft.volume=18&amp;rft.issue=6&amp;rft.pages=353-8&amp;rft.date=1999-12&amp;rft_id=info%3Adoi%2F10.1016%2FS0261-5614%2899%2980015-6&amp;rft_id=info%3Apmid%2F10634920&amp;rft.aulast=Cortez-Pinto&amp;rft.aufirst=H&amp;rft.au=Camilo%2C+ME&amp;rft.au=Baptista%2C+A&amp;rft.au=De+Oliveira%2C+AG&amp;rft.au=De+Moura%2C+MC&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Marchesini2001-133"><span class="mw-cite-backlink"><b><a href="#cite_ref-Marchesini2001_133-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFMarchesiniBriziBianchiTomassetti2001" class="citation journal cs1">Marchesini G, Brizi M, Bianchi G, Tomassetti S, Bugianesi E, Lenzi M,  et&#160;al. (August 2001). <a rel="nofollow" class="external text" href="https://doi.org/10.2337%2Fdiabetes.50.8.1844">"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome"</a>. <i>Diabetes</i>. <b>50</b> (8): 1844–50. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.2337%2Fdiabetes.50.8.1844">10.2337/diabetes.50.8.1844</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11473047">11473047</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Diabetes&amp;rft.atitle=Nonalcoholic+fatty+liver+disease%3A+a+feature+of+the+metabolic+syndrome&amp;rft.volume=50&amp;rft.issue=8&amp;rft.pages=1844-50&amp;rft.date=2001-08&amp;rft_id=info%3Adoi%2F10.2337%2Fdiabetes.50.8.1844&amp;rft_id=info%3Apmid%2F11473047&amp;rft.aulast=Marchesini&amp;rft.aufirst=G&amp;rft.au=Brizi%2C+M&amp;rft.au=Bianchi%2C+G&amp;rft.au=Tomassetti%2C+S&amp;rft.au=Bugianesi%2C+E&amp;rft.au=Lenzi%2C+M&amp;rft.au=McCullough%2C+AJ&amp;rft.au=Natale%2C+S&amp;rft.au=Forlani%2C+G&amp;rft.au=Melchionda%2C+N&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.2337%252Fdiabetes.50.8.1844&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Nobili06-134"><span class="mw-cite-backlink">^ <a href="#cite_ref-Nobili06_134-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Nobili06_134-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFNobiliMarcelliniDevitoCiampalini2006" class="citation journal cs1">Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D,  et&#160;al. (August 2006). <a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.21262">"NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice"</a>. <i>Hepatology</i>. <b>44</b> (2): 458–65. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1002%2Fhep.21262">10.1002/hep.21262</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/16871574">16871574</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=NAFLD+in+children%3A+a+prospective+clinical-pathological+study+and+effect+of+lifestyle+advice&amp;rft.volume=44&amp;rft.issue=2&amp;rft.pages=458-65&amp;rft.date=2006-08&amp;rft_id=info%3Adoi%2F10.1002%2Fhep.21262&amp;rft_id=info%3Apmid%2F16871574&amp;rft.aulast=Nobili&amp;rft.aufirst=V&amp;rft.au=Marcellini%2C+M&amp;rft.au=Devito%2C+R&amp;rft.au=Ciampalini%2C+P&amp;rft.au=Piemonte%2C+F&amp;rft.au=Comparcola%2C+D&amp;rft.au=Sartorelli%2C+MR&amp;rft.au=Angulo%2C+P&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1002%252Fhep.21262&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Pagano2002-135"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pagano2002_135-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFPaganoPaciniMussoGambino2002" class="citation journal cs1">Pagano G, Pacini G, Musso G, Gambino R, Mecca F, Depetris N,  et&#160;al. (February 2002). <a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fjhep.2002.30690">"Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association"</a>. <i>Hepatology</i>. <b>35</b> (2): 367–72. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1053%2Fjhep.2002.30690">10.1053/jhep.2002.30690</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/11826410">11826410</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Hepatology&amp;rft.atitle=Nonalcoholic+steatohepatitis%2C+insulin+resistance%2C+and+metabolic+syndrome%3A+further+evidence+for+an+etiologic+association&amp;rft.volume=35&amp;rft.issue=2&amp;rft.pages=367-72&amp;rft.date=2002-02&amp;rft_id=info%3Adoi%2F10.1053%2Fjhep.2002.30690&amp;rft_id=info%3Apmid%2F11826410&amp;rft.aulast=Pagano&amp;rft.aufirst=G&amp;rft.au=Pacini%2C+G&amp;rft.au=Musso%2C+G&amp;rft.au=Gambino%2C+R&amp;rft.au=Mecca%2C+F&amp;rft.au=Depetris%2C+N&amp;rft.au=Cassader%2C+M&amp;rft.au=David%2C+E&amp;rft.au=Cavallo-Perin%2C+P&amp;rft.au=Rizzetto%2C+M&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1053%252Fjhep.2002.30690&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Schwimmer2008-136"><span class="mw-cite-backlink"><b><a href="#cite_ref-Schwimmer2008_136-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFSchwimmerPardeeLavineBlumkin2008" class="citation journal cs1">Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S (July 2008). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996820">"Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease"</a>. <i>Circulation</i>. <b>118</b> (3): 277–83. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1161%2FCIRCULATIONAHA.107.739920">10.1161/CIRCULATIONAHA.107.739920</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996820">2996820</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/18591439">18591439</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Circulation&amp;rft.atitle=Cardiovascular+risk+factors+and+the+metabolic+syndrome+in+pediatric+nonalcoholic+fatty+liver+disease&amp;rft.volume=118&amp;rft.issue=3&amp;rft.pages=277-83&amp;rft.date=2008-07&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2996820%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F18591439&amp;rft_id=info%3Adoi%2F10.1161%2FCIRCULATIONAHA.107.739920&amp;rft.aulast=Schwimmer&amp;rft.aufirst=JB&amp;rft.au=Pardee%2C+PE&amp;rft.au=Lavine%2C+JE&amp;rft.au=Blumkin%2C+AK&amp;rft.au=Cook%2C+S&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2996820&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-Roberts07-137"><span class="mw-cite-backlink">^ <a href="#cite_ref-Roberts07_137-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Roberts07_137-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFRoberts2007" class="citation journal cs1">Roberts EA (June 2007). <a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2007.03.003">"Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?"</a>. <i>Journal of Hepatology</i>. <b>46</b> (6): 1133–42. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1016%2Fj.jhep.2007.03.003">10.1016/j.jhep.2007.03.003</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/17445934">17445934</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Hepatology&amp;rft.atitle=Pediatric+nonalcoholic+fatty+liver+disease+%28NAFLD%29%3A+a+%22growing%22+problem%3F&amp;rft.volume=46&amp;rft.issue=6&amp;rft.pages=1133-42&amp;rft.date=2007-06&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jhep.2007.03.003&amp;rft_id=info%3Apmid%2F17445934&amp;rft.aulast=Roberts&amp;rft.aufirst=EA&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1016%252Fj.jhep.2007.03.003&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-138"><span class="mw-cite-backlink"><b><a href="#cite_ref-138">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFGibsonLangDhawanFitzpatrick2017" class="citation journal cs1">Gibson PS, Lang S, Dhawan A, Fitzpatrick E, Blumfield ML, Truby H,  et&#160;al. (August 2017). <a rel="nofollow" class="external text" href="http://eprints.whiterose.ac.uk/116076/3/Gibson_Manuscript_080517_symplectic.pdf">"Systematic Review: Nutrition and Physical Activity in the Management of Paediatric Nonalcoholic Fatty Liver Disease"</a> <span class="cs1-format">(PDF)</span>. <i>Journal of Pediatric Gastroenterology and Nutrition</i>. <b>65</b> (2): 141–149. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1097%2FMPG.0000000000001624">10.1097/MPG.0000000000001624</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/28737568">28737568</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Journal+of+Pediatric+Gastroenterology+and+Nutrition&amp;rft.atitle=Systematic+Review%3A+Nutrition+and+Physical+Activity+in+the+Management+of+Paediatric+Nonalcoholic+Fatty+Liver+Disease&amp;rft.volume=65&amp;rft.issue=2&amp;rft.pages=141-149&amp;rft.date=2017-08&amp;rft_id=info%3Adoi%2F10.1097%2FMPG.0000000000001624&amp;rft_id=info%3Apmid%2F28737568&amp;rft.aulast=Gibson&amp;rft.aufirst=PS&amp;rft.au=Lang%2C+S&amp;rft.au=Dhawan%2C+A&amp;rft.au=Fitzpatrick%2C+E&amp;rft.au=Blumfield%2C+ML&amp;rft.au=Truby%2C+H&amp;rft.au=Hart%2C+KH&amp;rft.au=Moore%2C+JB&amp;rft_id=http%3A%2F%2Feprints.whiterose.ac.uk%2F116076%2F3%2FGibson_Manuscript_080517_symplectic.pdf&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-139"><span class="mw-cite-backlink"><b><a href="#cite_ref-139">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFWesolowskiKasmiJonscherFriedman2017" class="citation journal cs1">Wesolowski SR, Kasmi KC, Jonscher KR, Friedman JE (February 2017). <a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725959">"Developmental origins of NAFLD: a womb with a clue"</a>. <i>Nature Reviews. Gastroenterology &amp; Hepatology</i>. <b>14</b> (2): 81–96. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fnrgastro.2016.160">10.1038/nrgastro.2016.160</a>. <a href="/wiki/PMC_(identifier)" class="mw-redirect" title="PMC (identifier)">PMC</a>&#160;<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725959">5725959</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/27780972">27780972</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews.+Gastroenterology+%26+Hepatology&amp;rft.atitle=Developmental+origins+of+NAFLD%3A+a+womb+with+a+clue&amp;rft.volume=14&amp;rft.issue=2&amp;rft.pages=81-96&amp;rft.date=2017-02&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5725959%23id-name%3DPMC&amp;rft_id=info%3Apmid%2F27780972&amp;rft_id=info%3Adoi%2F10.1038%2Fnrgastro.2016.160&amp;rft.aulast=Wesolowski&amp;rft.aufirst=SR&amp;rft.au=Kasmi%2C+KC&amp;rft.au=Jonscher%2C+KR&amp;rft.au=Friedman%2C+JE&amp;rft_id=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC5725959&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-LIVERINTARAUJO2018-140"><span class="mw-cite-backlink"><b><a href="#cite_ref-LIVERINTARAUJO2018_140-0">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFAraújoRossoBedogniTiribelli2018" class="citation journal cs1 cs1-prop-long-vol">Araújo AR, Rosso N, Bedogni G, <a href="/wiki/Claudio_Tiribelli" title="Claudio Tiribelli">Tiribelli C</a>, Bellentani S (February 2018). <a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13643">"Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: What we need in the future"</a>. <i>Liver International</i>. 38 Suppl 1: 47–51. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<span class="cs1-lock-free" title="Freely accessible"><a rel="nofollow" class="external text" href="https://doi.org/10.1111%2Fliv.13643">10.1111/liv.13643</a></span>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/29427488">29427488</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Liver+International&amp;rft.atitle=Global+epidemiology+of+non-alcoholic+fatty+liver+disease%2Fnon-alcoholic+steatohepatitis%3A+What+we+need+in+the+future&amp;rft.volume=38+Suppl+1&amp;rft.pages=47-51&amp;rft.date=2018-02&amp;rft_id=info%3Adoi%2F10.1111%2Fliv.13643&amp;rft_id=info%3Apmid%2F29427488&amp;rft.aulast=Ara%C3%BAjo&amp;rft.aufirst=AR&amp;rft.au=Rosso%2C+N&amp;rft.au=Bedogni%2C+G&amp;rft.au=Tiribelli%2C+C&amp;rft.au=Bellentani%2C+S&amp;rft_id=https%3A%2F%2Fdoi.org%2F10.1111%252Fliv.13643&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
<li id="cite_note-141"><span class="mw-cite-backlink"><b><a href="#cite_ref-141">^</a></b></span> <span class="reference-text"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1133582631"><cite id="CITEREFVuppalanchiNoureddinAlkhouriSanyal2021" class="citation journal cs1">Vuppalanchi, Raj; Noureddin, Mazen; Alkhouri, Naim; Sanyal, Arun J. (June 2021). <a rel="nofollow" class="external text" href="https://www.nature.com/articles/s41575-020-00408-y">"Therapeutic pipeline in nonalcoholic steatohepatitis"</a>. <i>Nature Reviews Gastroenterology &amp; Hepatology</i>. <b>18</b> (6): 373–392. <a href="/wiki/Doi_(identifier)" class="mw-redirect" title="Doi (identifier)">doi</a>:<a rel="nofollow" class="external text" href="https://doi.org/10.1038%2Fs41575-020-00408-y">10.1038/s41575-020-00408-y</a>. <a href="/wiki/PMID_(identifier)" class="mw-redirect" title="PMID (identifier)">PMID</a>&#160;<a rel="nofollow" class="external text" href="https://pubmed.ncbi.nlm.nih.gov/33568794">33568794</a>. <a href="/wiki/S2CID_(identifier)" class="mw-redirect" title="S2CID (identifier)">S2CID</a>&#160;<a rel="nofollow" class="external text" href="https://api.semanticscholar.org/CorpusID:231859007">231859007</a>.</cite><span title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Nature+Reviews+Gastroenterology+%26+Hepatology&amp;rft.atitle=Therapeutic+pipeline+in+nonalcoholic+steatohepatitis&amp;rft.volume=18&amp;rft.issue=6&amp;rft.pages=373-392&amp;rft.date=2021-06&amp;rft_id=https%3A%2F%2Fapi.semanticscholar.org%2FCorpusID%3A231859007%23id-name%3DS2CID&amp;rft_id=info%3Apmid%2F33568794&amp;rft_id=info%3Adoi%2F10.1038%2Fs41575-020-00408-y&amp;rft.aulast=Vuppalanchi&amp;rft.aufirst=Raj&amp;rft.au=Noureddin%2C+Mazen&amp;rft.au=Alkhouri%2C+Naim&amp;rft.au=Sanyal%2C+Arun+J.&amp;rft_id=https%3A%2F%2Fwww.nature.com%2Farticles%2Fs41575-020-00408-y&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ANon-alcoholic+fatty+liver+disease" class="Z3988"></span></span>
</li>
</ol></div></div>
<h2><span class="mw-headline" id="External_links">External links</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;action=edit&amp;section=41" title="Edit section: External links">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<ul><li><a rel="nofollow" class="external text" href="https://web.archive.org/web/20110102082851/http://digestive.niddk.nih.gov/ddiseases/pubs/nash/">NIH</a> page on non-alcoholic steatohepatitis</li>
<li><a rel="nofollow" class="external text" href="https://www.mayoclinic.org/diseases-conditions/nonalcoholic-fatty-liver-disease/symptoms-causes/syc-20354567">Mayo Clinic</a> page on NAFLD</li></ul>
<div class="navbox-styles"><style data-mw-deduplicate="TemplateStyles:r1129693374">.mw-parser-output .hlist dl,.mw-parser-output .hlist ol,.mw-parser-output .hlist ul{margin:0;padding:0}.mw-parser-output .hlist dd,.mw-parser-output .hlist dt,.mw-parser-output .hlist li{margin:0;display:inline}.mw-parser-output .hlist.inline,.mw-parser-output .hlist.inline dl,.mw-parser-output .hlist.inline ol,.mw-parser-output .hlist.inline ul,.mw-parser-output .hlist dl dl,.mw-parser-output .hlist dl ol,.mw-parser-output .hlist dl ul,.mw-parser-output .hlist ol dl,.mw-parser-output .hlist ol ol,.mw-parser-output .hlist ol ul,.mw-parser-output .hlist ul dl,.mw-parser-output .hlist ul ol,.mw-parser-output .hlist ul ul{display:inline}.mw-parser-output .hlist .mw-empty-li{display:none}.mw-parser-output .hlist dt::after{content:": "}.mw-parser-output .hlist dd::after,.mw-parser-output .hlist li::after{content:" · ";font-weight:bold}.mw-parser-output .hlist dd:last-child::after,.mw-parser-output .hlist dt:last-child::after,.mw-parser-output .hlist li:last-child::after{content:none}.mw-parser-output .hlist dd dd:first-child::before,.mw-parser-output .hlist dd dt:first-child::before,.mw-parser-output .hlist dd li:first-child::before,.mw-parser-output .hlist dt dd:first-child::before,.mw-parser-output .hlist dt dt:first-child::before,.mw-parser-output .hlist dt li:first-child::before,.mw-parser-output .hlist li dd:first-child::before,.mw-parser-output .hlist li dt:first-child::before,.mw-parser-output .hlist li li:first-child::before{content:" (";font-weight:normal}.mw-parser-output .hlist dd dd:last-child::after,.mw-parser-output .hlist dd dt:last-child::after,.mw-parser-output .hlist dd li:last-child::after,.mw-parser-output .hlist dt dd:last-child::after,.mw-parser-output .hlist dt dt:last-child::after,.mw-parser-output .hlist dt li:last-child::after,.mw-parser-output .hlist li dd:last-child::after,.mw-parser-output .hlist li dt:last-child::after,.mw-parser-output .hlist li li:last-child::after{content:")";font-weight:normal}.mw-parser-output .hlist ol{counter-reset:listitem}.mw-parser-output .hlist ol>li{counter-increment:listitem}.mw-parser-output .hlist ol>li::before{content:" "counter(listitem)"\a0 "}.mw-parser-output .hlist dd ol>li:first-child::before,.mw-parser-output .hlist dt ol>li:first-child::before,.mw-parser-output .hlist li ol>li:first-child::before{content:" ("counter(listitem)"\a0 "}</style><style data-mw-deduplicate="TemplateStyles:r1061467846">.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}</style></div><div role="navigation" class="navbox" aria-labelledby="Diseases_of_the_digestive_system" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><style data-mw-deduplicate="TemplateStyles:r1063604349">.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}</style><div class="navbar plainlinks hlist navbar-mini"><ul><li class="nv-view"><a href="/wiki/Template:Digestive_system_diseases" title="Template:Digestive system diseases"><abbr title="View this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">v</abbr></a></li><li class="nv-talk"><a href="/wiki/Template_talk:Digestive_system_diseases" title="Template talk:Digestive system diseases"><abbr title="Discuss this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">t</abbr></a></li><li class="nv-edit"><a class="external text" href="https://en.wikipedia.org/w/index.php?title=Template:Digestive_system_diseases&amp;action=edit"><abbr title="Edit this template" style=";;background:none transparent;border:none;box-shadow:none;padding:0;">e</abbr></a></li></ul></div><div id="Diseases_of_the_digestive_system" style="font-size:114%;margin:0 4em">Diseases of the <a href="/wiki/Digestive_system" class="mw-redirect" title="Digestive system">digestive system</a></div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gastrointestinal_tract#Upper_gastrointestinal_tract" title="Gastrointestinal tract">Upper GI tract</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Esophageal_disease" title="Esophageal disease">Esophagus</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Esophagitis" title="Esophagitis">Esophagitis</a>
<ul><li><a href="/wiki/Esophageal_candidiasis" title="Esophageal candidiasis">Candidal</a></li>
<li><a href="/wiki/Eosinophilic_esophagitis" title="Eosinophilic esophagitis">Eosinophilic</a></li>
<li><a href="/wiki/Herpetiform_esophagitis" class="mw-redirect" title="Herpetiform esophagitis">Herpetiform</a></li></ul></li>
<li><i>Rupture</i>
<ul><li><a href="/wiki/Boerhaave_syndrome" class="mw-redirect" title="Boerhaave syndrome">Boerhaave syndrome</a></li>
<li><a href="/wiki/Mallory%E2%80%93Weiss_syndrome" title="Mallory–Weiss syndrome">Mallory–Weiss syndrome</a></li></ul></li>
<li><a href="/wiki/Upper_esophageal_sphincter" class="mw-redirect" title="Upper esophageal sphincter">UES</a>
<ul><li><a href="/wiki/Zenker%27s_diverticulum" title="Zenker&#39;s diverticulum">Zenker's diverticulum</a></li></ul></li>
<li><a href="/wiki/Lower_esophageal_sphincter" class="mw-redirect" title="Lower esophageal sphincter">LES</a>
<ul><li><a href="/wiki/Barrett%27s_esophagus" title="Barrett&#39;s esophagus">Barrett's esophagus</a></li></ul></li>
<li><a href="/wiki/Esophageal_motility_disorder" title="Esophageal motility disorder">Esophageal motility disorder</a>
<ul><li><a href="/wiki/Nutcracker_esophagus" title="Nutcracker esophagus">Nutcracker esophagus</a></li>
<li><a href="/wiki/Achalasia" class="mw-redirect" title="Achalasia">Achalasia</a></li>
<li><a href="/wiki/Esophagogastric_junction_outflow_obstruction" title="Esophagogastric junction outflow obstruction">Esophagogastric junction outflow obstruction</a></li>
<li><a href="/wiki/Diffuse_esophageal_spasm" title="Diffuse esophageal spasm">Diffuse esophageal spasm</a></li>
<li><a href="/wiki/Gastroesophageal_reflux_disease" title="Gastroesophageal reflux disease">Gastroesophageal reflux disease</a> (GERD)</li></ul></li>
<li><a href="/wiki/Laryngopharyngeal_reflux" title="Laryngopharyngeal reflux">Laryngopharyngeal reflux</a> (LPR)</li>
<li><a href="/wiki/Esophageal_stricture" title="Esophageal stricture">Esophageal stricture</a></li>
<li><a href="/wiki/Megaesophagus" title="Megaesophagus">Megaesophagus</a></li>
<li><a href="/wiki/Esophageal_intramural_pseudodiverticulosis" title="Esophageal intramural pseudodiverticulosis">Esophageal intramural pseudodiverticulosis</a></li>
<li><a href="/wiki/Acute_esophageal_necrosis" title="Acute esophageal necrosis">Acute esophageal necrosis</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Stomach_disease" title="Stomach disease">Stomach</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Gastritis" title="Gastritis">Gastritis</a>
<ul><li><a href="/wiki/Atrophic_gastritis" title="Atrophic gastritis">Atrophic</a></li>
<li><a href="/wiki/M%C3%A9n%C3%A9trier%27s_disease" title="Ménétrier&#39;s disease">Ménétrier's disease</a></li>
<li><a href="/wiki/Gastroenteritis" title="Gastroenteritis">Gastroenteritis</a></li></ul></li>
<li><a href="/wiki/Peptic_ulcer" class="mw-redirect" title="Peptic ulcer">Peptic (gastric) ulcer</a>
<ul><li><a href="/wiki/Cushing_ulcer" title="Cushing ulcer">Cushing ulcer</a></li>
<li><a href="/wiki/Dieulafoy%27s_lesion" title="Dieulafoy&#39;s lesion">Dieulafoy's lesion</a></li></ul></li>
<li><a href="/wiki/Dyspepsia" class="mw-redirect" title="Dyspepsia">Dyspepsia</a></li>
<li><a href="/wiki/Pyloric_stenosis" title="Pyloric stenosis">Pyloric stenosis</a></li>
<li><a href="/wiki/Achlorhydria" title="Achlorhydria">Achlorhydria</a></li>
<li><a href="/wiki/Gastroparesis" title="Gastroparesis">Gastroparesis</a></li>
<li><a href="/wiki/Gastroptosis" title="Gastroptosis">Gastroptosis</a></li>
<li><a href="/wiki/Portal_hypertensive_gastropathy" title="Portal hypertensive gastropathy">Portal hypertensive gastropathy</a></li>
<li><a href="/wiki/Gastric_antral_vascular_ectasia" title="Gastric antral vascular ectasia">Gastric antral vascular ectasia</a></li>
<li><a href="/wiki/Gastric_dumping_syndrome" class="mw-redirect" title="Gastric dumping syndrome">Gastric dumping syndrome</a></li>
<li><a href="/wiki/Gastric_volvulus" title="Gastric volvulus">Gastric volvulus</a></li>
<li><a href="/wiki/Buried_bumper_syndrome" title="Buried bumper syndrome">Buried bumper syndrome</a></li>
<li><a href="/wiki/Gastrinoma" title="Gastrinoma">Gastrinoma</a>
<ul><li><a href="/wiki/Zollinger%E2%80%93Ellison_syndrome" title="Zollinger–Ellison syndrome">Zollinger–Ellison syndrome</a></li></ul></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gastrointestinal_tract#Lower_gastrointestinal_tract" title="Gastrointestinal tract">Lower GI tract</a> <br /> <a href="/wiki/Enteropathy" title="Enteropathy">Enteropathy</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Small_intestine" title="Small intestine">Small intestine</a> <br /> (<a href="/wiki/Duodenum" title="Duodenum">Duodenum</a>/<a href="/wiki/Jejunum" title="Jejunum">Jejunum</a>/<a href="/wiki/Ileum" title="Ileum">Ileum</a>)</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Enteritis" title="Enteritis">Enteritis</a>
<ul><li><a href="/wiki/Duodenitis" title="Duodenitis">Duodenitis</a></li>
<li><a href="/wiki/Jejunitis" class="mw-redirect" title="Jejunitis">Jejunitis</a></li>
<li><a href="/wiki/Ileitis" title="Ileitis">Ileitis</a></li></ul></li>
<li><a href="/wiki/Peptic_ulcer" class="mw-redirect" title="Peptic ulcer">Peptic (duodenal) ulcer</a>
<ul><li><a href="/wiki/Curling%27s_ulcer" title="Curling&#39;s ulcer">Curling's ulcer</a></li></ul></li>
<li><a href="/wiki/Malabsorption" title="Malabsorption">Malabsorption</a>: <a href="/wiki/Coeliac_disease" title="Coeliac disease">Coeliac</a></li>
<li><a href="/wiki/Tropical_sprue" title="Tropical sprue">Tropical sprue</a></li>
<li><a href="/wiki/Blind_loop_syndrome" title="Blind loop syndrome">Blind loop syndrome</a></li>
<li><a href="/wiki/Small_intestinal_bacterial_overgrowth" title="Small intestinal bacterial overgrowth">Small intestinal bacterial overgrowth</a></li>
<li><a href="/wiki/Whipple%27s_disease" title="Whipple&#39;s disease">Whipple's</a></li>
<li><a href="/wiki/Short_bowel_syndrome" title="Short bowel syndrome">Short bowel syndrome</a></li>
<li><a href="/wiki/Steatorrhea" title="Steatorrhea">Steatorrhea</a></li>
<li><a href="/wiki/Milroy_disease" class="mw-redirect" title="Milroy disease">Milroy disease</a></li>
<li><a href="/wiki/Bile_acid_malabsorption" title="Bile acid malabsorption">Bile acid malabsorption</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Large_intestine" title="Large intestine">Large intestine</a> <br /> (<a href="/wiki/Vermiform_appendix" class="mw-redirect" title="Vermiform appendix">Appendix</a>/<a href="/wiki/Colon_(anatomy)" class="mw-redirect" title="Colon (anatomy)">Colon</a>)</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Appendicitis" title="Appendicitis">Appendicitis</a></li>
<li><a href="/wiki/Colitis" title="Colitis">Colitis</a>
<ul><li><a href="/wiki/Pseudomembranous_colitis" class="mw-redirect" title="Pseudomembranous colitis">Pseudomembranous</a></li>
<li><a href="/wiki/Ulcerative_colitis" title="Ulcerative colitis">Ulcerative</a></li>
<li><a href="/wiki/Ischemic_colitis" title="Ischemic colitis">Ischemic</a></li>
<li><a href="/wiki/Microscopic_colitis" title="Microscopic colitis">Microscopic</a></li>
<li><a href="/wiki/Collagenous_colitis" title="Collagenous colitis">Collagenous</a></li>
<li><a href="/wiki/Lymphocytic_colitis" title="Lymphocytic colitis">Lymphocytic</a></li></ul></li>
<li><a href="/wiki/Dysentery" title="Dysentery">Dysentery</a></li>
<li><a href="/wiki/Functional_colonic_disease" class="mw-redirect" title="Functional colonic disease">Functional colonic disease</a>
<ul><li><a href="/wiki/Irritable_bowel_syndrome" title="Irritable bowel syndrome">IBS</a></li>
<li><a href="/wiki/Intestinal_pseudoobstruction" class="mw-redirect" title="Intestinal pseudoobstruction">Intestinal pseudoobstruction</a>&#160;/ <a href="/wiki/Ogilvie_syndrome" title="Ogilvie syndrome">Ogilvie syndrome</a></li></ul></li>
<li><a href="/wiki/Megacolon" title="Megacolon">Megacolon</a>&#160;/ <a href="/wiki/Toxic_megacolon" title="Toxic megacolon">Toxic megacolon</a></li>
<li><a href="/wiki/Diverticulitis" title="Diverticulitis">Diverticulitis</a>/<a href="/wiki/Diverticulosis" title="Diverticulosis">Diverticulosis</a>/<a href="/wiki/Segmental_colitis_associated_with_diverticulosis" title="Segmental colitis associated with diverticulosis">SCAD</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Large and/or small</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Enterocolitis" title="Enterocolitis">Enterocolitis</a>
<ul><li><a href="/wiki/Necrotizing_enterocolitis" title="Necrotizing enterocolitis">Necrotizing</a></li></ul></li>
<li><a href="/wiki/Gastroenterocolitis" title="Gastroenterocolitis">Gastroenterocolitis</a></li>
<li><a href="/wiki/Inflammatory_bowel_disease" title="Inflammatory bowel disease">IBD</a>
<ul><li><a href="/wiki/Crohn%27s_disease" title="Crohn&#39;s disease">Crohn's disease</a></li></ul></li>
<li><i><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></i>: <a href="/wiki/Abdominal_angina" title="Abdominal angina">Abdominal angina</a></li>
<li><a href="/wiki/Mesenteric_ischemia" class="mw-redirect" title="Mesenteric ischemia">Mesenteric ischemia</a></li>
<li><a href="/wiki/Angiodysplasia" title="Angiodysplasia">Angiodysplasia</a></li>
<li><a href="/wiki/Bowel_obstruction" title="Bowel obstruction">Bowel obstruction</a>: <a href="/wiki/Ileus" title="Ileus">Ileus</a></li>
<li><a href="/wiki/Intussusception_(medical_disorder)" title="Intussusception (medical disorder)">Intussusception</a></li>
<li><a href="/wiki/Volvulus" title="Volvulus">Volvulus</a></li>
<li><a href="/wiki/Fecal_impaction" title="Fecal impaction">Fecal impaction</a></li>
<li><a href="/wiki/Constipation" title="Constipation">Constipation</a></li>
<li><a href="/wiki/Diarrhea" title="Diarrhea">Diarrhea</a>
<ul><li><a href="/wiki/Infectious_diarrhea" class="mw-redirect" title="Infectious diarrhea">Infectious</a></li></ul></li>
<li><a href="/wiki/Adhesion_(medicine)" title="Adhesion (medicine)">Intestinal adhesions</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Rectum" title="Rectum">Rectum</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Proctitis" title="Proctitis">Proctitis</a>
<ul><li><a href="/wiki/Radiation_proctitis" title="Radiation proctitis">Radiation proctitis</a></li></ul></li>
<li><a href="/wiki/Proctalgia_fugax" title="Proctalgia fugax">Proctalgia fugax</a></li>
<li><a href="/wiki/Rectal_prolapse" title="Rectal prolapse">Rectal prolapse</a></li>
<li><a href="/wiki/Anismus" title="Anismus">Anismus</a></li>
<li><a href="/wiki/Solitary_rectal_ulcer_syndrome" title="Solitary rectal ulcer syndrome">Solitary rectal ulcer syndrome</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Anal_canal" title="Anal canal">Anal canal</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Anal_fissure" title="Anal fissure">Anal fissure</a>/<a href="/wiki/Anal_fistula" title="Anal fistula">Anal fistula</a></li>
<li><a href="/wiki/Anal_abscess" class="mw-redirect" title="Anal abscess">Anal abscess</a></li>
<li><a href="/wiki/Hemorrhoid" title="Hemorrhoid">Hemorrhoid</a></li>
<li><a href="/wiki/Anal_dysplasia" title="Anal dysplasia">Anal dysplasia</a></li>
<li><a href="/wiki/Pruritus_ani" title="Pruritus ani">Pruritus ani</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gastrointestinal_bleeding" title="Gastrointestinal bleeding">GI bleeding</a></th><td class="navbox-list-with-group navbox-list navbox-even hlist" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Blood_in_stool" title="Blood in stool">Blood in stool</a></li>
<li><a href="/wiki/Upper_gastrointestinal_bleeding" title="Upper gastrointestinal bleeding">Upper</a>
<ul><li><a href="/wiki/Hematemesis" title="Hematemesis">Hematemesis</a></li>
<li><a href="/wiki/Melena" title="Melena">Melena</a></li></ul></li>
<li><a href="/wiki/Lower_gastrointestinal_bleeding" title="Lower gastrointestinal bleeding">Lower</a>
<ul><li><a href="/wiki/Hematochezia" title="Hematochezia">Hematochezia</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Accessory_digestive_gland" class="mw-redirect" title="Accessory digestive gland">Accessory</a></th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Liver_disease" title="Liver disease">Liver</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Hepatitis" title="Hepatitis">Hepatitis</a>
<ul><li><a href="/wiki/Viral_hepatitis" title="Viral hepatitis">Viral hepatitis</a></li>
<li><a href="/wiki/Autoimmune_hepatitis" title="Autoimmune hepatitis">Autoimmune hepatitis</a></li>
<li><a href="/wiki/Alcoholic_hepatitis" title="Alcoholic hepatitis">Alcoholic hepatitis</a></li></ul></li>
<li><a href="/wiki/Cirrhosis" title="Cirrhosis">Cirrhosis</a>
<ul><li><a href="/wiki/Primary_biliary_cirrhosis" class="mw-redirect" title="Primary biliary cirrhosis">PBC</a></li></ul></li>
<li><a href="/wiki/Fatty_liver" class="mw-redirect" title="Fatty liver">Fatty liver</a>
<ul><li><a class="mw-selflink selflink">NASH</a></li></ul></li>
<li><i><a href="/wiki/Vascular_disease" title="Vascular disease">Vascular</a></i>
<ul><li><a href="/wiki/Budd%E2%80%93Chiari_syndrome" title="Budd–Chiari syndrome">Budd–Chiari syndrome</a></li>
<li><a href="/wiki/Hepatic_veno-occlusive_disease" title="Hepatic veno-occlusive disease">Hepatic veno-occlusive disease</a></li>
<li><a href="/wiki/Portal_hypertension" title="Portal hypertension">Portal hypertension</a></li>
<li><a href="/wiki/Nutmeg_liver" class="mw-redirect" title="Nutmeg liver">Nutmeg liver</a></li></ul></li>
<li><a href="/wiki/Alcoholic_liver_disease" title="Alcoholic liver disease">Alcoholic liver disease</a></li>
<li><a href="/wiki/Liver_failure" title="Liver failure">Liver failure</a>
<ul><li><a href="/wiki/Hepatic_encephalopathy" title="Hepatic encephalopathy">Hepatic encephalopathy</a></li>
<li><a href="/wiki/Acute_liver_failure" title="Acute liver failure">Acute liver failure</a></li></ul></li>
<li><a href="/wiki/Liver_abscess" title="Liver abscess">Liver abscess</a>
<ul><li><a href="/wiki/Pyogenic_liver_abscess" title="Pyogenic liver abscess">Pyogenic</a></li>
<li><a href="/wiki/Amoebic_liver_abscess" title="Amoebic liver abscess">Amoebic</a></li></ul></li>
<li><a href="/wiki/Hepatorenal_syndrome" title="Hepatorenal syndrome">Hepatorenal syndrome</a></li>
<li><a href="/wiki/Peliosis_hepatis" title="Peliosis hepatis">Peliosis hepatis</a></li>
<li><a href="/wiki/Metabolic_disorder" title="Metabolic disorder">Metabolic disorders</a>
<ul><li><a href="/wiki/Wilson%27s_disease" title="Wilson&#39;s disease">Wilson's disease</a></li>
<li><a href="/wiki/Hemochromatosis" class="mw-redirect" title="Hemochromatosis">Hemochromatosis</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Gallbladder_disease" title="Gallbladder disease">Gallbladder</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Cholecystitis" title="Cholecystitis">Cholecystitis</a></li>
<li><a href="/wiki/Gallstone" title="Gallstone">Gallstone / Cholelithiasis</a></li>
<li><a href="/wiki/Cholesterolosis_of_gallbladder" title="Cholesterolosis of gallbladder">Cholesterolosis</a></li>
<li><a href="/wiki/Adenomyomatosis" title="Adenomyomatosis">Adenomyomatosis</a></li>
<li><a href="/wiki/Postcholecystectomy_syndrome" title="Postcholecystectomy syndrome">Postcholecystectomy syndrome</a></li>
<li><a href="/wiki/Porcelain_gallbladder" title="Porcelain gallbladder">Porcelain gallbladder</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Bile_duct" title="Bile duct">Bile duct</a>/ <br /> Other <a href="/wiki/Biliary_tree" class="mw-redirect" title="Biliary tree">biliary tree</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Cholangitis" class="mw-redirect" title="Cholangitis">Cholangitis</a>
<ul><li><a href="/wiki/Primary_sclerosing_cholangitis" title="Primary sclerosing cholangitis">Primary sclerosing cholangitis</a></li>
<li><a href="/wiki/Secondary_sclerosing_cholangitis" title="Secondary sclerosing cholangitis">Secondary sclerosing cholangitis</a></li>
<li><a href="/wiki/Ascending_cholangitis" title="Ascending cholangitis">Ascending</a></li></ul></li>
<li><a href="/wiki/Cholestasis" title="Cholestasis">Cholestasis</a>/<a href="/wiki/Mirizzi%27s_syndrome" title="Mirizzi&#39;s syndrome">Mirizzi's syndrome</a></li>
<li><a href="/wiki/Biliary_fistula" title="Biliary fistula">Biliary fistula</a></li>
<li><a href="/wiki/Haemobilia" title="Haemobilia">Haemobilia</a></li></ul>
<ul><li><i><a href="/wiki/Common_bile_duct" title="Common bile duct">Common bile duct</a></i>
<ul><li><a href="/wiki/Choledocholithiasis" class="mw-redirect" title="Choledocholithiasis">Choledocholithiasis</a></li>
<li><a href="/wiki/Biliary_dyskinesia" title="Biliary dyskinesia">Biliary dyskinesia</a></li></ul></li>
<li><a href="/wiki/Sphincter_of_Oddi_dysfunction" title="Sphincter of Oddi dysfunction">Sphincter of Oddi dysfunction</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Pancreatic_disease" title="Pancreatic disease">Pancreatic</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Pancreatitis" title="Pancreatitis">Pancreatitis</a>
<ul><li><a href="/wiki/Acute_pancreatitis" title="Acute pancreatitis">Acute</a></li>
<li><a href="/wiki/Chronic_pancreatitis" title="Chronic pancreatitis">Chronic</a></li>
<li><a href="/wiki/Hereditary_pancreatitis" title="Hereditary pancreatitis">Hereditary</a></li>
<li><a href="/wiki/Pancreatic_abscess" title="Pancreatic abscess">Pancreatic abscess</a></li></ul></li>
<li><a href="/wiki/Pancreatic_pseudocyst" title="Pancreatic pseudocyst">Pancreatic pseudocyst</a></li>
<li><a href="/wiki/Exocrine_pancreatic_insufficiency" title="Exocrine pancreatic insufficiency">Exocrine pancreatic insufficiency</a></li>
<li><a href="/wiki/Pancreatic_fistula" title="Pancreatic fistula">Pancreatic fistula</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list-with-group navbox-list navbox-odd hlist" style="width:100%;padding:0"><div style="padding:0 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th id="Hernia" scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Hernia" title="Hernia">Hernia</a></th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Diaphragmatic_hernia" title="Diaphragmatic hernia">Diaphragmatic</a>
<ul><li><a href="/wiki/Congenital_diaphragmatic_hernia" title="Congenital diaphragmatic hernia">Congenital</a></li></ul></li>
<li><a href="/wiki/Hiatus_hernia" class="mw-redirect" title="Hiatus hernia">Hiatus</a></li></ul>
<ul><li><a href="/wiki/Inguinal_hernia" title="Inguinal hernia">Inguinal</a>
<ul><li><a href="/wiki/Indirect_inguinal_hernia" class="mw-redirect" title="Indirect inguinal hernia">Indirect</a></li>
<li><a href="/wiki/Direct_inguinal_hernia" class="mw-redirect" title="Direct inguinal hernia">Direct</a></li></ul></li>
<li><a href="/wiki/Umbilical_hernia" title="Umbilical hernia">Umbilical</a></li>
<li><a href="/wiki/Femoral_hernia" title="Femoral hernia">Femoral</a></li>
<li><a href="/wiki/Obturator_hernia" title="Obturator hernia">Obturator</a></li>
<li><a href="/wiki/Spigelian_hernia" title="Spigelian hernia">Spigelian</a></li></ul>
<ul><li><i><a href="/wiki/Lumbar_hernia" class="mw-redirect" title="Lumbar hernia">Lumbar</a></i>
<ul><li><a href="/wiki/Petit%27s_hernia" title="Petit&#39;s hernia">Petit's</a></li>
<li><a href="/wiki/Grynfeltt%E2%80%93Lesshaft_hernia" title="Grynfeltt–Lesshaft hernia">Grynfeltt–Lesshaft</a></li></ul></li></ul>
<ul><li><i>Undefined location</i>
<ul><li><a href="/wiki/Incisional_hernia" title="Incisional hernia">Incisional</a></li>
<li><a href="/wiki/Internal_hernia" title="Internal hernia">Internal hernia</a></li>
<li><a href="/wiki/Richter%27s_hernia" title="Richter&#39;s hernia">Richter's</a></li></ul></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%"><a href="/wiki/Peritoneal_disease" class="mw-redirect" title="Peritoneal disease">Peritoneal</a></th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em">
<ul><li><a href="/wiki/Peritonitis" title="Peritonitis">Peritonitis</a>
<ul><li><a href="/wiki/Spontaneous_bacterial_peritonitis" title="Spontaneous bacterial peritonitis">Spontaneous bacterial peritonitis</a></li></ul></li>
<li><a href="/wiki/Hemoperitoneum" title="Hemoperitoneum">Hemoperitoneum</a></li>
<li><a href="/wiki/Pneumoperitoneum" title="Pneumoperitoneum">Pneumoperitoneum</a></li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table></div>
<div class="navbox-styles"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1061467846"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"><link rel="mw-deduplicated-inline-style" href="mw-data:TemplateStyles:r1129693374"></div><div role="navigation" class="navbox" aria-label="Navbox" style="width:100%; margin:0.5em 0 0.5em 0;;padding:3px"><table class="nowraplinks navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">Classification</th><td class="navbox-list-with-group navbox-list navbox-odd" style="width:100%;padding:0"><div style="padding:0 0.25em"><div style="position:relative; float:right; font-size:0.8em;"><a href="https://www.wikidata.org/wiki/Q1546498" class="extiw" title="d:Q1546498">D</a></div><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></b>: <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/K75.8">K75.8</a>, <a rel="nofollow" class="external text" href="https://icd.who.int/browse10/2019/en#/K76.0">K76.0</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10-CM" title="ICD-10-CM">10-CM</a></b>: <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/K75.81">K75.81</a>, <a rel="nofollow" class="external text" href="https://icdcodelookup.com/icd-10/codes/K76.0">K76.0</a></li><li><b><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" class="mw-redirect" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></b>: <a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=571.8">571.8</a></li><li><b><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></b>: <a rel="nofollow" class="external text" href="https://meshb.nlm.nih.gov/record/ui?ui=D065626">D065626</a></li><li><b><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></b>: <a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb29786.htm">29786</a></li></ul></div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%;background: #EAECF0">External resources</th><td class="navbox-list-with-group navbox-list navbox-even" style="width:100%;padding:0"><div style="padding:0 0.25em"><div class="hlist" style="text-align:left;"><ul><li><b><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></b>: <a rel="nofollow" class="external text" href="https://emedicine.medscape.com/med/775-overview">med/775</a></li></ul></div></div></td></tr></tbody></table></div>
<!-- 
NewPP limit report
Parsed by mw1358
Cached time: 20230621174439
Cache expiry: 1814400
Reduced expiry: false
Complications: [vary‐revision‐sha1, show‐toc]
CPU time usage: 2.541 seconds
Real time usage: 2.714 seconds
Preprocessor visited node count: 10614/1000000
Post‐expand include size: 475281/2097152 bytes
Template argument size: 5347/2097152 bytes
Highest expansion depth: 13/100
Expensive parser function count: 6/500
Unstrip recursion depth: 1/20
Unstrip post‐expand size: 568735/5000000 bytes
Lua time usage: 1.477/10.000 seconds
Lua memory usage: 8481040/52428800 bytes
Lua Profile:
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::callParserFunction      200 ms       13.2%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::match      160 ms       10.5%
    ?                                                                160 ms       10.5%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::plain      100 ms        6.6%
    <mw.lua:694>                                                      60 ms        3.9%
    safe_join <Module:Citation/CS1:897>                               60 ms        3.9%
    type                                                              60 ms        3.9%
    MediaWiki\Extension\Scribunto\Engines\LuaSandbox\LuaSandboxCallback::getEntityId       40 ms        2.6%
    concat                                                            40 ms        2.6%
    select_one <Module:Citation/CS1/Utilities:426>                    40 ms        2.6%
    [others]                                                         600 ms       39.5%
Number of Wikibase entities loaded: 0/400
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00% 2335.120      1 -total
 67.88% 1585.184      1 Template:Reflist
 52.43% 1224.308    133 Template:Cite_journal
  8.32%  194.193      6 Template:Navbox
  6.11%  142.752      1 Template:Gastroenterology
  4.26%   99.586      1 Template:Infobox_medical_condition_(new)
  3.56%   83.246      2 Template:Short_description
  3.45%   80.449      1 Template:Infobox
  2.21%   51.672     11 Template:Main_other
  2.15%   50.253      8 Template:Cite_web
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:6319906-0!canonical and timestamp 20230621174436 and revision id 1161272202. Rendering was triggered because: api-parse
 -->
</div><!--esi <esi:include src="/esitest-fa8a495983347898/content" /> --><noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript>
<div class="printfooter" data-nosnippet="">Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;oldid=1161272202">https://en.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;oldid=1161272202</a>"</div></div>
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Diseases_of_liver" title="Category:Diseases of liver">Diseases of liver</a></li><li><a href="/wiki/Category:Hepatitis" title="Category:Hepatitis">Hepatitis</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_French-language_sources_(fr)" title="Category:CS1 French-language sources (fr)">CS1 French-language sources (fr)</a></li><li><a href="/wiki/Category:CS1:_long_volume_value" title="Category:CS1: long volume value">CS1: long volume value</a></li><li><a href="/wiki/Category:Articles_with_short_description" title="Category:Articles with short description">Articles with short description</a></li><li><a href="/wiki/Category:Short_description_is_different_from_Wikidata" title="Category:Short description is different from Wikidata">Short description is different from Wikidata</a></li><li><a href="/wiki/Category:Good_articles" title="Category:Good articles">Good articles</a></li><li><a href="/wiki/Category:Articles_needing_additional_references_from_August_2022" title="Category:Articles needing additional references from August 2022">Articles needing additional references from August 2022</a></li><li><a href="/wiki/Category:All_articles_needing_additional_references" title="Category:All articles needing additional references">All articles needing additional references</a></li><li><a href="/wiki/Category:Articles_to_be_expanded_from_January_2022" title="Category:Articles to be expanded from January 2022">Articles to be expanded from January 2022</a></li><li><a href="/wiki/Category:All_articles_to_be_expanded" title="Category:All articles to be expanded">All articles to be expanded</a></li><li><a href="/wiki/Category:Articles_using_small_message_boxes" title="Category:Articles using small message boxes">Articles using small message boxes</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2018" title="Category:Articles containing potentially dated statements from 2018">Articles containing potentially dated statements from 2018</a></li><li><a href="/wiki/Category:All_articles_containing_potentially_dated_statements" title="Category:All articles containing potentially dated statements">All articles containing potentially dated statements</a></li><li><a href="/wiki/Category:Articles_containing_potentially_dated_statements_from_2021" title="Category:Articles containing potentially dated statements from 2021">Articles containing potentially dated statements from 2021</a></li></ul></div></div>
				</div>
			</main>
			
		</div>
		<div class="mw-footer-container">
			
<footer id="footer" class="mw-footer" role="contentinfo" >
	<ul id="footer-info">
	<li id="footer-info-lastmod"> This page was last edited on 21 June 2023, at 17:44<span class="anonymous-show">&#160;(UTC)</span>.</li>
	<li id="footer-info-copyright">Text is available under the <a rel="license" href="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons Attribution-ShareAlike License 4.0</a><a rel="license" href="//creativecommons.org/licenses/by-sa/4.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//foundation.wikimedia.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//foundation.wikimedia.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
</ul>

	<ul id="footer-places">
	<li id="footer-places-privacy"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Privacy_policy">Privacy policy</a></li>
	<li id="footer-places-about"><a href="/wiki/Wikipedia:About">About Wikipedia</a></li>
	<li id="footer-places-disclaimers"><a href="/wiki/Wikipedia:General_disclaimer">Disclaimers</a></li>
	<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
	<li id="footer-places-wm-codeofconduct"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Universal_Code_of_Conduct">Code of Conduct</a></li>
	<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Non-alcoholic_fatty_liver_disease&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
	<li id="footer-places-developers"><a href="https://developer.wikimedia.org">Developers</a></li>
	<li id="footer-places-statslink"><a href="https://stats.wikimedia.org/#/en.wikipedia.org">Statistics</a></li>
	<li id="footer-places-cookiestatement"><a href="https://foundation.wikimedia.org/wiki/Special:MyLanguage/Policy:Cookie_statement">Cookie statement</a></li>
</ul>

	<ul id="footer-icons" class="noprint">
	<li id="footer-copyrightico"><a href="https://wikimediafoundation.org/"><img src="/static/images/footer/wikimedia-button.png" srcset="/static/images/footer/wikimedia-button-1.5x.png 1.5x, /static/images/footer/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation" loading="lazy" /></a></li>
	<li id="footer-poweredbyico"><a href="https://www.mediawiki.org/"><img src="/static/images/footer/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/static/images/footer/poweredby_mediawiki_132x47.png 1.5x, /static/images/footer/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"></a></li>
</ul>

</footer>

		</div>
	</div> 
</div> 
<div class='vector-settings'>
	
<button
	id=""
	class="cdx-button cdx-button--icon-only vector-limited-width-toggle"
	><span class="vector-icon mw-ui-icon-fullScreen mw-ui-icon-wikimedia-fullScreen"></span>

<span>Toggle limited content width</span>

</button>

</div>
<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgHostname":"mw1455","wgBackendResponseTime":127,"wgPageParseReport":{"limitreport":{"cputime":"2.541","walltime":"2.714","ppvisitednodes":{"value":10614,"limit":1000000},"postexpandincludesize":{"value":475281,"limit":2097152},"templateargumentsize":{"value":5347,"limit":2097152},"expansiondepth":{"value":13,"limit":100},"expensivefunctioncount":{"value":6,"limit":500},"unstrip-depth":{"value":1,"limit":20},"unstrip-size":{"value":568735,"limit":5000000},"entityaccesscount":{"value":0,"limit":400},"timingprofile":["100.00% 2335.120      1 -total"," 67.88% 1585.184      1 Template:Reflist"," 52.43% 1224.308    133 Template:Cite_journal","  8.32%  194.193      6 Template:Navbox","  6.11%  142.752      1 Template:Gastroenterology","  4.26%   99.586      1 Template:Infobox_medical_condition_(new)","  3.56%   83.246      2 Template:Short_description","  3.45%   80.449      1 Template:Infobox","  2.21%   51.672     11 Template:Main_other","  2.15%   50.253      8 Template:Cite_web"]},"scribunto":{"limitreport-timeusage":{"value":"1.477","limit":"10.000"},"limitreport-memusage":{"value":8481040,"limit":52428800},"limitreport-profile":[["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::callParserFunction","200","13.2"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::match","160","10.5"],["?","160","10.5"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::plain","100","6.6"],["\u003Cmw.lua:694\u003E","60","3.9"],["safe_join \u003CModule:Citation/CS1:897\u003E","60","3.9"],["type","60","3.9"],["MediaWiki\\Extension\\Scribunto\\Engines\\LuaSandbox\\LuaSandboxCallback::getEntityId","40","2.6"],["concat","40","2.6"],["select_one \u003CModule:Citation/CS1/Utilities:426\u003E","40","2.6"],["[others]","600","39.5"]]},"cachereport":{"origin":"mw1358","timestamp":"20230621174439","ttl":1814400,"transientcontent":false}}});});</script>
<script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Non-alcoholic fatty liver disease","url":"https:\/\/en.wikipedia.org\/wiki\/Non-alcoholic_fatty_liver_disease","sameAs":"http:\/\/www.wikidata.org\/entity\/Q1546498","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q1546498","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-03-09T10:47:23Z","dateModified":"2023-06-21T17:44:32Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/7\/7b\/Stage_of_liver_damage_high.jpg","headline":"storing of excess fat in liver cells, not caused by heavy alcohol use"}</script><script type="application/ld+json">{"@context":"https:\/\/schema.org","@type":"Article","name":"Non-alcoholic fatty liver disease","url":"https:\/\/en.wikipedia.org\/wiki\/Non-alcoholic_fatty_liver_disease","sameAs":"http:\/\/www.wikidata.org\/entity\/Q1546498","mainEntity":"http:\/\/www.wikidata.org\/entity\/Q1546498","author":{"@type":"Organization","name":"Contributors to Wikimedia projects"},"publisher":{"@type":"Organization","name":"Wikimedia Foundation, Inc.","logo":{"@type":"ImageObject","url":"https:\/\/www.wikimedia.org\/static\/images\/wmf-hor-googpub.png"}},"datePublished":"2004-03-09T10:47:23Z","dateModified":"2023-06-21T17:44:32Z","image":"https:\/\/upload.wikimedia.org\/wikipedia\/commons\/7\/7b\/Stage_of_liver_damage_high.jpg","headline":"storing of excess fat in liver cells, not caused by heavy alcohol use"}</script>
</body>
</html>